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ABSTRACT

PLASMODIUM IMPAIRS ANTIBACTERIAL INNATE IMMUNITY TO SYSTEMIC
INFECTIONS IN PART THROUGH HEMOZOIN-BOUND BIOACTIVE
MOLECULES
Christopher L. Harding
June 13, 2020

Despite efforts to decrease the global health burden of malaria, infections with
Plasmodium species continue to cause over 200 million episodes of malaria each year which
resulted in 405,000 deaths in 2018 [1]. One complication of malaria is increased

susceptibility to invasive bacterial infections. Plasmodium infections impair host
immunity to non-Typhoid Salmonella (NTS) through activities of heme oxygenase I
(HO-I) )-induced release of immature granulocytes and myeloid cell-derived IL-10. Yet,
it is not known if these mechanisms are specific to NTS. We show here, that Plasmodium
yoelii 17XNL (Py) infected mice had impaired clearance of systemic Listeria
monocytogenes (Lm) during both acute parasitemia and up to 2 months after resolution
of Py infection that was independent of HO-I and IL-10. Py-infected mice were also
susceptible to Streptococcus pneumoniae (Sp) bacteremia, a common malaria-bacteria
coinfection, with higher blood and spleen bacterial burdens and decreased survival
compared to naïve mice. Mechanistically, impaired immunity to Sp was independent of
HO-I, but was dependent on Py-induced IL-10. Splenic phagocytes from Py infected
mice exhibit an impaired ability to restrict growth of intracellular Lm, and neutrophils
vi

from Py-infected mice produce less reactive oxygen species (ROS) in response to Lm or
Sp. Analysis also identified a defect in a serum component in Py infected mice that
contributes to reduced production of ROS in response to Sp. Finally, treating naïve mice
with Plasmodium-derived hemozoin (Hz) containing naturally bound bioactive
molecules, excluding DNA, impaired clearance of Lm. Collectively, we have
demonstrated that Plasmodium infection impairs host immunity to diverse bacteria,
including S. pneumoniae, through multiple effects on innate immunity, and that a
parasite-specific factor (Hz+bound bioactive molecules) directly contributes to
Plasmodium-induced suppression of antibacterial innate immunity.

IMPORTANCE Our findings provide evidence that there are multiple factors involved
in Plasmodium-induced suppression of antibacterial innate immunity. Given the
increased mortality rate associated with malaria and invasive bacterial coinfections, these
results may provide insight into new approaches to treat those individuals. Finally, this
report provides the first description, to our knowledge, of a murine model system of
Plasmodium and S. pneumoniae coinfection. In this model, Plasmodium infections impair
host immunity to S. pneumoniae, which resulted in increased mortality. As S.
pneumoniae is one of the most common bacteria identified in individuals with invasive
bacterial infections during malaria, this model has the potential to provide further
knowledge into the dynamics of this coinfection and identify approaches to treat this
coinfection.
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CHAPTER I
GENERAL INTRODUCTION AND METHODS

Malaria background
Despite the advances in vaccine development and treatments of infectious
diseases in recent years, protozoan parasites of the Plasmodium genus cause over 200
million cases of malaria each year and in 2018 resulted in an estimated 405,000 deaths.
The overwhelming majority of these fatal malaria cases occur in Africa (94% of total
fatalities 2018) and children under 5 years old are most susceptible (67% of deaths
worldwide in 2018) [1, 2]. Malaria is an ancient and widespread disease, caused by
infection with protozoan parasites of the Plasmodium genus. As one of the most
successful pathogens, Plasmodium has plagued humans for the entirety of our history,
with the disease being mentioned in historical writings of ancient societies in China,
India, Mesopotamia, Egypt and Greece [3]. Recent discoveries suggest that malaria
significantly pre-dates human history, as dinosaurs were almost certainly infected with
malaria-like parasites of the Paleohaemoproteus species. Supporting the theory that
malaria may have played a role in extinction of the dinosaurs, 100 million year-old fossils
of biting midge insect vectors have been found from the early Cretaceous period
containing P. burmacis parasites [4]. Almost 200 species of Plasmodium have been
described to date, infecting a wide variety of vertebrate hosts, including birds, reptiles,
and other mammals [5]. There are currently around 30 different species of Plasmodium
that are known to naturally infect non-human primates, and 5 are known to infect
1

humans, the most deadly of which is Plasmodium falciparum [6, 7]. Plasmodium
employs female Anopheles mosquitoes as primary hosts and vectors that transmit the
parasite to vertebrate secondary hosts while the mosquito acquires a bloodmeal [8].
As its name suggests, malarial disease was historically attributed to “bad air” due
to the early association between the disease and proximity to swamps and marshlands. In
1897, Ronald Ross was able to demonstrate presence of pigmented parasite structures
within mosquitos that had fed on blood of malaria patients, which then invaded the
mosquitos’ salivary glands [3]. The parasite stage found in mosquito salivary glands is
known as sporozoites, which are infectious to vertebrate hosts when transmitted by the
bite of an infected mosquito (Figure 1).

Figure 1. Lifecycle of Plasmodium Adapted from Michalakis and Renaud Nature 2009 “Malaria:
Evolution in vector control” [9]. a. Female Anopheles mosquitoes requires a blood meal for development
of their eggs. In the process, infected females inject the sporozoite form of the parasite into a human host.
b. Sporozoites are carried in the bloodstream to liver cells, where they proliferate asexually, and then, as
merozoites, invade red blood cells. c. Replication within red blood cells initiates the blood stage of malaria,
which manifests as fever and chills. This precedes the production of male and female gametocytes that are
transmitted back to a mosquito during a blood meal, where they fuse to form oocysts that divide to create
sporozoites. These migrate to the mosquito salivary glands, where the cycle of infection starts again.
Details of the life cycle differ for different species of Plasmodium. Development within the mosquito takes
10–14 days or longer.
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Parasite lifecycle and malaria disease
Within the human host, a small proportion of sporozoites exit the skin dermal
layer by migrating to and penetrating a blood vessel within 1-3 hours [10]. From there,
sporozoites travel through the bloodstream to the liver and actively transverse a capillary
barrier, called sinusoids, until suitable hepatocytes (liver cells) are invaded. Here they
undergo a process called schizogony, asexual reproduction where individual sporozoites
divide and differentiate into merozoite daughter cells [11]. The liver-stage of
Plasmodium’s lifecycle is clinically asymptomatic, making it an ideal target for vaccine
development. Despite significant efforts, to date there are still no highly effective
vaccines that target the liver stage [12]. Parasites within hepatocytes undergo schizogony
within a membrane-bound vesicle, known as merosomes, which develop for 10-12 days
in the liver during P. falciparum infection. Merosomes are released from hepatocytes
and enter the blood where they rupture and give rise to up 40,000 merozoites per
merosome. In the bloodstream merozoites go on to infect erythrocytes (red blood cells),
initiating the blood-stage of the Plasmodium lifecycle [13].
Blood-stage malaria consists of a chronic cycle of asexual schizogony where
merozoites infect a new erythrocyte, undergo multiple rounds of intracellular asexual
reproduction for a period of 48 hours. Infected erythrocytes exhibit synchronized
development and their simultaneous release from host cells and elicit a robust
inflammatory immune response [14]. This 48-hour lifecycle, combined with an apparent
ability to sense the hosts’ circadian rhythm, is thought to either increase chances for
transmission to a new mosquito vector [15, 16], or for optimal avoidance of host immune
responses when extracellular parasites are most vulnerable [17, 18]. This timed parasite
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release into the bloodstream is also responsible for the characteristic cycling fevers
generally associated with malaria.
Symptoms of uncomplicated malaria include bouts of fevers lasting 6 to 10 hours,
headaches, nausea and vomiting, as well as body aches and general malaise.
Manifestations of severe malaria are more likely to occur in children under 5 years old,
pregnant women, immune-compromised individuals such as those with HIV/AIDS, and
non-immune persons or travelers who have not had previous exposure to Plasmodium
[19]. The complications of severe malaria are often fatal and can materialize as cerebral
malaria, severe anemia, acute respiratory distress syndrome, and others related to
hyperparasitemia, which refers to a high proportion of infected red blood cells (greater
than 5% in humans) [20]. Enlargement and swelling of the liver and spleen are also
common and splenic rupture is possible, though quite rare. Since symptoms of malaria
do not differ significantly from many other infectious diseases, diagnosis of malaria
generally requires the demonstration of parasites in a blood smear [21]. Plasmodium
infections that are left untreated can last from several weeks to months, and prolonged
low-level (low parasitemia), asymptomatic infections can last several years with delays in
clinical symptoms as high as 2, 4, or even 8 years after exposure [22-24].

Malaria geography and burdens of disease

The geographical range of malarial disease is currently restricted to tropic and
subtropical regions (Figure 2). Global climate change threatens to increase vector
stability in regions that have had little to no transmission of malaria in the past century, as
the map below indicates for Europe (Figure 3).
4

Figure 2. Case incidence rate of malaria, 2018 (cases per 1,000 population at risk). Adapted from
World Malaria Report 2019

Among the many reasons that the massive efforts to “eradicate” malaria have
fallen short so far, the prevalence and persistence of the Anopheles mosquito vector,
maintenance of the parasite within its human reservoir (including asymptomatic
infections), and the emergence of drug and insecticide resistance represent major
challenges to Plasmodium eradication [25-29]. Malaria disproportionally impacts parts
of the world with the highest levels of poverty, which is clear when considering countries
that eradicated malaria in the second half of the 20th century had significantly higher
economic growth after eliminating the disease than their malaria plagued neighbors [30].
The debilitating effects of moderate and even mild malaria cases also have a major
negative impact on cognitive function, learning, and the number economic opportunities
individuals in malaria endemic regions are able to capitalize from [31, 32]. When
considering the economic burdens and time spent caring for infected individuals, the
consequences of malaria transmission are even greater.
5

Figure 3 Climate change models predict increase in vector stability in Europe. Adapted from Hertig
2019 (Parasit Vectors) [33].

Immune response during malaria
The clinical disease ‘malaria’ is mainly driven by the host’s inflammatory
immune response, where a carefully regulated effort is needed to be able to successfully
clear the parasite while also avoiding collateral damage of host tissues. Although the
host immune system recognizes infected hepatocytes, failure to eliminate every infected
hepatocyte results in progression to the blood-stage of infection [34]. At the onset of
parasite replication in the bloodstream, cells of the innate immune system recognize
molecular signatures of the parasite that activate them to either engulf and kill cell free
parasites and infected red blood cells (a process called phagocytosis), produce toxic
substances that kill Plasmodium, and attract other immune cells that function to eliminate
Plasmodium [35]. Innate cells such as dendritic cells and macrophages can act as antigen
presenting cells that communicate with the adaptive immune system by presenting pieces
of the parasite directly or produce chemical signals that help initiate an adaptive immune
response that will be developed specifically to the invading microorganism. Neutrophils,
also called polymorphonuclear neutrophils (PMN), respond to Plasmodium infection
6

through the release of reactive oxygen species (ROS) and granules, which are internal
compartments that store other toxic molecules capable of killing Plasmodium parasites
and other microorganisms [36]. While PMNs are quickly mobilized, they generally live
for 24 hours or less. In contrast, macrophages are long-lived cells capable of
phagocytosing and killing parasites and infected red blood cells [37]. Macrophages in the
spleen, an organ that functions to filter the blood, normally uptake and remove damaged
red blood cells. During Plasmodium infection macrophages phagocytose free parasites
and infected red blood cells, thereby preventing uncontrolled replication that would lead
to hyperparasitemia [38, 39].
Another aspect of the immune system that is involved in infections is the
complement system. Components of this system can bind pathogens directly causing
their destruction and send recruitment signals to attract immune cells. Infected cells or
pathogens bound with complement components are “tagged” for destruction by innate
immune cells. Complement also interacts and cooperate with antibodies as a separate
mechanism for improved pathogen neutralization [40]. While the innate immune system
protects the host from an overwhelming Plasmodium infection, efficient clearance of
Plasmodium is mediated by the ensuing adaptive immune system [41].

Malaria and secondary coinfections
In Plasmodium endemic areas, malaria was identified as a major risk factor for
developing bacteremia that correlated with a worse clinical outcome and higher
morbidity [42-49]. Evidence of bacterial coinfections with malaria have been found in
analysis of 4 heads of mummies from ancient Lower Egypt in ca. 800, where DNA
analysis found the co-occurrence of P. falciparum with Tuberculosis [50]. More
7

recently, in four separate clinical studies conducted in sub-Saharan Africa, between 4 and
23% of children with severe malaria had concomitant sepsis [42, 49, 51, 52]. A
population-based case study found that in a malaria-endemic region of Kenya, authors
estimated that malarial disease predisposed children to bacteremia and accounted for
more than half of all bacteremia cases [42]. Finally, a systematic review of clinical
studies revealed that African children (from 25 different studies in 11 different countries
that met criteria) with recent or acute malaria are at risk of bacterial infection and that
such coinfections resulted in increased risk of mortality [53]. Gastrointestinal and
pulmonary bacterial pathogens such as non-typhoid Salmonella (NTS) and Streptococcus
pneumoniae (Sp), respectively, are the most common organisms isolated from blood of
Plasmodium-bacteria co-infected individuals [42, 45, 49, 51, 52, 54, 55].
A 2010 meta-review of invasive bacterial infections in Africa reported that across
all studies having appropriate diagnostic methods, approximately 6.5% of patients with
Plasmodium positive blood smears also had a concomitant bloodstream fungal or
bacterial infection [45]. Several clinical reports have identified NTS as the most
prevalent bacterial pathogen isolated in blood of malaria patients and some also mention
that this trend is especially prominent during rainy seasons, when transmission of
Plasmodium falciparum is more frequent [56]. Clinicians also observed a difference in
the pathogenic nature of NTS infections occurring simultaneously with malaria.
Normally, NTS infections are limited to the gastrointestinal tract and result in overt
diarrheal disease with little to no systemic invasion to other tissues due to control of
infection via the innate immune response [57]. However, during coinfection with
Plasmodium, NTS is able to colonize the intestines and disseminate systemically,
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resulting in bacteremia [58]. The recognition of strong correlation between malaria and
invasive bacterial infections from analysis of clinical observations has provided
researchers with sufficient rationale to investigate the mechanisms by which Plasmodium
infection increases host susceptibility to NTS. Currently, studies conducted with both
mouse models of malaria and samples from malaria patients suggest that enhanced
susceptibility to NTS is due to hemolysis and anemia related to the parasite infection, but
have not identified a parasite factor to be involved [59-64].

Other malaria coinfections:
Other than NTS and Sp coinfections with malaria, the incidence of malaria with
several other concomitant bacterial, viral, fungal, and protozoan pathogens have been
reported. A long history of malaria occurring simultaneously with Tuberculosis is
indicated by researchers who have found evidence of this coinfection during molecular
analysis of Egyptian mummy remains [50]. Although incidence of malaria is
geographically associated with rural areas and tuberculosis is more prevalent in areas
with higher population density, there are reports of malaria occurring in 3% of
tuberculosis patients in an epidemiological study in Tanzania and another in Angola
demonstrated malaria coinfections in over 37% of tuberculosis patients [65, 66]. Finally,
a study in Guinea-Bissau found that malaria was associated in an increased mortality in
tuberculosis infected individuals and showed an improved outcome for tuberculosis
patients when transmission of malaria was prevented [48]. Given the general endemicity
of malaria and tuberculosis, studies have been conducted to determine the interaction
between the Mycobacterium bovis (BCG) vaccine strain, or the fully virulent
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Mycobacterium tuberculosis, which causes human tuberculosis disease, and immunity to
malaria. While some studies demonstrated that BCG conferred protection against a
normally lethal Plasmodium strain in a murine model, others have shown either enhanced
severity of malaria or exacerbation of acute BCG infection or M. tuberculosis (see Table
1) [67].
Table 1. Malaria-Tuberculosis coinfection studies in murine models. These studies suggest tuberculosis
infection can modulate immune response to subsequent Plasmodium infection and influence the clinical
outcome. Adapted from dissertation of R. Frita, 2014 University of Lisbon, “Malaria and Tuberculosis
coinfection: a role for Hemozoin immunosuppression”

Other respiratory bacterial infections such as Haemophilus influenzae,
Staphylococcus aureus, and Pseudomonas aeruginosa or gastroenteric pathogens like E.
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coli and cholera have been identified in patients with malaria, but these coinfections are
not as commonly detected as NTS, Sp or tuberculosis – mentioned above.

Malaria HIV coinfections
With the multitude of information known about immune suppression and
increased susceptibility to secondary infections in HIV positive individuals, and the large
overlap in geographical endemicity of HIV and malaria, it is crucial to understand the
interactions between the two pathogens and how they may influence an individual’s
immune response to an invasive bacterial infection. It has been demonstrated that
malaria can enhance viral replication in HIV coinfections and reactivate latent infection
[68-70]. Malaria-driven cytokine responses and inflammation contribute to this by
inducing the activation of CD4+ T cells and rendering them more susceptible to viral
invasion and replication [69]. This coinfection was associated with higher viral loads in a
clinical study in rural Malawi and East sub-Saharan Africa [69, 71]. It has also been
shown in vitro that treatment with the parasite by-product, hemozoin, increases the HIV
RNA load in human peripheral blood mononuclear cells (PBMCs), as well as lead to
functional defects in monocyte-derived DCs and monocytes which impede maturation
and promote transfer of HIV-1 to CD4+ T-cells [72-74].
In respect to the work exhibited here, due to the widespread incidence of HIV in
sub-Saharan Africa, it will be important for future studies to examine how HIV and AIDS
complicates and likely further impairs immunity to bacterial coinfections during malaria.
It would also be diligent of clinicians to make an intentional effort to test for and report
HIV status, tuberculosis infection, and any acute or recent malaria episodes when
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accumulating data or presenting clinical reports. This information is important to provide
researchers with a more complete picture of the interplay between these three highly
endemic pathogens so that we may design more appropriate studies to explore their
complex interactions and mechanisms of manipulating host immunity to invasive
bacterial diseases.
The risk of developing bacterial sepsis is significantly higher in individuals with
severe malaria and this combination is associated with increased mortality [49, 75, 76].
This major global health problem is compounded by the lack of availability of accurate
testing in malaria endemic areas. Additionally, while malaria is commonly over
diagnosed, only one third of cases of invasive bacterial disease are accurately diagnosed,
leading to the misuse of antibiotic treatments [75]. Aside from the difficulties of
obtaining the information in the clinic for optimal treatment of patients with these
coinfections, there is a fundamental lack of understanding of the mechanisms that
increase host susceptibility to invasive bacterial disease during malaria. The aim of this
work is to expand our knowledge of the factors by which the Plasmodium parasites
impair host immunity to bacterial coinfections, and expand beyond what has already been
learned about coinfections with non-Typhoid Salmonella. In this work I also seek to
provide evidence that the parasite factor, hemozoin, contributes to impaired bacterial
immunity, introduce a novel method of hemozoin isolation and the first murine model of
Plasmodium Pneumococcal coinfection. Scientific efforts in all fields related to malaria
are of critical importance considering the inextricable connection between this disease
and poverty human suffering. A temporally suitable comparison can be made between the
current pandemic with COVID-19 which has had major global consequences. At the time
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this is written, there are nearly 7.5 million confirmed cases and 420,000 deaths from
COVID-19 worldwide, while in 2018 malaria infected 200 million people and killed over
400,000 people [2, 77]. Although the mortality rate of COV-SARS2 is considerably
higher, this comparison offers a useful way to reflect on the overall public health burden
of malaria. For these reasons, it is essential that we improve the public health of the
impoverished communities most heavily affected by conducting research that aims to
understand the interactions between Plasmodium and host immunity, as well as the other
comorbidities and factors that influence malaria-related morbidity.

13

Materials and Methods
Mice
Female C57BL/6N mice 6-12 weeks old were obtained from Charles River Laboratories
(Wilmington, MA) and housed at the University of Louisville under appropriate biosafety
level conditions. All mice were housed in a specific pathogen-free facility and
acclimatized for a minimum of 7 days before starting experiments. Male mice are
generally more prone to higher parasitemia, more severe Plasmodium infections, and
often become moribund [78-80]. Since we are not interested in gender differences, and to
have more comparable groups, only female mice will be used for all experiments
Animals were fed the NIH-31 diet (Modified Open Formula Mouse/Rat Irradiated Diet;
Harlan 7913; Envigo, Indianapolis, IN) and provided autoclaved, non-acidified reverseosmosis water ad libitum. The mice were kept on a 12-hour light/dark cycle from 6 AM
to 6PM and 6PM to 6AM, respectively. All animal handling and experimentation were
reviewed and approved by the University of Louisville Institutional Animal Care and Use
Committee based on the recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.

Infections
Plasmodium yoelii: Mice were infected i.v. with 5x106 parasitized red blood cells
(pRBC) Plasmodium yoelii 17XNL (Py). Parasitemia (% of infected red blood cells) was
determined by analyzing samples of peripheral blood obtained from day 5 post Py
infection and alternating days afterward until mice cleared the infection. Blood samples
were fixed in 0.02% glutaraldehyde and stained with antibodies specific to CD45-APC
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(clone 104) and Ly-76 (clone Ter119) from Biolegend (San Diego, CA) and dyes
dihydroethidium, and Hoechst 33342 (Sigma-Aldrich, St. Louis, MO). Parasitemia was
analyzed with flow cytometry using a BD Fortessa, where pRBCs were identified as the
population of CD45- , Ter119+, dihydroethidium+, Hoechst+ cells. All flow cytometry
data was analyzed with FlowJo software.
Plasmodium berghei: Mice were infected via intraperitoneal injection with 1x104
pRBCs of strain NK65 or mutants obtained from peripheral blood preparations of
infected donor mice. In the NK65 infections were initiated with wild type, Δdpap, Δpm4
strains kindly provided by Dr. Phileppe Van den Steen at University of Leuven, Belgium
[81]. Parasitemia was tracked on days 6, 7, and 9 post infection and Lm infection was
initiated as with Py coinfections, on day 7 post Pb. Parasite burdens were determined as
described for Py.
Listeria monocytogenes: Strain 1043S actA-deficient Listeria monocytogenes, or
1043S wild type, were grown from freezer stock aliquot in tryptic soy broth and then
washed with PBS and resuspended in sterile saline. Mice were infected i.v. with
5x106(ActA-), or 1x104(wildtype 1043S) CFU on indicated days post Py infection or as
an initial infection in age-matched mice.
Streptococcus pneumoniae: S. pneumoniae (Sp) ATCC strain 6303, a type 3
capsule isolate cultures were started from freezer stocks and grown in brain heart infusion
broth containing 50mM HEPES buffer and incubated statically at 37˚C with 5% CO2.
Cultures were washed in PBS and resuspended in sterile saline. Mice were infected with
1x106 CFU of Sp intranasally to naïve mice or Py infected mice on day 7 post Py
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infection in a volume of 30μl. Inoculum dose was confirmed by plating serial dilutions
on blood agar and counting colonies after 12 to 18 hours of growth at 37˚C with 5% CO2.
Salmonella enterica serovar Typhimurium (NTS): Frozen aliquots of Salmonella
enterica serovar Typhimurium strain 12023 were thawed and resuspended in LB broth
and grown shaking at 37˚C. Cultures were then washed in sterile 1X PBS and
resuspended in sterile saline. Mice were infected on day 10 post Py infection via
intraperitoneal injection of 1x103 cfu in 200μl. Inoculum dose was verified by plating
serial dilutions on LB agar containing 50μg/mL carbenicillin.

Bacterial burden quantification analysis
Spleens and livers from Lm infected mice were collected in 0.2% IGEPAL
(Sigma Aldrich, St. Louis, MO) at the indicated time points. Organs were homogenized
and plated in serial dilutions on tryptic soy agar plates with 50 μg/mL streptomycin.
Lungs and spleens from Sp infected mice were collected in sterile 1X PBS. Organs were
homogenized and plated in serial dilutions on tryptic soy agar plates supplemented with
10% sheep blood (company, city state). Peripheral blood was collected via retro-orbital
bleed and plated directly on tryptic soy agar plates with 10% sheep blood agar. For
analysis of bacterial burdens in NTS infections, peripheral blood and organ homogenates
were plated in serial dilutions on LB agar plates containing 50μg/mL carbenicillin.
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In vivo Inhibition of IL-10 and HO-1
Py-infected and naïve mice were injected i.p. with 300, 200, and 100μg of rat
anti-IL-10 IgG1 kapa monoclonal antibody (clone JES5-2A5) or rat anti-horseradish
peroxidase IgG1 isotype control (InVivoMAb, West Lebanon, NH) in 0.2 mL sterile
saline on days Py+6, 7, and 8 for Lm coinfection (day Lm -1, 0, and +1), days Py+7, 8,
and 9 for Sp coinfection (day Sp -1, 0, and +1), and days Py+9, 10, and 11 (days NTS -1,
0, +1) for NTS coinfections. Similarly, Py-infected and naïve mice were treated i.p. with
40μmol/kg Tin Protoporphyrin IX (chloride) (Sn PP) (Cayman Chemical, Ann Arbor,
MI) in 0.2mL 1X PBS on days Py+5, 6, 7, and 8 for Lm coinfection (day Lm -2, -1, 0,
and +1), days Py+6, 7, 8, and 9 for Sp coinfection (day Sp -2, -1, 0, and +1), and days
Py+8, +9, 10, and 11 (days NTS -2, -1, 0, +1) for NTS coinfections.

In vivo IFNγ inhibition and recombinant IFNγ treatments
Neutralization of IFNγ activity was achieved by treating mice with i.p. injections
of 0.5mg anti-IFNγ monoclonal antibody (clone XMG1.2) (InVivoMAb) suspended in
0.2ml sterile saline 8 hours before Lm infection and 1- and 2- days post Lm infection.
Treatment was only given to Lm only groups, while a separate Lm only and coinfected
groups were given i.p. injections of 0.2ml sterile saline. In contrast, 0.5 mg of
recombinant IFNγ (Abcam, Cambridge, MA) was given to coinfected mice in 3 separate
i.p. injections in 0.2ml sterile saline 8 hours before Lm infection and also 1- and 2- days
post Lm.
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Splenic myeloid cell analysis
Spleens were removed on the indicated days post Py infection or from agematched naïve mice and placed in HyClone RPMI 1640 (Thermo Fisher Scientific,
Waltham, MA) supplemented with 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA), 1.19 mg/ml HEPES (Corning, New York, NY), 0.2 mg/ml Lglutamine (Research Products International, Mt. Prospect, IL), 0.05M 2-mercaptoethanol
(Thermo Fisher Scientific), 0.05 mg/mL penicillin/streptomycin (Invitrogen, Grand
Island, NY), and 0.05 mg/mL gentamicin (Corning). Single cell suspensions were treated
with ammonium chloride potassium solution (0.15 mM NH4Cl, 1.0 mM KHCO3, 0.1 mM
Na2 EDTA, 1 N HCl) to lyse red blood cells and then washed in RPMI then resuspended
in FACS buffer (1XPBS, 1%FBS, 0.02% sodium azide) containing Fc block (antiCD16/32; clone 2.4G2). Splenocytes were then stained with cell surface marker-specific
antibodies. Anti-CD3ϵ FITC (clone 145-2C11), anti-CD19 FITC (clone 6D5), antiCD11b PE/Cy7 (clone M1/70), anti-CD11c BV650 (clone N418), anti-Ly-6G BV421
(clone 1A8), anti-Ly-6C PerCP/Cy5.5 (clone AL-21), anti-F4/80 PE Dazzle 594 (clone
BM8) were from Biolegend (San Diego, CA). Anti-CD209b APC (clone eBio 22D1),
anti-CD169 (clone SER-4) were from eBiosciences (San Diego, CA). Anti-SIGLEC-F
APC R700 (clone E50-2240) was from BD Pharmingen (San Diego, CA). Cells were
incubated with antibodies at 4˚C for 15 minutes. Cells were then fixed in 4%
paraformaldehyde fixation buffer (Biolegend) and then washed three times in FACS
buffer before being analyzed on a BD LSRFortessa.

18

Spleen phagocytic cell isolation and intracellular bacterial survival assay
Single cell suspensions from 3 naïve or Py infected mice were generated as
described above and pooled together. Splenic phagocytes were enriched by negative
depletion of CD3+ and CD19+ cells using anti-CD3ϵ and anti-CD19 microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany), according to manufacturer recommendations.
CD3- and CD19- flow through cells were stained with anti-CD11b PE/Cy7 (clone M1/70)
and CD11c APC (clone N418) from Biolegend (San Diego, CA). CD11bhi/CD11c- cells
were sort purified with a BD FACSAria III. Sorted cells were plated and incubated at
37˚C with 5% CO2 for 1 hour. For some experiments, cells from naïve mice were
incubated for 30 minutes with 30μg Py hemozoin (PyHz). Sorted cells were infected with
Lm that had been opsonized by incubating in RPMI with 10% homologous mouse serum
(naïve cells + Lm opsonized with naïve serum; Py cells + Lm opsonized with Py serum)
rotating for 30 minutes at 37˚C. Bacteria was washed once in RPMI and cells were
infected with a multiplicity of infection (MOI)=100. One hour after the infection, media
was removed from cells and replaced with RPMI containing 5 µg/mL gentamicin to kill
extracellular Lm. Intracellular Lm burden was determined after 1 hour and 4 hours of
incubation in RPMI with gentamicin by removing the media containing gentamicin and
resuspending the cells in sterile deionized H2O (dH2O) to lyse cells and release surviving
Lm. Fold change in intracellular Lm was determined by dividing cfu at 4 hours post
infection by cfu/well at 1 hours after the addition of gentamicin.
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Microscopy
Cells were from either peripheral blood, obtained through tail snip, or spleen or
liver single cells isolated and passed through a 100-micron pore size nylon mesh. In some
experiments, CD11bhi/CD11c- cells were sort purified from T cell and B cell depleted
spleen samples. Blood samples were smeared on a glass slide and allowed to dry, spleen
and liver cells were placed onto a glass slide in a drop of RPMI containing 15% mouse
serum and incubated at 37˚C with 5% CO2 for 30 minutes to allow cells to adhere. For all
samples, cells were fixed in methanol for 20 minutes and stained with Giemsa dye (Azer
Scientific, Morgantown, PA) for 20 minutes and rinsed with ddH2O. In some cases, cells
were incubated with Hz as described above and Hz is visible as brown pigment. Images
were obtained with a Nikon eclipse Ci light microscope at 100X magnification or a Zeiss
Axio Imager .A1 microscope with an AxioCam MRm digital camera (Zeiss) at 63 or 96X
in oil emersion. Scale bars were estimated based on average diameter of murine
erythrocytes (Nikon) or with Axiovision SE64 imaging software (Carl Zeiss Microscopy,
LLC, White Plains, NY).

Isolation of P. yoelii-derived hemozoin (PyHz)
Livers and spleens were obtained from mice previously infected with Py after
clearance of the parasite infection, between 30- and 65-days post-infection. Organs were
collected and homogenized with a tissue homogenizer in de-ionized H2O (dH2O) and
kept on ice for 1 hour. Homogenates were centrifuged at 3100 x g for 10 minutes. Pellets
were washed twice in dH2O and passed through 100-micron nylon mesh (ELKO Filtering
Co.). Flow-through was collected, washed and resuspended in sterile PBS before being
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added to the top of a discontinuous Percoll density gradient containing 40% (1.07g/mL)
and 80%(1.12g/mL) fractions. Gradients were centrifuged at 5,000 x g for 20 minutes
with slow acceleration/deceleration at 4˚C. Hemozoin from Py infected mouse organs
(PyHz) was collected from the interphase between the 40% and 80% fractions, as well as
from the dark pellet beneath the 80% fraction. Samples were washed twice in dH2O and
finally resuspended in sterile PBS. Purification of ‘clean’ PyHz was performed for some
experiments with a method adapted from Coban et al. [82], where organ homogenate was
lysed in 0.2% IGPAL and washed 3-4 times in 2% sodium dodecyl sulfate (SDS) and
then incubated overnight in 10mM Tris-HCl (pH 8.0), 0.5% SDS, 1mM CaCl2, and
2mg/mL proteinase K at 37˚C. Next, samples were washed again in 2% SDS and then
incubated at 37˚C for 3 hours in 6M urea, washed in 1X PBS and resuspended in saline
for experimental use. For quantification of Hz in mouse tissues, organs were
homogenized and incubated in 1% Proteinase K (VWR, Solon, OH) overnight at 37˚C.
Hz was quantified using a protocol adapted from Deroost, et al., 2012 [83]. Briefly, Hz
was centrifuged at 3100 x g and pellets were washed three times in 100mM NaHCO3, pH
9.0 with 2% SDS. Hz, and a dilution series of synthetic hemozoin (InVivoGen, San
Diego, CA) of known concentration, were resuspended in 100mM NaOH, 2% SDS, 3mM
EDTA and then sonicated for 5 minutes before incubating for 30 minutes at room temp to
dissolve hemozoin into soluble heme. Quantification was determined by reading
absorbance at OD400 and comparing values of samples prepared from Py-infected mouse
organs to the synthetic Hz standards. For some experiments, PyHz was incubated at 37˚C
in 100 U/mL DNase with 1mM CaCl2 and 2mM MgCl2 for 2 hours. These samples were
then washed twice in 2mM mannitol-containing phosphate buffer and resuspended in
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sterile saline. Absence of DNA in PyHz sample was verified by staining with GelRed
Nucleic Acid stain and running samples on 1% agarose gel.

Plasmodium falciparum culture and preparation of hemozoin
Natural P. falciparum hemozoin (PfHZ) was prepared from in vitro human
erythrocytes cultures infected with P. falciparum (Palo Alto strain, mycoplasma-free)
treated with DNase (Sigma, St. Louis, MO). Contamination with endotoxin (LPS) was
excluded by E-Toxate assay (Sigma, St. Louis, MO), as previously described [84].
Briefly, synchronized parasite cultures were supplemented with DNase (5 U/ml) 12-15
hours previous to schizogony. PfHZ which was naturally expelled during schizogony,
was harvested at the 25/40% interface of a discontinuous percoll gradient, incubated with
40U/ml DNase, 2 mM MgCl2 and 1mM CaCl2 in PBS at 37°C for 1h and subsequently
washed several times in a 10 mM phosphate buffer (pH 8.0) containing 2 mM mannitol.
HZ was quantified by its heme content using a luminol-enhanced luminescence assay as
previously described [85].

In vivo Hz treatments
Mice were treated with 1-1.5mg of the indicated preparations of Hz intravenously
by injection through the tail vein, or retro-orbital vein. Prior to injection, Hz was washed
twice from storage solution, 1X PBS with 2mM Mannitol and 20mM HEPES with 1X
PBS and resuspended in sterile saline. The entire volume of the final Hz preparation was
then passed 3 to 5 times through a series of syringe needles with 21, 25, 27.5 , and 30 ½
gauges. Mice were then slowly and carefully injected with 200 to 300μl of Hz to avoid
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cardio-pulmonary distress. In some cases, mice received 2 injections to achieve a total of
1-1.5mg on consecutive days. Lm or Sp infections were initiated 7 days after Hz
infections

Reactive oxygen species assay
Spleens and blood (for opsonizing bacteria) were collected from naïve control and
Py-infected mice (days 10-16 post infection). Spleens were processed to generate single
cell suspensions. Cells were plated at 2x106 cells/well resuspended in RPMI with 10%
fetal calf serum incubated at 37˚C for 30 minutes with 5% CO2. Cells were then
incubated with the following antibodies; anti-CD3ϵ APC (clone 145-2C11), anti-CD19
APC (clone 6D5), anti-CD11b PE/Cy7 (clone M1/70), anti-Ly-6G BV421 (clone 1A8),
and 2’,7’-dichloro-hydrofluorescein diacetate (DCF; Abcam Cambridge, MA) for 20
minutes. Cells were then left untreated or treated for 20 minutes at 37˚C with 5% CO2
with 20 μM phorbol 12-myristat 13-acetate (PMA), unopsonized Lm or Sp, naïve serum
opsonized Lm or Sp, or Py serum opsonized Lm or Sp at an MOI of 10 Sp was heat
treated (Ht Sp) at 65˚C for 1 hour. Lm and Ht Sp were opsonized in 10% serum, from
naïve or Py-infected mice, in RPMI while incubating at 37˚C and rotating. After
treatment, cells were centrifuged at 300 x g for 5 minutes then incubated at 37˚C for 20
minutes followed immediately by analysis on a BD LSRFortessa.

Statistical analysis
Data were analyzed as indicated in each figure legend using GraphPad Prism v7.
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CHAPTER II
CHARACTERIZATION OF MALARIA AND BACTERIAL COINFECTIONS

Introduction:
An association between malaria and increased susceptibility to invasive bacterial
disease has been recognized by several clinical reports. With the exception of emerging
insight into mechanisms by which malaria increases susceptibility to NTS, there is still
little known about the underlying mechanisms by which Plasmodium infection
suppresses host antibacterial immunity. In regard to NTS, Plasmodium-induced
hemolysis results in the activation of heme oxygense-1 (HO-1), which mobilizes
functionally immature granulocytes from the bone marrow. These immature
granulocytes exhibit impaired production of reactive oxygen species in response to PMA
stimulation, and decreased killing of NTS [62]. Similar impairments to NTS immunity
were observed when mice were treated with phenylhydrazine to induce hemolysis or
hemin to mimic hemolysis, leading to the conclusion that impaired bacterial immunity
during Plasmodium infection is attributed to hemolysis with no parasite-specific factor
contributing to the immunosuppression [61]. Additionally, Plasmodium-induced IL-10
from myeloid cells suppresses the ability of myeloid cells to control NTS, resulting in
increased systemic colonization in co-infected mice [59]. Moreover, IL-10 signaling
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through the IL-10 receptor can directly induce HO-1 to suppress anti-bacterial immunity,
creating an environment that favors intracellular growth and dissemination of NTS [86].
Streptococcus pneumoniae (Sp), also known as “Pneumococcus”, is a commensal
bacterium in the human nasopharynx, but is capable of causing disease when symbiosis
between the bacterium and host is disrupted. A systemic review of pneumococcal
carriage in sub-Saharan Africa found children under 5 years old had approximately 60%
carriage, while children 5-15 years old had about 40% carriage [87]. When symbiosis
between the host and Sp is disrupted, Sp can cause a variety of infections including;
pneumonia, sinusitis, otitis media, bacteremia/sepsis, and meningitis [88]. Importantly,
pneumococcus has been identified as one of the most common pathogens isolated from
blood samples of children in Africa with invasive bacterial infections [45].
While clinical studies do not unanimously agree that Sp is frequently concomitant
with malaria, several features of these studies may be limiting Sp detection. For
example, one study that presented low abundance of Sp detected in blood of children
with malaria excluded patients that showed signs of respiratory tract illness, a symptom
that is commonly associated with malaria and MA-ARDS and would be likely to occur in
a patient with invasive pneumococcal disease [46]. The same study reported a high
amount of known contaminant organisms, such as Staphylococcus aureus, which
accounted for 43% of all bacteria isolated from blood cultures, compared to 3% Sp.
Other factors that could have decreased Sp detection are its fastidious nature in culture,
tendency to autolyze during static growth conditions, and many diagnostic labs may not
have the resources on hand to examine Gram stains, colony morphology, and hemolysis
phenotype [89]. Contrary to these potentially problematic reports, several broad scale
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clinical reviews have shown that Sp is among the bacterial infections most commonly
found in association with malaria in children (Reddy et al., Churchet al.) and adults
(Aumaet al., Morton et al., Nadjm et al., and Reddy et al.) [43-45, 53, 90]. Moreover, an
analysis of Mozambican children in a rural hospital identified Sp as the leading pathogen
associated with malarial anemia and severe malaria [91]. In contrast to NTS, to our
knowledge there are no mechanistic studies that have assessed the interaction between
malaria and Sp coinfection, and no animal models of malaria and Sp infection have been
described. To this end, I have developed a malaria and Sp coinfection mouse model.
The outcome of malaria depends in large part on the timing and magnitude of
cytokine production, and the balance of inflammatory and immune suppressive responses
induced by Plasmodium infection. There is a well-known correlation between the
severity of malarial disease and high levels of systemic IFNγ, TNFα and other proinflammatory cytokines [92-94]. Ideally, these cytokine signals work synergistically to
orchestrate the production of anti-parasitic factors like NO and other radicals [95]. To
balance these pro-inflammatory responses, the host induces anti-inflammatory cytokines,
in particular TGF-β and IL-10. Yet, elevated levels of these anti-inflammatory cytokines
can also lead to increased mortality and hyperparasitemia [96-98].
While cytokines play a major role in both innate and adaptive immune responses
during malaria, IL-10 activity during malaria in particular has garnished attention as a
potential contributor to Plasmodium-induced suppression of immunity to non-typhoid
Salmonella [59, 99]. Observations have been made in laboratory animal studies and
human clinical studies that show an IL-10-dependent inhibition of neutrophil function
and recruitment to infected tissues during acute and recently cleared Plasmodium
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infections, making a clear case for IL-10 in suppressing immunity to bacterial
coinfections. Experiments conducted by the laboratory of Renee Tsolis found that P.
yoelii-infected IL-10 deficient mice as well as P. yoelii-infected mice treated with antiIL-10 antibody to block activity had decreased systemic levels of non-Typhoid
Salmonella following the secondary infection [59]. Alternatively, the Tsolis group found
mice treated with recombinant IL-10 elevated bacterial burdens similar to both P. yoeliiinfected mice and mice with anti-RBC antibody treatment-induced anemia [59]. The
connection between IL-10, anemia, and Plasmodium infection also involves heme
oxygenase-1, an enzyme also linked to increased susceptibility to non-Typhoid
Salmonella during malaria – whereby both IL-10 and free heme during anemia can
independently induce HO-1 [62]. This interaction that renders a host with limited antiSalmonella immunity is fundamentally linked to parasite-driven hemolysis during bloodstage malaria, where the continuous rupture of schizonts from infected erythrocytes leads
to anemia. The physiological effects of anemia eventually normalize as homeostasic
concentration of RBCs/mL blood occurs within 10 days of parasite clearance from
circulation [62]. Together, these mechanisms are thought to impair neutrophil functions,
recruitment and activation of innate immune cells, thereby providing an environment
which favors the growth of Salmonella and systemic spread of invasive infection.
Since the overall goals of this work relate to the impact of Plasmodium infection
on immunity to bacterial coinfection, it is critical to consider whether factors that are
known to be involved in the heightened susceptibility to Salmonella during malaria are
also important in other bacterial coinfections. The limitation of malaria-bacterial
coinfection mechanistic studies to Plasmodium and NTS creates a knowledge gap as it is
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unknown whether the mechanisms of Plasmodium-driven immune suppression are
specific to NTS or if they will apply broadly to all invasive bacterial infections.
Furthermore, no parasite-specific factor has been identified to contribute towards
Plasmodium-induced impaired immunity to bacterial coinfections. These represent
important knowledge gaps that impede treatment of bacteria coinfections during malaria.
The focus of this chapter is dedicated to testing the nature of Plasmodiumbacterial coinfections other than NTS, and also determine whether the same hemolysisdependent mechanisms found to impair immunity to NTS are involved. While some
progress has been made in exploring the factors involved in Plasmodium-induced
susceptibility to NTS infection, there is a critical need for additional animal model
systems to investigate other coinfections with malaria. One of the overall aims of this
work is to provide a model for Plasmodium-Pneumococcal coinfection which can be used
to identify factors associated with the increased risk of invasive pneumococcal
bacteremia/sepsis and where treatments and therapies can be designed and tested. This
chapter will describe two models of murine Plasmodium-bacterial (Listeria
monocytogenes, and Streptococcus pneumoniae) coinfection used to examine the
mechanisms by which innate immunity to bacterial infections is impaired during malaria.
Using these models, I assessed the ability of IL-10 and HO-I activation to determine if
these pathways that contribute to impaired control of NTS during malaria, also impact
control of other bacterial infections. Finally, the duration of Plasmodium-driven
suppression of anti-bacterial innate immunity is explored.

28

Results:
Plasmodium yoelii infection results in long-term suppression of innate immunity during
systemic bacterial coinfection
In order to investigate Plasmodium-infection related immunosuppression and
subsequent impaired immunity to bacterial coinfections, we began probing immune
responses using a model bacterium, Listeria monocytogenes (Lm) ΔactA mutant strain,
which is attenuated due to the deletion of the virulence factor gene that allows actin
polymerization-dependent intracellular mobility and the ability to spread from cell to cell
[100]. While Lm is not a common bacterial infection seen in coinfections during malaria,
it is useful due to the vast amount of knowledge about its interaction with innate and
adaptive immune responses. Thus, the creation of a malaria-bacteria coinfection model
with Lm provided an insightful means to probe a predictable and well-characterized
infection system. The readout of bacterial burdens in form of colony forming units (cfu)
from spleens and livers at time points ranging 1 to 3 days post Lm infection presents a
quantitative way to evaluate the quality of the innate immune response to a bacterial
infection.
To examine Plasmodium-induced suppression of innate immunity during systemic
bacterial infection C57BL/6N mice were first infected with Plasmodium yoelii 17XNL
(Py), which resulted in increasing parasitemia through about three-weeks post infection
that was followed by resolution of the infection during the ensuing week (Fig. 4A).
Control and Py-infected mice were subsequently infected, via intravenous injection, with
Lm ΔactA 7-days post Py infection. Clearance of Lm was delayed, in particular in the
spleen, in Py-infected mice compared to control mice (Fig. 4B). To examine Py-induced
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suppression over the course of Py-infection, mice were infected with Lm on day 7, 14,
and 28 post-Py infection and spleens were removed 2-days later to quantify Lm burden.
Throughout the course of Py infection, mice had elevated bacterial burdens (Fig. 4C).
Remarkably, impaired innate immunity to Lm was also observed at both one-month (day
63) and two-months (day 98) post-Py infection (Fig. 4C). Collectively, these data
demonstrate that Py suppresses the innate immune response during systemic bacterial
infection with Lm, including time points well beyond resolution of the Py infection.

Figure 4. P. yoelii infection induces long-term suppression of anti-bacterial innate immunity during
bacteremia. A) C57BL/6N mice were infected with 105 Py pRBCs. Percent parasitemia (percent of RBCs
infected with Py) was evaluated during the course of infection. Data (meanS.D.) are from 9 mice and
representative of 3 independent experiments. B) C57BL/6N mice were infected with 105 Py pRBCs, seven
days later both control and Py-infected mice were infected with 5x106 CFU Lm ΔactA. Lm burden was
determined in the spleen and liver on days 2, 3, 6, and 9 post-Lm infection. Data are cumulative results
from two-independent experiments with 3 or 6 mice per group per time point. Each symbol represents an
individual mouse. Data were analyzed by two-tailed Fisher’s exact test. LOD = limit of detection.
[cfu/spleen day 11 (4) data was originally published in The Journal of Immunology. White C.E., Villarino
N.F., Sloan S.S., Ganusov V.V., and Schmidt N.W. 2015. Plasmodium Suppresses Expansion of T Cell
Responses to Heterologous Infections. J. Immunol. 194: 697-708. Copyright © 2015 The American
Association of Immunologists, Inc.] C) C57BL/6N mice were infected with 105 Py pRBCs. On days 7, 14,
28, 63, and 98 post-Py infection both Py-infected and control mice were infected with 5x106 CFU Lm.
Bacterial burdens were determined 2 days post Lm infection. Data (meanS.E.) are cumulative results from
2- to 3-independent experiments with 4 to 9 mice per group. Data were analyzed with Mann-Whitney test,
n.s., not significant.
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Py infection impairs IFNγ production in response to ΔactA Lm during parasitemia, but
enhances Lm induction of IFNγ after parasite clearance.
IFNγ is an important inflammatory cytokine produced during Plasmodium
infections that activates innate immune cells to enhance anti-parasite functions, such as
uptake and killing of infected RBCs and enhance production of other inflammatory
signals to amplify the immune response [101, 102]. There is an early burst of IFNγ,
produced primarily by natural killer T-cells (NK), and to a lesser degree, CD4+ T cells, in
the early days of a blood-stage infection [103, 104]. There is also an induction of
immunosuppressive factors such as IL-10 that functions to prevent immunopathology
associated with the production of inflammatory cytokines, which can also suppress the
overall immune response. It is also well established that IFNγ signaling is paramount in
initiating an effective immune response to Lm infection [105].
To test whether Py infection impairs the production of IFNγ in response to
secondary ΔactA Lm infection, mice were either challenged with Py followed by Lm 7
days later or only Lm. Serum was collected from peripheral blood before Lm infection
(day 7 post Py) and both spleens and serum were collected 24 hours after i.v. Lm
infection. Prior to Lm infection, baseline levels of IFNγ were detected in either
coinfected or Lm only infected mice. One day after Lm infection, however, coinfected
mice had significantly lower levels of IFNγ in both whole spleen homogenate and in
serum (Fig. 5 A).
Since we already observed that Py-infected mice had an impaired ability to
eliminate Lm infection up to 2 months after parasite clearance (Fig. 4C), we sought to
examine whether or not IFNγ production in response to Lm was reduced in coinfected
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mice at this late timepoint post Py infection. Unlike the Py-induced suppression of IFNγ
seen when Lm infection was initiated 7 days post Py, when Lm infections began 100 days
post Py, levels of IFNγ in serum of coinfected mice were significantly higher than mice
receiving only Lm both 1 and 2 days after Lm infection. A similar trend was seen in
spleens 2 days post Lm (Fig. 5B). These results suggest that although IFNγ production is
limited in Py-infected mice during acute parasitemia, the response to Lm infection
becomes primed at later timepoints and able to produce a more robust IFNγ burst.
In order to determine the degree to which the lack of IFNγ production contributed
to the inability of coinfected mice to clear Lm at early time points, IFNγ activity was
blocked in coinfected mice and mice infected with Lm only. C57BL/6 mice were
infected with Py and given i.p. treatments of either anti-IFNγ antibody or isotype control
8 hours prior to Lm infection and additional treatments 24- and 48-hours post Lm.
Spleens and livers from these mice were then collected 3 days post Lm (day Py+10).
Analysis of bacterial burdens showed that blocking IFNγ in Lm only mice did not impair
clearance from spleens (Fig. 6C). In an alternative approach, coinfected mice received
treatments of recombinant IFNγ via i.p. injection 8 hours prior to Lm infection on day 7
post Py as well as 24- and 48-hours post Lm. Spleens and livers from these mice were
then collected 3 days post Lm (day Py+10), while coinfected and Lm only infected
mouse groups received no treatment. Treating coinfected mice with recombinant IFNγ
did not improve Lm clearance in the spleen or liver (Fig. 4D). In a single experiment
(shown in Figure 5E), coinfected mice given wildtype Lm did not appear to have as
significant of a decrease in serum IFNγ 1 day after Lm infection compared to what was
observed with in the Py coinfection with the ΔactA mutant (Fig. 5A and B) and had
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similar IFNγ levels as mice that received wildtype Lm alone by 2 day post Lm infection
(Fig 5E). Together, these results do not support the hypothesis that the Py-infection
induced decrease in IFNγ production in response to Lm infection plays a major role in the
delayed Lm clearance that we have observed.
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Figure 5. IFNγ production during early and late coinfection. (A,C-D)C57BL6 mice were infected with
105 Py pRBCs followed by 5x106 cfu Lm on days indicated in figure. A) Serum was collected via retroorbital bleeds 7 days post Py infection, prior to ΔactA Lm infection, and both serum and spleens were
collected 24 hours after Lm infection (day Py+8). B and E) Mice were infected with Lm 100 days post Py
infection, or Lm wt on day Py+7. Serum was collected 1- and 2-days post Lm and spleens were harvested
2 days post Lm (day Py+102) B), day Py+9 E). IFNγ concentrations from serum and spleen homogenate
were determined with ELISA. C) Mice were treated with anti-IFNγ monoclonal antibody 8 hours prior to
Lm infection and 1- and 2-days post Lm D) Mice were treated with recombinant IFNγ 8 hours prior to and
1- and 2- days after Lm infection. C-D) or wildtype Lm (E). Tissues were collected for cfu analysis day 3
post Lm Data are mean S.D. (A, C,-D) and are from a single independent experiment that represent 2-3
repeated experiments. Data in B. are meanS.E. and are cumulative results from 2 independent
experiments. Data in E are mean  S.D from only one experiment. Statistics are One-Way ANOVA with
Kruskal-Wallis multiple comparisons test or unpaired t-tests.
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Py infection improves clearance of wild-type Lm with functional actin polymerization
ability
Our initial observations with the Py+Lm coinfection model were made with an attenuated
mutant strain of Lm that is lacking the actA gene, which is involved in the ability of Lm
to polymerize actin and is a major virulence factor that allows Lm to invade nearby cells
and evade the immune system [100, 106]. One advantage of using the attenuated ΔactA
mutant was due to the higher inoculum that can be delivered to mice through intravenous
injection without producing a lethal infection, allowing injections of 5x106 cfu rather than
104 cfu of wildtype Lm that is consistently lethal in C57BL/6 mice [107]. In order to
determine whether the impaired clearance of Lm following Py infection was dependent
on a functional actA gene in Lm, C57BL/6 mice were infected with Py followed by
infection with 104 cfu i.v. wildtype Lm 10403S 7 days later. Control mice received only
the wildtype Lm infection. Two days after bacterial infection spleens and livers were
collected from Lm only and Py+Lm coinfected mice and bacterial burdens were assessed.
Surprisingly, when using virulent Listeria, coinfected mice had drastically lower bacterial
burdens in the spleen than mice that received wildtype Lm alone (Figure 5A). While
these results raised interesting questions pertaining to Listeria biology and how the ability
to polymerize actin and escape from the intercellular space of a cell or invade
neighboring cells impacts outcome of Listeria during coinfection with Py, these ideas
were not further explored.
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Figure 6. Py infection confers protection against wildtype
Lm. C57BL/6 mice were infected with 105 Py pRBCs followed
by 5x106 cfu wildtype Lm 7 days later. Serum was collected 24and 48- hours post Lm infection via retro-orbital bleed and
spleens were collected 2 days post Lm Data (meanS.D.) are
from a single independent experiment that represent 3
independent experiments. Statistical analysis was performed
with a Mann-Whitney U test.

Contribution of P. yoelii-induced HO-1 and IL-10 to impaired innate immunity is
bacteria-dependent
Previous studies have identified mechanisms by which Plasmodium suppresses
immunity to NTS [59, 61, 62, 108, 109]. Currently, nearly all mechanistic investigations
of impaired immunity to non-Typhoid Salmonella (NTS) coinfections during malaria
have built upon the key findings that the activities of HO-1 and IL-10, which are
produced during active Plasmodium infection, play an important role in the increased
severity of bacterial infection [59, 62]. Plasmodium infections result in the release of
heme, which activates HO-1. HO-1 induces the release of immature granulocytes that
exhibit impaired oxidative burst in response to PMA stimulation [61]. Additionally,
Plasmodium infections induce myeloid cells to produce IL-10 that impairs control of
NTS infection [59]. To determine whether those mechanisms of impaired immunity to
bacterial coinfections are specific to NTS coinfections, we first confirmed the results of
those studies by infecting mice with P. yoelii followed by coinfection with NTS. As
shown before, P. yoelii-infected mice treated with tin protoporphyrin IX (Sn PP; a
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synthetic heme analog that inhibits activity of HO-1) or an anti-IL-10 monoclonal
antibody had reduced bacterial burdens compared to the respective control treated mice
(Fig.7 A and B). Contrary to observations in NTS coinfections, Sn PP treatment did not
improve anti-bacterial immunity in Py+Lm (Fig. 7C) co-infected groups, as bacterial
burdens of Sn PP treated mice were comparable to control treated groups. Blocking IL-10
with an anti-IL-10 monoclonal antibody treatment prior to Lm infection also did not
improve bacterial clearance in co-infected mice (Fig. 7D). These data show that our use
of Sn PP and anti-IL-10 antibodies to block activity of HO-1 and IL-10, respectively, is
valid in our model of Py bacterial coinfections since we have shown the same trend as
Cunnington et al. replicated data from Lokken et al. with the same strain of NTS [59, 62].
The data also show that unlike in NTS coinfections with Py, HO-1 and IL-10 do not play
a role in the impaired antibacterial immunity in Lm+Py coinfections. Together, this
suggests that there may be other mechanisms by which Plasmodium infection induces
defective immune responses to bacterial coinfections.
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Figure 7. Py induction of HO-1 and IL-10 impair immunity to NTS but not Lm C57BL/6N mice were
infected with 105 Py pRBCs, ten days later both control and Py-infected mice were infected via
intraperitoneal injection with 103 CFU Salmonella enterica serovar Typhimurium (NTS). Spleen, liver, and
peripheral blood bacterial burdens were determined day 2-post NTS infection. Mice were treated with tin
protoporphyrin IX (Sn PP) or PBS control at 48, 24 and 8 hours before NTS infection and 18 hours postNTS infection (A), or anti-IL-10 antibody or IgG isotype control on days 9, 10, and 11 post Py (B). Data
(meanS.D.) are representative of two independent experiments with 5 mice per group (A) or are from a
single experiment with 5 mice per group (B). C-D) C57BL/6N mice were infected with 105 Py pRBCs,
seven days later both control and Py-infected mice were infected with 5x106 CFU Lm. Spleen and liver
bacterial burdens were determined day 2-post Lm infection. Mice were treated with tin protoporphyrin IX
(Sn PP) or PBS control at 48, 24 and 8 hours before Lm infection A), or IL-10 antibody or isotype control
on days 6, 7, and 8 post Py B). Data (meanS.E.) are cumulative results from two independent experiments
with 3 to 6 mice per group analyzed with one-way ANOVA followed by Tukey’s multiple comparisons
test.
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Plasmodium yoelii infection suppresses innate immunity to Streptococcus pneumoniae
(Sp) is one of the most common bacteria observed in individuals co-infected with
malaria and an invasive bacterial infection [42, 45]. To formally test the ability of
Plasmodium to impair innate immunity to Sp, mice were infected with Py followed by
intranasal Sp infection 7-days later. Following infection, diplococci were clearly evident
in the blood of co-infected mice (Fig. 8A), which showed lower survival through 84hours post Sp infection compared to control Sp-only infected mice (Fig. 8B).
Surprisingly, there was no difference in Sp burdens 3-days post-infection in the lungs of
Py-infected and control mice (Fig. 8C), suggesting that Py infection does not impair
colonization of Sp in the lung. In contrast to the lung, and consistent with the decreased
survival of Py-infected mice following Sp infection, there were substantial increases in
Sp burden in both the blood (Fig. 8D) and spleen (Fig. 8E). These data demonstrate that
Py infection also impairs the innate immune response to Sp bacteremia.
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Figure 8. P. yoelii infection increases severity of Pneumococcal infection. C57BL/6N mice were
infected (i.v.) with 105 P. yoelii infected RBCs, 7-days later Py-infected and naïve mice were infected (i.n.)
with 106 CFU Streptococcus pneumoniae (Sp). A) Giemsa stained blood smear from co-infected mouse.
Arrows indicate Sp diplococci, arrow heads indicate P. yoelii infected RBCs. B) Survival of mice following
Sp infection. Data are pooled results from 4 independent experiments with a total of 21 Sp only mice and
25 Py+Sp co-infected mice. Survival data was analyzed by log-rank (Mantel-Cox) test. C-E) Mice were
sacrificed at either day 3 post Sp infection (10 days post Py infection) or when mice became moribund. Sp
burden was quantified in lungs (C), blood (D), and spleen (E). (C-E) Data (meanS.D.) are from a single
experiment that is representative of 3 independent experiments with 5 to 7 mice per group.
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Py infection induces long-term impaired immunity to Sp infection.
Similar to the long-term defect in innate immunity to Lm in mice following
clearance of Py infection (Fig. 4C), mice infected with Sp, both 30 days-post Py infection
(Fig. 9A-C) or 65-72 days-post Py infection (Fig. 9D-F), had increased bacterial burdens
two days-post Sp infection in lungs, peripheral blood, and spleens compared to age
matched mice infected with only Sp. These data demonstrate that Py infection also
impairs the innate immune response to Sp bacteremia, and that the Plasmodium-driven
susceptibility to Sp is prevalent beyond the duration of the parasite infection.

Figure 9. Py infection induces long-term impaired immunity to Sp infection. C57BL/6N mice were
infected with 105 P. yoelii infected RBCs, then infected with 106 CFU Sp either 30 (F-H) or 65-72 (I-K)
days later. Sp bacterial burdens in blood and organs were obtained from mice sacrificed 2 days after Sp
infection. (F-H) Data (meanS.D.) representative of 2 independent experiments with 5 to 7 mice per group.
(I-K) Data (meatS.E.) cumulative results from 2 independent experiments with 7 to 10 mice per group.
(C-K) Dotted lines indicate limit of detection. Each symbol represents a single mouse. Statistical
significance was determined with Mann-Whitney test.

41

P. yoelii-induced IL-10 contributes to impaired resistance to Pneumococcal coinfection
Since HO-1 and IL-10 have been found to impair innate immune responses in the
context of malaria coinfections with NTS, we explored the possibility that these factors
also contribute to the impaired resistance to Sp that we have observed in our Py
coinfection model system. Contrary to observations in NTS coinfections, Sn PP treatment
did not improve anti-bacterial immunity in Py+Sp co-infected mice (Fig. 10A), as
bacterial burdens of Sn PP treated mice were comparable to control treated groups.
Blocking IL-10 with an anti-IL-10 monoclonal antibody treatment prior to Lm infection
did not improve bacterial clearance in co-infected mice (Fig. 7B). Similar to NTS (Fig.
7B) while in contrast to LM (Fig. 7D), anti-IL-10 monoclonal antibody treatment in
Py+Sp co-infected mice was sufficient to significantly reduce the severity of
Pneumococcal infection compared to control IgG treated Py+Sp mice (Fig. 10B). These
data demonstrate that Plasmodium-induced IL-10 is part of the mechanism by which Py
infection impairs control of Sp. The data from our explorations of both the Py+Lm and
Py+Sp coinfection model systems indicate that there may be additional mechanisms by
which Plasmodium infections impair control of systemic bacterial infections.
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Figure 10. IL-10 derived from Py infection impairs immunity to Sp. C57BL/6N mice were infected
with 105 Py pRBCs, eight days later both control and Py-infected mice were infected i.n. with 5x105 CFU
Sp. Lung, spleen, and peripheral blood bacterial burdens were determined day 2-post Sp infection. Mice
were treated with tin protoporphyrin IX (Sn PP) or PBS control at 48, 24 and 8 hours before Sp infection
and 24 hours post Sp infection A), or IL-10 antibody or isotype control on days 6, 7, and 8 post Py B).
Data (meanS.E.) are cumulative results from two independent experiments with 5 mice per group and
analyzed with one-way ANOVA followed by an uncorrected Fischer‘s LSD test with multiple
comparisons, n.s., not significant.
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Discussion
Complications associated with bacterial coinfections during malaria have been the
subject of numerous clinical reports. Several basic scientific studies have reported
mechanisms by which Plasmodium infections impact susceptibility to invasive bacterial
infections, but these have exclusively focused on suppressed immunity to NTS. A broad
range of bacterial pathogens are isolated from bacteremic patients with malaria, yet, other
than what is known about NTS coinfections, very little is known about the mechanisms
that cause increased risk for invasive bacterial diseases during malaria. Identifying
specific or more general deficiencies in innate immune responses during Plasmodium
infections that are responsible for diminished bacterial immunity is necessary to improve
the treatment of these cases. In this project, we sought to create tools that could be used
to explore the underlying mechanisms of malaria-induced immune suppression and
investigate what factors contribute to impaired innate immunity to invasive bacterial
infection during acute Plasmodium infection and during convalescence. Prior reports on
NTS infections during malaria, demonstrated that infection-induced IL-10 production and
infection-induced hemolysis, and activation of HO-1, were central to impaired immunity
to NTS. Here, we have demonstrated that Plasmodium infections also impair innate
immunity to bacterial infections independent of HO-1 and IL-10. By establishing
coinfection model systems with Lm and Sp, we have found that this defect in immunity
to secondary bacterial infection extends beyond clearance of the parasite and that the
impaired immunity to Sp is partly due to the immune suppressive activity of Py induced
IL-10.
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It has been postulated that Plasmodium-induced immune suppression and
susceptibility to invasive bacterial infections is not attributed to a parasite-specific factor,
but rather is due to Plasmodium-induced hemolysis, and subsequent activation of HO-1
[109]. Additionally, Cunnington and colleagues demonstrated that neutrophils collected
from patients previously infected with Plasmodium falciparum had defective ROS burst
following PMA stimulation that lasted up to 8 weeks-post treatment [61]. Another recent
clinical investigation found decreased cellular- and serum- mediated bacterial(NTS)
capacity in Malawian children with current or convalescent P. falciparum malaria [64].
This long-term Plasmodium-driven defect in NTS immunity was attributed to impaired
opsonophagocytic activity and contributed to decreased PMN production of reactive
oxygen species (ROS) following stimulation with serum-opsonized NTS. We
demonstrate that Py-induced immune suppression lasts up to 2-months post clearance of
Py, when the effects of hemolysis are likely no longer in play. Of note, tissue deposition
of hemozoin byproducts from P. berghei infection remains deposited in liver, bone
marrow, and spleen tissues as well as within isolated CD11b+ cells isolated from those
tissues and peripheral blood of mice for at least 196 days post infection [110]. The
contribution of hemozoin as a factor involved in Plasmodium-dependent suppression of
anti-bacterial immune functions will be revisited in Chapter IV.
In our examination of the impact of Plasmodium infection on production of an
inflammatory cytokine, IFNγ, we observed that the capacity of IFNγ production in
response to Lm infection was dependent on the amount of time post Py infection that
mice were infected with Lm (Fig. 6A and B). Py+Lm coinfected mice responded with
lower production when Lm infection began 7 days post Py infection compared to mice
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only receiving Lm. Surprisingly, the opposite was true when the Lm infection occurred
100 days post Py infection, as we found higher levels of IFNγ in serum and spleens of
coinfected mice. The data in this set of experiments may suggest that Py infection may
induce a state of hyperresponsive “trained immunity”, where the Plasmodium infection
induces an innate immune “memory” that increases responses to a secondary infection
[111]. The concept of innate immune memory refers to a hypo- or hyperresponsive state
that occurs in innate immune cells where they are primed by an initial stimulus to
respond in an extreme manner [111]. Several previous studies have demonstrated data
that support the idea of trained immunity in malaria. Schrum et al. showed that in vitro
treatment of healthy human PBMCs with synthetic hemozoin or P. falciparum infected
RBCs, and also cells from Kenyan children with febrile malaria, were hyperresponsive in
response to TLR2 stimulation in an IFNγ independent manner [112]. Another study
describes hyperresponsive of human PBMCs and murine splenocytes from P. falciparum
or P. chabaudi infected individuals, respectively, that was dependent on TLR9, MyD88,
and to a greater extent IFNγ-signaling [113].
The hyperresponsiveness of innate immune cells in the context of malaria has also
been attributed to the increased susceptibility to secondary bacterial infections. One
study tested responses of PBMCs from febrile malaria patients and observed that malariaprimed cells produced pathological amounts of IL-1β following stimulation with LPS,
modeling a secondary bacterial “superinfection” [114]. In this study IFNγ was required
for inflammasome activation and IL-1β production in P. chabaudi infected mice and
treatment of these mice with IL-1 receptor agonist (IL1RA) improved their survival
following intragastric infection with NTS. Given the range of results in studies that focus
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on the immunomodulatory role of IFNγ in malaria, it is unclear whether this or other
cytokines are dispensable for the induction of trained immunity [112]. While hyper
responses were seen in studies with P. chabaudi + NTS coinfection and P. chabaudi +
LPS challenge where observations were made 7 days post Plasmodium infection, our
challenge of Py-infected mice with Lm 7 days post Py did not have a greater IFNγ
response to Lm than mice infected with Lm alone. Alternatively, when the Lm infection
began 100 days post Py infection in our Py+Lm coinfection model, we did see that the
innate immune response of coinfected mice was primed to respond with a greater level of
IFNγ than Lm only mice. Our data therefore suggests that Plasmodium infection induces
trained innate immunity (at least) after the initial acute phase of the blood stage of
malaria, and that this affect lasts long (up to 2 months) after clearance of the parasite.
By blocking the activity of IFNγ with an anti-IFNγ antibody and comparing
bacterial burdens in spleens of Lm infected treated and untreated mice to Py+Lm
coinfected mice, we were able to determine whether the impaired IFNγ response
following Lm infection that we observed in Py-infected mice during the early stage of
parasitemia (7 days post Py) contributed to their delayed clearance of Lm from spleens
(Fig. 6C). In another experiment recombinant IFNγ was given to coinfected mice to test
whether providing exogenous IFNγ would improve their ability to clear Lm. We found
that neither the intervention of blocking IFNγ activity in Lm only mice nor the addition
of recombinant IFNγ to coinfected mice changed their abilities to clear Lm from spleens
as compared to their respective control groups. Hence, during the early blood stage of
malaria the impaired IFNγ production in response to a secondary bacterial infection does
not appear to play a role in the suppressed antibacterial innate immunity in this model.
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This finding is in agreement with our data showing a decreased IFNγ response to Lm
infection early in Py infection but heightened IFNγ long after Py clearance. If IFNγ were
involved in the delayed clearance of Lm in coinfected mice, we would expect IFNγ
responses to be similar at both timepoints post Py infection. Additional experiments are
required to understand the underlying mechanisms and kinetics of both the impaired
production of proinflammatory cytokines during Plasmodium infections as well as the
hyperresponsive, “trained” innate immunity that occurs in the time following clearance of
the parasite. There is also strong rationale to examine how repeated Plasmodium
infections in individuals over time may affect these occurrences, and whether they have a
detrimental impact on host immunity to other bacterial pathogens, such as NTS and Sp.
Clinical reports of invasive bacterial disease coinciding with malaria often report
both NTS and Sp as the two organisms most commonly isolated from blood.
Experimental studies to date have focused almost exclusively on NTS and it is unknown
whether the mechanisms of Plasmodium-induced immune suppression to NTS will be
important for Sp or other bacterial pathogens found in coinfections with malaria (e.g.,
Haemophilus influenzae, Mycobacterium tuberculosis, Staphylococcus aureus,
Streptococcus pyogenes, etc. [42-49, 54]). We report for the first time, to our knowledge,
a murine Plasmodium and pneumococcal coinfection. Mice were infected with
Plasmodium yoelii 17XNL followed by a Streptococcus pneumoniae ATCC #6303, a
type 3 capsule serotype strain, via the natural intranasal route. Consistent with the risk of
invasive Sp infections in humans with malaria [42], we found decreased survival and
increased bacterial burdens in co-infected mice compared to control Sp only infected
mice (Figure 8). Further work is required to achieve a better understanding of the factors
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at play in this coinfection. Future efforts should examine different serotypes of Sp, as the
pathogenicity of Sp is highly variable in many disease models and to suggest that ATCC
strain #6303, or even that type 3 capsule Sp represent all Sp would be an overstatement
[115].
The impact of hemolysis-related immune suppression initiated by Plasmodium
infection (activation of HO-1 and IL-10) has been well studied in the context of NTS in
both animal models and clinical studies [59, 61, 109]. By exploring coinfection models
with different bacterial pathogens during malaria, we sought to determine whether the IL10-dependent and HO-1-dependent mechanisms were specific to NTS coinfection, or if
they also play a role in malaria-related immunosuppression to other bacterial
coinfections. While our results indicated that HO-1 inhibition with Sn PP failed to
improve immunity to either Lm or Sp coinfections (Fig. 4C and Fig. 7A), we did see a
reduction in Sp bacterial burdens in co-infected mice treated with anti-IL-10 (blocking)
antibody (Fig. 7B). This result is in line with observations made in influenza and
pneumococcal coinfections, where IL-10 production following influenza virus infection
disrupts the inflammatory response to Sp in a manner that favors dissemination and
invasive disease [116]. Blocking IL-10 activity in the Py+Sp coinfection may, similarly
to what is seen in the influenza coinfection [116], results in increased levels of
inflammatory factors in the respiratory tract, such as TNFα and IFNγ, enhanced PMN
infiltration to lungs, and restore the antibacterial immune response to Sp to normal. IL-10
is known to impair neutrophil chemotaxis, which may contribute to “neutrophil paralysis”
that has been characterized in samples from patients with P. vivax malaria [117]. Thus,
the anti-IL-10 treatments may have restored neutrophil function, resulting the reduction
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in pneumococcal burden in anti-IL-10 treated co-infected mice compared to isotypetreated controls. While this result shows that IL-10 is involved in suppressing the immune
response to Sp during Py infection, it likely does not explain the long-term impaired
immunity to Sp we have demonstrated (Fig. 6), since levels of IL-10 decrease following
parasite clearance [118].
Curiously, we found that defective immunity to Lm following Py infection
occurred only with the ActA-deficient mutant strain, while wildtype Lm 10403S was
cleared more efficiently in coinfected mice (Fig. 5A). Since the strain used exclusively
while characterizing the model also expressed chicken ovalbumin protein (OVA) allows
for measurement of Lm-OVA-specific T-cells and quantitative assessment of adaptive
immune response (also used in C. White et. al [119]), an actA-deficient strain that does
not express OVA was also tested in the coinfection model prior to testing wildtype Lm.
In vivo clearance of this OVA-negative, actA-deficient strain was impaired in coinfected
mice similarly to the OVA-expressing strain used in the majority of this study (data not
shown), suggesting that differences in immune-clearance and effect of Py infection are
dependent on the presence of functional actA gene expression
Based on this biological difference of actA-positive and actA-negative Lm, it is
possible that factors such as opsonizing complement factors involved in
opsonophagocytosis, are absent or are rendered inactive or defective by Py infection and
therefore unable to function normally against actA-negative Lm that invades new cells
from extracellular space [120]. This deficiency would have no negative consequence for
Lm that invades new cells mainly via direct intercellular actin-propulsion into nearby
cells. In this scenario, the inflammatory nature of the Py infection may help to activate
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innate immune cells to enhance their ability to kill intracellular Lm that is unable to
escape via function of actA. Combined with less reliance on evading extracellular
immune components (due to their limited time spent outside of cells compared to actAdeficient Lm), enhanced killing by the Py-induced inflammatory response may explain
the improved wildtype Lm clearance during coinfection that is contrary to the defective
clearance observed in Py+actA-deficient Lm coinfection.
The result that demonstrated enhanced clearance of wildtype Lm conferred by Py
infection is interesting, highly repeatable and further exploration of the mechanisms
behind Py infection-mediated protection could uncover potential therapies for invasive
Lm disease. For the scope of this project, however, continuing to pursue mechanisms in
Listeria biology behind the actA-dependent defective clearance in Py coinfection would
be tangential and not helpful in our pursuit of understanding Plasmodium-driven
immunosuppression related to impaired to invasive bacterial coinfection. For this reason,
wildtype Lm is not used experimentally or investigated in the Py coinfection model for
the remainder of the project.
These findings provide a translational picture of malaria-driven long-term defects
in anti-bacterial innate immunity, where we have observed Py-driven impaired immunity
to Lm and Sp coinfections at all time points examined, including more than two months
after clearance of infected red blood cells. Furthermore, these data indicate that the
immune suppression occurs independent of Py-induced hemolysis, given that the duration
of hemolysis and related physiology during malaria is limited to the active blood stage of
the infection and effects of hemolysis return to normal relatively quickly. For instance,
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HO-1 activity significantly decreases in Py infected mice five days after antimalarial
treatment and is comparable to uninfected mice ten days post treatment [121].
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CHAPTER III
IMPACT OF PLASMODIUM YOELII INFECTION ON SPLENIC MYELOID CELL
POPULATIONS AND THEIR ANTI-BACTERIAL EFFECTOR FUNCTIONS

Introduction

The spleen, splenic innate immune cells, and their roles in infection
Plasmodium infection induces a robust inflammatory immune response
characterized by substantial production of inflammatory cytokines, the effects of which
are eventually regulated by anti-inflammatory factors in order to reduce collateral
damage to host tissues in the process. Several organs are damaged during Plasmodium
infection, including the liver, kidneys, lungs, brain, bone marrow and spleen. There is
sufficient reason to believe that pathology of the spleen during Plasmodium infection is
particularly important in the context of invasive bacterial infection. Under normal
conditions, the spleen is responsible for clearance of senescent and damaged erythrocytes
and other debris [122]. Another critical function of the spleen is to clear pathogens that
have entered the blood stream. This is achieved by strategically positioned macrophages
that internalize and kill circulating pathogens. By residing in close proximity to the
marginal zone and the small, open ended capillaries of the penicillar arteriole [47],
marginal zone macrophages (MZM), and marginal metallophilic macrophages (MMM)
function as scavenger phagocytes patrolling the marginal zone space for pathogens and
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other cell debris. MZMs can interact directly with MZ B cells while MMMs can enter
the white pulp of the spleen and present antigen to DCs in the marginal zone [123, 124].
From the marginal zone, approximately 10% of circulating blood flows slowly through
the perifollicular zone to the reticular meshwork of the red pulp, and here damaged
erythrocytes, debris, and blood borne pathogens can also become stuck and internalized
by red pulp macrophages (RPM) [38]. These specific subsets of tissue-resident
macrophages are equipped with a unique set of recognition receptors that allow them to
efficiently identify, uptake, and kill invading pathogens.
The role of these splenic tissue-resident macrophages during blood-borne
infections is well characterized for several pathogens. A direct recognition of Sp capsule
polysaccharide by SIGNR-1(CD209b), a C-type lectin receptor which is highly expressed
on MZMs, is involved in uptake of Sp and has been demonstrated to be critical for
protection of mice against pneumococcal septicemia [125, 126]. SIGNR-1 also interacts
with components of the complement cascade to promote protection vs. pneumococcal
septicemia by binding C1q and initiating C3-convertase, initiating an Ig-independent
activation of the classical complement pathway [127]. MZMs also express a scavenger
receptor, MARCO, which is known to recognize gram negative bacteria and works in
concert with toll-like receptor signaling to facilitate cell activation and enhanced
phagocytosis functions [128, 129]. MARCO, unlike SIGNR-1, recognizes unopsonized
pathogens [130]. Specific functions of MMMs during blood-borne infections have also
been described, including early control of Lm infection independent of T- and B-cell
interaction in a bacteremia model, antigen presentation and indirect activation of CD8+ T
cells, and recognition and phagocytosis of blood-borne pathogens involving MOMA-1, a
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surface molecule enriched on spleen MMMs [131, 132]. Like MZMs, RPMs have the
ability to eliminate Sp in vivo [133]. This anti-pneumococcal ability of RPMs, however,
was demonstrated in mice that were previously infected with Leishmania donovani where
RPMs become more important in capture of blood-borne pathogens due to the
Leishmania donovani-induced loss of MZMs. A similar phenomenon occurs in
Plasmodium chabaudi infection, where both MZMs and MMMs are nearly completely
lost at the height of parasitemia [134]. To what degree these splenic macrophage
populations are loss following Py infection and the effect that potential loss may have on
control of bacterial coinfections are not known.
One of the key indicators of a Plasmodium infection, in addition to measurable
fever, is splenomegaly that is often diagnosed by clinicians when the spleen is palpable at
least 10 cm below costal margin of the patients thoracic cage [135]. Splenomegaly
during malaria, also referred to as hyper-reactive malarial splenomegaly syndrome
(HMS), is the result of constant stimulation with parasite antigen during blood stage of
malaria . Plasmodium-specific antibodies, especially IgM, aggregate in the form of
immune complexes to drive HMS pathology [136]. Other byproducts of the heavy
parasite burden in the spleen includes deposition of large amounts of malarial pigment
(hemozoin), and destruction of splenic architecture that is important in maintaining
normal physiological functions and innate and adaptive immune functions in context of
infections [123, 134, 137]. Since the spleen is the primary organ involved in filtration of
blood and cleanup and turnover of erythrocytes and cellular or foreign debris (i.e. bloodborne microbes), the spleen and the specialized phagocytic cells have several critical and
direct roles in controlling the blood stage of Plasmodium infections. For this reason,
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spleen/splenic macrophages during Plasmodium infection has been the subject of many
previous studies. During blood stage malaria parasitized and damaged erythrocytes, as
well as other parasite and cellular debris are filtered out circulation by RPMs [39].
Based on the clear evidence that destruction and architectural disruption of the
marginal zones occurs in the spleen following Plasmodium infection, it has been
hypothesized that this decreases overall functional ability of the spleen to perform its role
in defense against a blood-stream bacterial infection [47, 134, 137, 138]. Splenomegaly
and loss of both marginal zone macrophages (MZMs) and metallophilic macrophages
(MMMs) occur in spleens of malaria patients who have increased risk to invasive
bacterial infections [47]. Subsets of splenic macrophages serve as sentinels and provide
clearance of blood-borne bacterial infections [39]. The importance of these cell types has
been well documented in connection to resistance to blood-stream infections with
Streptococcus pneumoniae, Listeria monocytogenes, Escherichia coli, and Salmonella
typhimurium [125, 139]. Experiments utilizing low dose clodronate liposome treatments
do deplete MMMs and MZMs have further demonstrated the importance of these cells
based on the impaired survival of clodronate treated mice compared to untreated control
mice following infection with sub-lethal Lm infection [131]. The observation that
MMMs and MZMs are lost during Plasmodium chabaudi infection led us to the
hypothesis that a similar loss or decrease in these cells in the spleen following Py
infection may be contributing to the impaired clearance of Lm and increased
susceptibility of Sp we have described in coinfection models in Chapter II [134]. This
Chapter will explore this hypothesis.
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In addition to tissue resident macrophages in the spleen, innate immune cells that
are recruited from circulation also play essential roles in controlling bacteremia in both
Lm and Sp infections [140-142]. Considering our data showing increased Lm and Sp
burdens in spleens of Py-coinfected mice compared to control mice receiving only
bacteria, we also examined the possibility that Plasmodium infection changes numbers
and proportions of these cells over the course of Py infection. Robust inflammatory
responses at the onset of the erythrocytic stage of Plasmodium infection activate the
recruitment of neutrophils and “inflammatory” monocytes into circulation from the bone
marrow where they contribute to the host control of parasite burden and induction of
inflammation through production of cytokines [36, 143]. Clinical reports have found that
increasing numbers of circulating neutrophils in infected individuals is positively
correlated with parasite burden [144]. While monocytes are known to migrate to tissue
sites of parasite sequestration [145], neutrophils do not seem to infiltrate such tissues
despite systemic increases in chemokines [146]. The general lack of neutrophils in
parasite loaded tissues is thought to be due to parasite-induced decreases in surface
expression of CXCR2 or an increase in free heme and activity of heme oxygenase-1 [61,
117, 146]. Both monocytes and neutrophils uptake and kill pRBCs by recognizing
opsonins, such as complement factors or antibody-bound pRBCs [36, 47]. While
parasite-specific IgG is not required for phagocytosis by monocytes, they enhance uptake
and reduce risk of severe symptomatic malaria and complement is still needed in the
absence of antibody [147, 148]. Monocytes and tissue resident macrophages (especially
RPMs) also recognize unopsonized pRBCs through CD36, which also facilitates
phagocytosis [149].
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There is also rational to suspect that Plasmodium infection induces faulty
antimicrobial functions in monocytes and neutrophils. Although they are critical in
controlling parasite burden, studies describe defective phagocytosis functions of
monocytes and neutrophils in patients with current or recent Plasmodium infection [36,
64, 150]. Another observation has been made describing a decrease in cytokine
production, such as TNF-alpha and IL-6, in LPS-stimulated monocytes from Malawian
children with severe malaria [151].
One of the most effective mechanisms of cell-mediated clearance of both
intracellular and extracellular microbial pathogens is the production of reactive oxygen
species (ROS). Through formation of ROS and its radical molecular dismutations, innate
immune cells are able to directly damage and kill many pathogens and release pathogen
associate molecular patterns (PAMPS) that can act as a signal for activation and
recruitment of nearby cells [152]. As Plasmodium infections can alter spleen monocyte
populations and impair the ability of phagocytic cells to produce ROS, both of which are
important in the context of controlling blood-borne bacterial infections, we hypothesized
that Plasmodium-dependent loss of monocytes and defective ROS production may be
responsible for the impaired anti-bacterial immunity described in Chapter II.
The complement system acts as a critical innate immune defense against
microbial infections by recognizing and labeling pathogens for both direct complementmediated killing and by enhancing the antimicrobial functions of phagocytic cells via
opsonophagocytosis. It is well documented that mice with dysfunctional complement
factors or lacking components of the complement system have impaired immunity to
bacterial infections, including Lm, Sp, and STm [57, 127, 153, 154]. Moreover, the
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complement cascade is activated during Plasmodium infection through interactions with
parasitized RBCs, leading to lower levels of serum C1q and defective complement
activity compared to uninfected individuals [120, 155]. These findings led us to
hypothesize that Plasmodium-induced functional defect of a serum component, such as a
complement factor or opsonizing antibody, may contribute to impaired immunity against
secondary bacteria coinfections. This hypothesis will be considered while testing the
ability of splenic phagocytes from Plasmodium infected mice to control intracellular
bacterial replication in this chapter by infecting splenic phagocytes with Lm opsonized
with serum collected from either naïve or Py-infected mice.
In this chapter, the total numbers of splenic myeloid cell types will be determined
over the course of P. yoelii infection and up to 2 months after clearance of the parasite
using flow cytometry. Additionally, the overall control of intracellular Lm replication
and the capacity of reactive oxygen species production of splenic phagocytes from Py
infected mice will be assessed using a gentamicin protection assay and a flow cytometrybased method for detection of intracellular reactive oxygen species, respectively.
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Results
Analysis of splenic myeloid cell population during Plasmodium yoelii infection and
beyond parasite clearance
P. chabaudi infections disrupt splenic architecture and lead to the loss of
marginal zone macrophages (MZMs) and marginal metallophilic macrophages (MMMs)
[134]. As the spleen plays a vital role in the clearance of bacteria in the blood via these
macrophage populations [125, 131, 156], it led to the hypothesis that Py infection results
in a loss of these cell populations that contribute to impaired clearance of Lm. To
determine the impact of Py infection on splenic myeloid cell populations, mice were
infected with Py and various days after infection spleens were removed for quantification
of polymorphonuclear cells (PMNs), inflammatory monocytes, red pulp macrophages
(RPMs), MZMs, and MMMs. Cell types definitions are shown in Figure 11 as flow
cytometry layouts describing our gating strategy. As expected, the total cellularity of the
spleen increased through resolution of Py infection, followed by a return to baseline at
one- and two-months post clearance of Py (Fig. 12A). Analysis of PMNs revealed a
fairly consistent expansion in frequency (Fig. 12B) and total number (Fig. 12C) of PMNs
at days 10, 30-33, and 65-67 post-infection. Whereas the frequency of inflammatory
monocytes remained consistent between Py-infected and control mice (Fig. 12D), there
was an increase in the total number of these cells at days 10 and 30-33 in Py-infected
mice (Fig. 12E). The frequency of RPMs were lower in Py-infected mice at days 30-33
and 65-67 post-infection (Fig. 12F), yet the total cell numbers remained fairly consistent
during acute parasitemia and following resolution of infection (Fig. 12G). Consistent
with the previous report [134], we observed a decrease in the frequency (Fig. 12H) and
total number (Fig. 12I) of MZMs at days 30-33, 65-67, and 101-102 post-Py infection;
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however, there was no difference in % of total splenocytes at day 10 post-Py infection.
In contrast, the frequency (Fig. 12J) and total number (Fig. 12K) of MMMs remained
fairly consistent following Py infection. Although we did not expect changes in
abundance of eosinophils or dendritic cells to have an impact on bacterial clearance, we
included these cell types in our analysis to avoid misidentifying them as any of the other
cells of interest (Fig. 13). Collectively, there is no consistent increase or decrease in
these cell populations that correlates with impaired clearance of Lm in Py-infected mice,
suggesting that alternative mechanisms explain impaired anti-bacterial innate immunity
following Py infection.
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Figure 11. Gating strategy for splenic myeloid cell populations.
Single cell suspensions of spleens collected from mice infected with Py or age-matched naïve controls were
prepared and stained with antibodies for flow cytometry analysis. Representative contour plots are from a
naïve mouse. Arrows represent the hierarchical gating strategy that was used to determine the indicated cell
populations. RPMs were gated early to avoid misidentification due to the highly auto-fluorescent nature of
this cell type [157].
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Figure 12. P. yoelii-induced temporal changes in splenic myeloid cell populations do not correlate
with impaired immunity during bacteremia. C57BL/6N mice were infected with 105 Py pRBCs. Spleens
were collected from control or Py-infected mice on the indicated days post infection. A) Total numbers of
cells per spleen on the indicated days. Myeloid cell populations were defined as follows: PMNs (CD3 -,
CD19-, F4/80-, SIGLEC-, CD11b+, Ly-6G+ ) (B-C), inflammatory monocytes (CD3-, CD19-, F4/80-,
SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Chi) (D-E), RPMs (CD3-, CD19-, F4/80hi) (F-G), MZMs (CD3-,
CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Clo, CD209b-, CD169+) (H-I), MMMs (CD3-,
CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Clo, CD169-, CD209b+ ) (J-K). B, D, F, J) Percent
of splenocytes that are the indicated myeloid cell population. C, E, G, I, K) Total number of indicated
myeloid cell population per spleen. Data (meanS.E.) are combined results from 1* to 3-independent
experiments per timepoint with 3-5 mice per group analyzed with t-tests. *Analysis of MMMs on day 10
post Py infection is a single experiment.
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Figure 12 Continued
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Figure 13. Analysis of Eosinophils and CD11chi Dendritic Cell populations over the course of P.
yoelii infection. C57BL/6N mice were infected with 105 Py pRBCs. Spleens were collected from control
or Py-infected mice on the indicated days post infection. A, C) Total numbers of cells per spleen on the
indicated days. Myeloid cell populations were defined as follows: Eosinophils (CD3-, CD19-, F4/80-,
SIGLEC+, CD11b+), CD11chi Dendritic Cells (CD3-, CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11chi).
B, D) Percent of splenocytes that are the indicated myeloid cell populations . Data (meanS.E.) are
combined results from 3-independent experiments per timepoint with 3-5 mice per group analyzed with ttests.

Effect of Plasmodium yoelii Infection of Anti-bacterial Functions of Innate Immune Cells
Data obtained from the myeloid cell analysis did not show changes that correlated
with our observation that Py+Lm coinfected mice have impaired Lm clearance up to 100
days post Py-infection (Fig. 4), suggesting that antimicrobial functions of innate immune
cells may be compromised by Plasmodium infection. To determine if impaired ROS
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production is a mechanism by which Py suppresses innate immunity during bacteremia,
spleens were removed from naïve control and Py-infected mice. ROS production was
quantified in whole spleen single cell suspensions in untreated cells or cells stimulated
with PMA, unopsonized Lm, Lm opsonized with serum from naïve mice (N-Ops Lm), or
Lm opsonized with serum from Py-infected mice (Py-Ops Lm). In general ROS
production was much more pronounced in Ly-6G+CD11b+ PMNs than Ly-6G-CD11b+
“macrophages” (Fig. 14A). Consistent with increased Lm burden in Py-infected mice,
PMNs from Py-infected mice showed decreases in intracellular ROS production (DCF
geometric mean fluorescence intensity signal) in each of the stimulated groups (Fig. 14BC). In contrast, there was no difference in ROS production in Ly-6G-CD11b+ cells from
Py-infected and naïve mice (Fig. 14D). Similar results were also observed when
splenocytes were stimulated with heat-treated (Ht) Sp, Ht N-ops Sp, or Ht Py-ops Sp
(Fig. 15).
Additional analysis of the data suggests that Py infection may impede immunity to
Sp, at least in part, through a serum-dependent effect. As seen in Figure 15C, Ht Sp
opsonized with serum from naive mice (Ht N-ops Sp) compared to Ht Sp opsonized with
serum from Py-infected mice (Ht Py-ops Sp) elicited increased ROS production in PMNs
from naïve mice (naïve cells treated with Ht N-Ops Sp vs. naïve cells treated with Ht PyOps Sp; open circle comparison in last two groups; unpaired t-test, p=0.00087). An even
more pronounced serum-dependent effect was observed in PMNs from Py-infected mice
(Py cells Ht N-Ops Sp vs. Py cells Ht Py-Ops Sp; gray-filled circle comparison in last
two groups; unpaired t-test, p=0.00042). Of note, this serum-dependent effect was not
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observed following stimulation of Lm (Fig. 14C). Collectively, these results identify
impairment of ROS production in neutrophils as a potential mechanism by which Py
suppresses antibacterial innate immunity during systemic bacterial infections, with an
additional serum-dependent factor further hindering the cellular response to Sp.
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Figure 14. Splenic PMNs from P. yoelii infected mice have defective ROS production in response to
Lm. C57BL/6N mice were infected with 105 Py pRBCs. Single cell suspensions from whole spleens of
naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular ROS. Cells
were then treated with PMA, Lm, or Lm opsonized with 10% serum from naïve or Py-infected mice. A)
Heat map displays DCF fluorescence in CD11b x Ly6G cells to indicate amount of intracellular ROS. Heat
maps are from an individual mouse in each group that are representative of a single experiment and of three
total independent experiments. B) Histogram showing DCF fluorescence of splenic PMNs
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(CD11b+/Ly6G+) as shown in box in (A). DCF geometric mean fluorescence intensity in PMNs
(CD11b+/Ly6G+) (C) and macrophages/monocytes (CD11b+/Ly6G-) (D) populations as indicated in (A).
Each symbol represents an individual mouse. Data (meanS.D.) are representative of three total
independent experiments with 3 mice per group. Statistical significance was determined with multiple
unpaired t-tests.
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Figure 15. Splenic PMNs from P. yoelii infected mice have defective ROS production in response to
heat-killed Sp. C57BL/6N mice were infected with 105 Py pRBCs. Single cell suspensions from whole
spleens of naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular
ROS. Cells were then treated with PMA, heat treated Sp (Ht Sp), or Ht Sp opsonized with 10% serum from
naïve or Py-infected mice. A) Heat map displays DCF fluorescence in CD11b x Ly6G cells to indicate
amount of intracellular ROS. Heat maps are from an individual mouse in each group that are representative
of a single experiment and of three total independent experiments. B) Histogram showing DCF
fluorescence of splenic PMNs (CD11b+/Ly6G+) as shown in box in (A). DCF geometric mean fluorescence
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intensity in PMNs (CD11b+/Ly6G+) (C) and macrophages/monocytes (CD11b+/Ly6G-) (D) populations as
indicated in (A). Each symbol represents an individual mouse. Data (meanS.D.) are representative of three
total independent experiments with 3 mice per group. Statistical significance was determined with multiple
unpaired t-tests (D).

Plasmodium yoelii infection impairs intracellular bacterial killing capacity of splenic
phagocytes
To test impaired antibacterial responses at the cellular level, enrichment of splenic
phagocytes was necessary because of the low overall abundance of macrophage,
monocyte, and neutrophil subsets in the spleen, especially from Py infected mice (~~less
than 10% of total splenocytes during Py infection). Single cell suspensions of
splenocytes from naïve control and Py-infected mice were enriched via depletion of
CD3+ and CD19+ cells using a magnetic column. Figure 16A shows expression of
CD11b and CD11c on all viable cells after column depletion. In order to further enrich
for phagocytes, CD11b+CD11c- cells were then sort purified as indicated by the gate in
Figure 16B. Analysis of CD11b+CD11c- splenocytes identified that about half were Ly6G+ cells (Naïve=43.9%±3.95; Py-infected day 10=52.28%±7.40), indicating mixed
populations of PMNs and mononuclear cells. Sort purified CD11b+CD11c- cells were
infected with Lm in a 5-hour gentamycin protection assay. Consistent with elevated
bacterial burden in Py-infected mice, CD11b+CD11c- cells from Py-infected mice
exhibited impaired ability to kill intracellular Lm compared to cells from naïve mice (Fig.
16C).
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Figure 16. P. yoelii
infection impairs antibacterial functions of
splenic phagocytes. AC) After C57BL/6N
mice were infected with
105 Py pRBCs, splenic
phagocytes were
enriched from naïve or
Py-infected mice day 9
post Py. Magnetic
columns were used to
enrich for splenic
phagocytes by negative
selection of CD3+CD19+
cells. A) Contour plot
showing CD11b and
CD11c expression on
viable splenocytes prior
to T and B cell depletion
on magnetic column. B)
Contour plot showing
CD11b and CD11c
expression on
splenocytes following
magnetic column
depletion of T and B
cells. Circle indicates the
population of splenic
phagocytes that was sort
purified for gentamicin
protection assays.
CD11bhiCD11c- cells
were then sort purified
for experiments. C and
D) 105 sort-purified
CD11bhiCD11c- splenic
phagocytes were plated
in each well and infected
with Lm opsonized with
homologous mouse
serum with MOI=100.
Intracellular Lm burden
was determined after 2
hours and 5 hours (C) in
a gentamicin protection
assay to evaluate fold
change at 5 hours post
infection (D). Fold
change in intracellular
bacteria was determined by cfu/well at 5 hours post infection divided by cfu/well at 2 hours post infection.
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Discussion
Due to the consistent outcome of elevated bacterial burdens in spleens of
coinfected mice for both Lm and Sp models described in Chapter II, and the overall
importance of this organ and the specific subsets of tissue-resident macrophages within
during invasive bacterial infections, we sought to explore how populations of innate
immune cells fluctuate over the course of P. yoelii infection. While other published work
has shown decreases or even complete loss of some myeloid cell subsets in P. chabaudi
or P. berghei murine malaria models, this Chapter aimed to characterize these changes in
P. yoelii infection and describe difference between Py infected and naïve mice from day
10 post infection to 2 months beyond clearance of the infection. A major difference
between the methods used in this work and previous work is that we used a flow
cytometric analysis that allowed for quantitative measurement of surface marker
expression on a single cell level, whereas other work was conducted on the somewhat
qualitative method confocal microscopy. An advantage of using our flow cytometric
method is that it allows us to examine how the total numbers of each population changed
over time and how the relative abundance of each cell subset changed with respect to the
total numbers of cells in each spleen. Also, compared to analysis of tissue sections via
confocal microscopy, our method of cellular analysis by flow cytometry allows for
quantitative measurement of a higher amount of cell surface markers, providing a more
complete picture of splenic myeloid cell populations.
Due to the exhaustive nature of our splenic myeloid cell population analysis, we
found no existing study that examined a similar multitude of cell types in the context of
Plasmodium infection or any other disease. Therefore, many considerations were made
in generating the panel of cell surface markers that were used to identify specific cell
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populations, choosing proper combinations of conjugated fluorochromes, and conceiving
an informed gating strategy. In this manner, we took advantage of literature describing
surface markers that are known to have specific levels of expression on cell population
subsets of interest in order to improve the accuracy and power of our analysis.
Characterizations of multiple cell populations within an organ or tissue are able to
identify a specific cell type based on high expression or absence of a single surface
marker that has been associated with an individual cell-type. In this work, however,
several cell subtypes examined share nearly identical expression of multiple identifying
surface markers due to their common hematopoietic origin. Since RPMs are known to be
frustratingly autofluorescent [157, 158], they were the first cell type defined in our gating
strategy immediately following the elimination of lymphocytes from the analysis, where
CD3/CD19 positive cells separated (Fig. 11). To improve this cell analysis scheme in the
future, the intrinsic autofluorescence of RPMs could be utilized by including and
recording an open fluorescence channel, such as FITC, APC, or PE-Cy7, each of which
have previously been demonstrated to have clear peaks that identify unstained RPMs as
distinct from unstained dendritic cells as shown in Franken et. al [157] in Supplementary
Figure 1. This method for identifying RPMs has also been demonstrated by Mitchell et.
al 2012 [159].
Our results indicate that significant changes in several of the cell types examined
occur during Py parasitemia and remain for up two months after parasite clearance.
Among the cell types that are known to be important in clearance of invasive bacteria in
the bloodstream, only MZMs were decreased in spleens of Py infected mice 101-102
days post Py infection. Lower numbers of MZMs at this time point correlates with
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impaired antibacterial innate immunity. Yet, MZMs were elevated in Py infected mice
compared to control mice day 10 post Py infection when mice also displayed impaired
bacterial clearance. Consequently, the initial increase and subsequent loss of MZMs in
the spleen does not appear to change the bacterial clearance abilities in this model
system.
There is strong rationale to hypothesize that one or more of the phagocytic cell
populations characterized in this work become unable to perform anti-microbial functions
during and following Plasmodium infection. While we were able to show defective
control of intracellular replication in a more generally defined population of splenocytes
from Py-infected mice that contained a mixture of macrophages, monocytes, and
neutrophils (Figure 16), more work is needed to determine whether this defect is specific
to a single cell type or if it is common to multiple. Similar results were obtained when
using sorted splenic phagocytes from Py-infected mice on both days 9-11 (Figure 16) and
day ~30 (data not shown) post infection in the ex vivo gentamicin killing assay,
suggesting that there could be a common mechanism during acute parasitemia and at a
time point shortly after parasite clearance. Chapter IV will seek to test the hypothesis
that exposure to hemozoin is sufficient to impair control of intracellular Lm replication.
Another limitation of the in vitro gentamicin protection assay is the inability to
determine whether a particular cell type has defective functions or if there is a general
defect in multiple splenic phagocyte populations. Given that both Plasmodium chabaudi
and Leishmania donovani infections induce loss of MZMs and MMMs, and Sp sepsis
increases involvement of RPMs in their absence following L. donovani infection, there is
rationale to specifically test the ability of RPMs to eliminate Sp, and compare this to
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purified cultures of MZMs, MMMs, and mixed cultures [133, 134]. This type of
experiment would potentially show stronger phenotypes if there are cells with normal
functional ability diluting and diminishing the effect. Knowledge of functional capacity
of specific cell types to control bacteria in vitro would provide meaningful insight into
the potential mechanisms of the enhanced mortality we’ve observed in our Py+Sp
coinfection model. There are, however, other factors that may contribute to the impaired
clearance of Lm at early and late time points post infection, respectively. For example,
loss of functional complement components during the parasite infection could decrease
bactericidal capacity of the innate immune cells despite the initial increase in MZMs that
would otherwise aid in bacterial clearance under normal conditions. Additionally, at time
points that follow clearance of Py, complement factor function returns to normal (only
observed in P. berghei/chabaudi), yet at this time the loss of total numbers of MZMs may
be responsible for the long-term impaired clearance of Lm. Further experiments are
needed in order to completely understand exactly which anti-bacterial mechanisms of
which specific cell types are impaired at different timepoints in this model system.
Additionally, our analysis is not able to detect changes in the ability of migratory
innate immune cell populations to infiltrate the spleen in response to a secondary
bacterial infection. There is strong evidence suggesting that monocyte, neutrophil, and
dendritic cells have impaired chemotaxis [117, 160], antigen presentation, and other
antimicrobial functions in the context of Plasmodium infections [61, 161-164]. It is
likely that the during/after Plasmodium infection the inability of these cells to
migrate/egress from circulation into the spleen impedes the clearance and overall
immunity to bacterial coinfections
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Prior studies characterizing changes in populations of splenic myeloid cells during
disease have utilized confocal microscopy of spleen sections, which allows for
characterization of splenic architecture and the position of cells relative to landmarks
such as red pulp, white pulp, marginal zones, and germinal centers [134]. While this
approach is useful for evaluating the stage of maturation or extent of adaptive immune
responses, it is only partly quantitative and therefore does not provide a full picture of
spleen functions. Splenomegaly and disruption of marginal zone architecture during
malaria makes analysis of cell types based on location in tissue problematic due to a lack
of important landmarks. We chose to use a flow cytometry method for analysis of
splenic innate immune cell populations because it allowed us to take advantage of
differential expression of surface markers to identify specific subsets, such as MMMs and
MZMs, without limiting the number of cell types we could explore in a single sample.
The gating strategy and definitions of cell populations was developed by
combining strategies from previous studies – for neutrophils, eosinophils, dendritic cells,
inflammatory monocytes, and red pulp macrophages [165]. Since no other study had
previously characterized MMMs and MZMs with flow cytometry, a method for detecting
these cells was devised by drawing gates based on the fluorescence-minus-one(FMO)
samples, which were stained with all antibodies other than the one being examined.
Discrepancies in background autofluorescence of PE and APC (recognizing CD169 and
CD209b and identifying MMMs and MZMs, respectively) were evident between samples
from naïve and Py-infected mice at all timepoints post Py infection and gates were drawn
accordingly for all samples in respective naïve or Py infected mouse groups
independently for each experiment/repeat. In each experiment cells from Py-infected
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mice appeared to have higher background autofluorescence in APC and PE channels than
cells from naïve mice despite the trend of these markers being expressed more highly in
cells from naïve mice (data not shown). Whether or not this observation was occurring in
other cell types/fluorophore channels was not assessed, and further analysis should be
done to determine the overall impact it may have had on these results. One explanation
for this observation that convoluted the analysis is that some factor related to the Py
infection increased the overall autofluorescence of MMMs, MZMs, and possibly other
cell populations, which would potentially impact absolute and relative numbers of every
cell type that was examined.
The activity of Plasmodium-induction of serine proteases presents another
potential explanation of both the observed loss of splenocyte subpopulations during some
but not all timepoints analyzed post-Py infection, and the technical problem of
inconsistent baseline (unstained) levels of MMM and MZM markers. During the blood
stage of Plasmodium infection both parasite and host immune cells produce factors, such
as Plasmodium serine proteases and neutrophil elastase (also a serine protease), that are
capable of cleaving surface molecules from innate immune cells, including toll-like
receptors, and intracellular adhesion molecule-1(ICAM-1/MAC1/CD54) [166, 167].
This receptor-cleaving activity may be occurring during Py infection and cleaving
immune cell surface proteins that are not yet known to be affected. In this scenario, the
impact of proteases on immune cell surface markers may vary over the course of
infection with cleavage decreasing as the course of the infection nears senescence and
eventually having no affect. Hypothetically, this situation would have an immense impact

78

on our analysis and accounting for this phenomenon would be essential for accurate
comparisons between naïve and Py-infected mouse splenocyte populations.
Previous work from both clinical studies and animal models describe impaired
ROS production by PMNs isolated from Plasmodium-infected individuals and mice [61,
62, 64]. These reports linked the lack of sufficient respiratory burst observed during
acute severe malaria cases as well as months after senescence to the clinical observations
that demonstrated an elevated susceptibility to invasive NTS coinfections [53, 56, 168,
169]. The experiments performed in these investigations measured ROS production from
neutrophils isolated peripheral blood or bone marrow following stimulation with PMA, in
one case, 1x108 cfu of opsonized S. typhimurium in vitro [64]. To date, defective
neutrophil functions, including impaired ROS production, chemotaxis, and general
impairment of bacterial killing – is attributed to the activity of HO-1 related to
Plasmodium infection induction of hemolysis [61, 62, 64]. While the impaired ability of
PMNs to produce sufficient level of ROS needed to kill intracellular NTS was clearly
demonstrated, these studies raise several questions. Both Cunnington et al. [61] and
Nyirenda et al. [64] detected decreased ROS production in PMNs from patient samples
obtained either 4 to 8 weeks after the initial check and treatment with artemetherlumefantrine or other anti-malarial drugs.
In this work we sought to examine ROS production in myeloid cells from spleens
from Py infected mice compared to naïve mice. Since parasite-dependent hemolysis
occurs only during active replication of the parasite in the erythrocytic stage of infection,
and we had found impaired clearance of Lm and increased susceptibility to Sp during Py
coinfection (Figures 4 and 8 in Chapter II), we hypothesized that factors other than HO-1
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and hemolysis may be contributing to the Plasmodium-dependent defect in PMN ROS
production. Additionally, we sought to characterize ROS production in myeloid cells
from the spleen, an organ of great importance during invasive bacterial infections [39,
124, 156], rather than from peripheral blood. Also, we hoped to determine whether the
impaired ROS production occurred in macrophages and monocytes within the spleen, or
if this defect was specific to PMNs. Finally, our ex vivo assay was designed to test
intracellular ROS production of splenocytes in response to Lm and Sp, with the addition
of PMA stimulation to serve as a positive control.
We found that Py infection significantly impaired ROS production by PMNs, but
not “macrophages” (CD11b-, Ly-6G-), when treated with PMA, Lm, and heat-treated Sp.
It is known that PMN production of ROS is sufficient to kill intracellular Lm [154], and
therefore, this result supports our hypothesis that Py-infection induced reduction in PMN
ability to produce ROS contributes to the impaired clearance of Lm in spleens of
coinfected mice. We also observed reduced ROS production of splenic PMNs from Pyinfected mice in response to heat-treated Sp. This defect likely does not affect killing or
clearance of Sp since it is know that Pneumococcus can survive significant levels of
oxygen radicals and in fact produces hydrogen peroxide (H2O2), which acts together with
pneumolysin toxin to kill host cells independent of caspases [170], and disrupts alveolar
epithelium as a mechanism to initiate firm adherence while invading the respiratory tract
[171]. It is possible, however, that the decreased ROS production in splenic PMNs from
Py-infected mice is a symptom of a larger defect in anti-microbial functions. This idea
will be explored further in Chapters IV and V.
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Py infection may also impair the innate immune response to invasive bacteria via
serum-dependent effects. Complement components C1q and C3 interact with parasitized
RBCs during P. falciparum infection, initiating the complement cascade, which leads to
reduced serum levels of C1q and lower complement activity compared to uninfected
individuals [120, 155]. Several components of the complement system are considered
essential for immunity to Sp infection, as individuals with genetic defects in C3, which is
involved in both the classical and alternative complement pathways, experience recurring
pneumococcal infections and infections with other encapsulated bacteria. Similarly, mice
lacking expression of C3, factor B, C1qa, or C4 genes are more susceptible to Sp
infections [153]. Moreover, killing of Sp by neutrophils has been shown to require active
complement opsonophagocytosis via CR3 (CD11b/CD18 heterodimer complement
receptor) [172]. Consistent with Plasmodium-induced depletion of complement and a role
for complement in immunity to Sp, we observed decreased ROS production in splenic
PMNs from naïve mice stimulated with heat-killed Sp opsonized with serum from Pyinfected mice compared to splenic PMNs stimulated with heat-killed Sp opsonized with
serum from naïve mice (Fig. 15A-C). Similarly, PMNs from Py-infected mice showed
increased ROS production following stimulation with heat-killed Sp opsonized with
serum from naïve mice compared to serum from Py-infected mice. This observation
could indicate a serum factor-dependent defect in neutrophil opsonophagocytosis that
may lead to impaired immunity to Sp during malaria. Although ROS bursts within
neutrophil phagolysosomes are not sufficient to kill Sp [172], deficiency in PMN ROS
production in response to heat-killed Sp opsonized with serum from Py-infected mice
compared to heat-killed Sp opsonized with serum from naïve mice suggests that
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phagolysosome maturation, or other events that follow opsonophagocytosis, may be
inhibited or less responsive. It has also been shown that serum from febrile P. falciparum
infected individuals results in decreased C3 deposition on NTS compared to serum from
non-febrile P. falciparum negative individuals [63]. Collectively, these observations
suggest that complement depletion during Plasmodium infections may be a general
deficiency associated with invasive bacterial infections.
To better understand the interaction between phagocytic cells of the spleen and
Lm in the context of malaria, the gentamicin protection assay was developed. This
technique allowed us to compare intracellular bacterial burdens in cells from spleens of
Py-infected and naïve at various times post-infection to determine whether Plasmodium
infection effected the cell’s ability to control intracellular replication (Fig. 16). At the
early timepoint of 2 hours post Lm infection, fewer CFUs were detected in cells from Py
infected mice. This result can be interpreted in several ways. First, a difference in Lm
adherence could alter either uptake of Lm by phagocytosis or Lm invasion of cells in this
assay. Since gentamicin was added to the culture 1 hour after infection, attached Lm and
other extracellular Lm are killed and differences in Lm attachment to the surface of cells
from naïve and Py-infected at this time would no longer impact the resulting bacterial
burdens 1 or 4 hours later when bacteria was plated for cfu analysis. It may be that
splenic phagocytes from Py-infected mice have some modified surface components that
impede Lm attachment, and subsequent invasion or uptake. Alternatively, changes in
serum factors during Py infection, such as opsonins: antibody and complement factors,
could change dynamics of Lm ability to induce its uptake. Some other factors that could
influence numbers of intracellular bacterial burdens after 2 hours are differences in
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extracellular and intracellular killing. Neutrophils encountering Lm in these in vitro
conditions would be capable of producing bactericidal granules and NETs. They would
also have adequate time to internalize Lm and fuse Lm-containing phagosomes with
granules and combining anti-microbial components such as proteases and ROS.
Therefore, lower CFUs in cells from Py-infected mice may have resulted in increased
ability of these cells to kill extracellular Lm, intracellular Lm, or both. Finally, the
decreased bacterial burdens seen in cells from Py-infected mice could be explained by a
general defect in Lm phagocytosis, which has been previously described in the context of
malaria and hemozoin [85, 173, 174].
While results at 2 hours post Lm infection indicated lower intracellular Lm
burdens in cells from Py-infected mice, CFU analysis at 5 hours post-Lm infection
showed a drastic increase compared to almost no change in cells from naïve mice
(Fig. 16 C). This result indicates that cells from Py-infected mice, despite having lower
Lm burdens at 2 hours post infection, were permissive to Lm growth between 2 and 5
hours, whereas cells from naïve mice were capable of controlling Lm intracellular
replication (Fig. 16 C and D). This result introduces several important questions
pertaining to the Py-dependent mechanism(s) that are rendering splenic phagocytes into
permissive to bacterial growth. Previous reports that investigated Plasmodium
coinfections with NTS have found that Py hemolysis-induced HO-1 and IL-10 inhibit
essential functions of innate immune cells and are sufficient to increase the overall
severity of NTS infection [59, 61, 62, 64]. In the case of immunity to Lm in our Py+Lm
coinfection model, however, it is unlikely HO-1 or IL-10 are contributing to the defective
control of Lm growth as we found that inhibiting either of these factors did not improve
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Lm clearance in coinfected mice (Fig. 6). Lm is susceptible to intracellular production of
ROS within phagocytic cells, specifically neutrophils [175]. We found that PMNs from
Py-infected mice have defective ROS production in response to Lm (Fig. 14). Additional
experiments are required to determine whether defective ROS production is contributing
to this phenotype and if the defect is specific to a particular cell type (monocyte,
macrophage, and/or neutrophils), as the cells sorted for this assay contained a mixture of
all CD3/CD19-/-, CD11c- and CD11b+, which should only eliminate all lymphocytes, and
some types of dendritic cells. The impact of Hz on this system is explored in Chapter IV.
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CHAPTER IV
THE PARASITE FACTOR HEMOZOIN IMPAIRS INNATE IMMUNITY TO
BACTERIAL COINFECTIONS DURING MALARIA

Introduction:
During the blood stage of Plasmodium infection, parasites within infected
erythrocytes release proteases to digest protein components of hemoglobin within their
digestive vacuoles resulting in the release of free heme, which is toxic to the parasite.
Heme is detoxified within the parasite digestive vacuole via non-enzymatic
polymerization into hemozoin (Hz), which is an insoluble crystal structure[176].
Following erythrocyte rupture and merozoite escape, Hz is released into circulation and
engulfed by phagocytic cells resulting in deposition in tissues and organs such as spleen,
liver, brain, lungs, and bone marrow. Hz deposition following Plasmodium berghei
infection was evident in the spleen, liver, bone marrow, and peripheral blood 196 days
after infection [110]. Hz has also been reported in lung and brain tissue of P. berghei and
Plasmodium chabaudi infected mice [83] and is involved in the malaria-driven
pathologies specific to those organs, such as malaria-associated acute respiratory distress
syndrome and cerebral malaria, respectively [81, 177, 178] .
The immune modulatory potential of Hz has been examined in several studies
with a wide variety of Hz preparations and cell types being used. While synthetically
generated Hz has been described in some cases as “immunologically inert”, others have
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found Hz formed naturally during erythrocyte infection to alter and impair many immune
cell functions [179]. For example, uptake of parasitized RBCs or purified Hz by human
monocyte-derived macrophages causes impaired phagocytosis of additional RBCs or
production of a PMA-induced oxidative burst [173], which are impaired via Hzdependent inactivation of protein kinase C and NADPH-oxidase [164, 180]. Purified
digestive vacuoles with intact membranes (not sonicated or detergent treated) isolated
from P. falciparum-infected RBC culture have been shown to activate complement, and
decrease ROS production and bactericidal capacity of human PMNs [161, 162].
Internalization of Hz has also been found to induce the production of pro-inflammatory
cytokines such as IL-1β and TNF and also increase chemokine production and enhance
expression of their receptors (CCL3-5, MCP-1) in mouse macrophages and human
peripheral blood monocytes [181, 182]. Antigen presentation functions and overall
functional maturation of dendritic cells are also impacted, as decreased surface
expression of CD54, CD11c, and MHC-class II in human PBMCs following stimulation
with IFN-γ has also been observed during co-incubation with Hz [163].
Few studies, however, have looked directly at the interactions between innate
immune cells and Hz in the context of in vivo bacterial infection or the effect of Hz on
neutrophil function, and we have found none to date that have explored interactions with
Streptococcus pneumoniae infection. Moreover, previous work has shown impaired
antimicrobial functions of innate immune cells from African children with uncomplicated
malaria that lasted up to 8 weeks after antimalarial treatment [61]. Of note, there is
unlikely to be parasite-induced hemolysis during convalescence, which is the current
hypothesis by which Plasmodium suppresses anti-bacterial innate immunity. Collectively,
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this leads to the hypothesis that Hz contributes to Plasmodium-induced suppression of
innate immunity to bacterial infections.
The aim of this Chapter is to explore the immunomodulatory properties of Hz in
the context of bacterial infections and the innate immune cell functions that are vital to
controlling invasive bacterial infection. To test these hypotheses, a novel method of
isolating and purifying hemozoin from livers and spleens of Py-infected mice (PyHz) was
developed. The addition of PyHz to cultures of innate immune cells in vitro and injecting
intravenously into naïve mice prior to bacterial infection allowed us to gain insight into
the interaction between this parasite metabolic byproduct and how bioactive molecules
associated with Hz contribute to Plasmodium-induced immunosuppression.

Results
Impact of Plasmodium-derived hemozoin on anti-bacterial functions and control of
intracellular bacterial replication in splenic phagocytes
Hemozoin has been shown to remain in host tissues, including the spleen, for many
months after the clearance of infection [83, 110]. This physical characteristic of Hz and
the long-term suppression of innate immunity to bacteremia following clearance of
Plasmodium yoelii (Fig. 4C), led to the hypothesis that Hz is a parasite-derived factor that
is capable of impairing anti-bacterial effector functions. To perform these studies, we
developed an approach to isolate Hz from the spleens and livers of mice that had cleared
Py infections (Figure 17). An image of Hz formed in food vacuole of P. falciparum is
shown in Figure 17A [183]. After collecting the organs (spleens of naïve and Py-infected
mice shown in picture Figure 17B) they were thoroughly homogenized and then washed
in de-ionized water and then passed through a 100-micron nylon mesh filter to remove
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remaining pieces of tissue. Next hemozoin was suspended in PBS before being added to
the top of a discontinuous Percoll density gradient with 40% and 80% fractions (Fig. 17
C). Hemozoin was collected from the interface between the 40 and 80% fractions as well
as beneath the 80% fraction. Isolated hemozoin from Py-infected mouse organs (PyHz)
was finally washed in 2mM mannitol-containing buffer and resuspended in sterile saline
prior to use. Details of other Hz preparations can be found in the Materials and Methods
section.
Figure 17. Hemozoin isolation from
liver and spleens of Py-infected mice. A)
Hemozoin crystals within the digestive
vacuole of P. falciparum, color was added
with imaging software (adapted from D.
Jani et al. 2008 [183]. B) Spleens from
naïve, 14, and 28 day Py-infected mice.
Dark color in Py-infected spleens due to
Hz deposition. Adapted from C) Percoll
gradient used for isolation of hemozoin
collected from homogenized spleens and
livers from Py-infected mice.
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To test the hypothesis that Hz contributes to Py-induced immune suppression, we
first examined whether Hz contributed to the defective production of ROS that was
observed in splenic PMNs isolated from Py-infected mice (Fig. 14 and 15). Single cell
suspensions from whole spleens isolated from naïve mice were incubated with PyHz for
6 or 16 hours prior to stimulation with Lm, Sp, or control PMA (Fig. 18). One hour after
stimulation with bacteria or PMA, cells were treated with DCF and intracellular ROS was
measured via flow cytometry. Low levels of ROS were detected in both untreated cells
and cells treated with PyHz alone (Fig. 18A,C-D). While PMA stimulation induced
similar ROS in untreated and PyHz treated PMNs, opsonized Lm and heat-treated
opsonized Sp did not elicit a robust ROS response (Fig. 18A-D). In contrast, both
untreated and PyHz-treated PMNs infected with live-opsonized Sp had high levels of
ROS (Fig. 18A-D), with PyHz-treated PMNs exhibiting significantly higher ROS than
untreated samples (Fig 18D). Similar results were observed in the spleen CD11b+/Ly6G- populations (Fig. 18E).
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Figure 18. PyHz treatment does not alter intracellular
ROS production of splenic neutrophils in whole spleen
single cell suspension. Single cell suspensions from whole
spleens of naïve mice were incubated with 60μg hemozoin
isolated from liver and spleen homogenate from Py-infected
mice(PyHz) for 6 or 16 hours. After incubation with PyHz,
cells were incubated with DFC to detect intracellular ROS.
Cells were then treated with PMA, opsonized ΔactA Lm
(Ops-Lm), heat treated opsonized Sp (Ht Ops-Sp), or
opsonized live Sp (Ops-Sp). A and B) Heat map displays
DCF fluorescence in CD11b x Ly6G cells to indicate amount
of intracellular ROS. A) and B) display the same data for the
Ht Ops-Sp group, B) includes the live Ops-Sp group with an
increased maximum DCF signal for improved visualization of changes in ROS production. Heat maps are
from an individual mouse in each group that are representative of a single experiment and of three total
independent experiments. C) Histogram showing DCF fluorescence of splenic PMNs (CD11b+/Ly6G+) as
shown in box in (A). DCF geometric mean fluorescence intensity in PMNs (CD11b +/Ly6G+) (D) and
macrophages/monocytes (CD11b+/Ly6G-) (E) populations as indicated in (A and B). Each symbol
represents an individual mouse. F) DCF geometric mean fluorescence of untreated and PyHz-treated
PMNs (CD11b+/Ly6G+) as shown in box in (A) incubated in the indicated conditions for 6 and 16 hours
prior to DCF treatment and PMA stimulations or infections. Data (meanS.D.) are representative of three
total independent experiments with 3 mice per group for (D - F). Statistical significance was determined
with multiple unpaired t-tests (D).

90

Since we did not observe differences in ROS production between PyHz treated and
untreated PMNs, or other cell populations from whole spleen single cell suspensions, a
purified population of neutrophils were isolated from bone marrow of naïve mice and
incubated with PyHz prior to infection with Lm and Sp in order to increase the amount of
interaction between our cells of interest and the Hz. The purity of neutrophils in the
population was determined based on the Ly-6G+/CD11b+ gate drawn in Figure 19 A and
compared to total single cells (Fig. 19C). These conditions were also performed with
hemozoin isolated from red blood cell cultures of the important human pathogen, P.
falciparum (PfHz). Following incubation with Hz, cells were treated with DCF and then
stimulated with PMA or with opsonized Lm, Ht Ops Sp, or live Ops-Sp. Similar to what
was observed using whole spleen single cell suspensions, incubation with PyHz or PfHz
did not impair intracellular ROS production in bone marrow purified neutrophils (BMNs)
(Fig. 19). Increased ROS in cells stimulated with live opsonized Sp was seen again in
this experiment, comparable to the result in Figure 18 with whole spleen single cell
suspension and Hz treatment. Purified BMNs with PyHz or PfHz treatment contained
high levels of ROS when stimulated with live opsonized Sp (though not as high as in
PMNs in whole spleen single cell suspension), yet BMNs that were not treated with PyHz
or PfHz displayed similar DCF signal as unstimulated cells following infection with live
opsonized Sp (Fig. 19D). Together, these data indicate that the ability of BMNs as well as
PMNs from whole spleen single cell suspensions to produce ROS is not impeded by Hz.
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Figure 19. Hemozoin treated bone-marrow-purified
Neutrophils do not have defective ROS responses.
Purified bone marrow neutrophils (BMNs) were isolated
from naïve mice and incubated with 60μg of either hemozoin
isolated from liver and spleen homogenate from Py-infected
mice(PyHz) or hemozoin isolated from Plasmodium
falciparum-infected human red blood cell culture (PfHz).
After incubation with PyHz or PfHz for 4-5 hours, cells were
incubated with DFC to detect intracellular ROS. Cells were
then treated with PMA, opsonized ΔactA Lm (Ops-Lm), heat
treated opsonized Sp (Ht Ops-Sp), or opsonized live Sp
(Ops-Sp). A) Heat map displays DCF fluorescence in
CD11b+ x Ly6G+ cells to indicate amount of intracellular
ROS. Each heat map layout is from an individual mouse in each group that are representing one of three
independent experiments. B) Histogram showing DCF fluorescence of purified BMNs (CD11b+/Ly6G+) as
shown in the gate in (A). DCF geometric mean fluorescence intensity in BMNs (CD11b+/Ly6G+) (C).
Percent purity of BMNs in each sample determined as percent of CD11b+/Ly6G+ single cells (D). Each
symbol represents an individual mouse. ed in box in (A) incubated in the indicated conditions for 6 and 16
hours prior to DCF treatment and PMA stimulations or infections. Data (meanS.D.) are representative of
three total independent experiments with 3 mice per group for (C and D). Statistical significance was
determined with one-way ANOVA followed by Tukey’s multiple comparisons test.
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In order to assess the ability of parasite derived hemozoin to contribute to
impaired innate immunity to bacterial coinfections, we sought to create a coinfection
model that utilizes a Plasmodium parasite that is deficient in Hz production. Mutant
strains of P. berghei (Pb) NK65 were obtained to determine whether the absence or a
significant decrease of Hz production during Plasmodium infection would improve
clearance of Lm compared to wild-type Pb NK65. We acquired Δpm4, a Pb NK65 mutant
strain that lacks plasmepsin 4 (pm4), a gene encoding a protease involved in digesting
hemoglobin [184]. Given the importance of Hz formation in the detoxification of heme
within infected RBCs, Pb strains with impaired Hz production have an attenuated
phenotype characterized by a significantly reduced parasitemia during infection [184].
To ensure that decreases in parasitemia were not responsible for any phenotypes
observed, we also obtained a Pb strain lacking a gene encoding dipeptidyl
aminopeptidase 2 (Δdpap) that exhibits attenuated parasitemia similar to Δpm4. These
strains were kindly provided by Dr. Phillipe Van den Steen from KU Leuven–University
of Leuven, in Leuven, Belgium. Mice were given intraperitoneal injections with 104
pRBCs of the wild type Plasmodium berghei strain NK65 (Pb wt), Pb Δdpap, and Δpm4
obtained from infected donor mice and parasitemia was measured on days 6, 8, and 9.
On day 7 post Pb infection, injections of 5x106 CFU of ΔactA Lm were administered to
Pb-infected mice and naïve controls. As expected, mice infected with Pb Δdpap, and
Δpm4 strains had lower parasitemia than wild type (Fig. 20A). While Δpm4 infected mice
had significantly less Hz than WT in both liver and spleens by day 9 post Pb infection,
Hz levels in Δdpap infected mice trended lower in spleens compared mice infected with
WT Pb NK65, and was significantly less than levels found in livers of WT infected mice
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(Fig. 20B and C). On day 9 post Pb NK65 infection (day 2 post Lm), spleens and livers
were removed, and bacterial burdens were analyzed. Similar to what was observed in
Py+Lm, mice coinfected with Pb and Lm had higher bacterial burdens in spleens and
livers than mice infected with Lm alone. However, contrary to our hypothesis, Lm
burdens in Δpm4-infected mice were higher than Pb wt-infected mice in spleens and
trended higher than Δdpap-infected mice (Fig. 20D and E). Based on the data gathered
from these experiments, deficiency in Hz production in this coinfection model do not
impair clearance of Lm and more work is required to produce a model system where a
normal Plasmodium infection can occur with the absence of Hz deposition in tissues and
innate immune cells.
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Figure 20. Infection with
Plasmodium berghei mutant
deficient in Hz does not
delay ΔactA Lm clearance.
C57BL/6 mice were given an
intraperitoneal injection of
1x104 pRBCs collected from
donor mice infected with
strains Pb NK65 (wt), Pb
NK65 DPAP- (DPAP-), or Pb
NK65 PM4- (Pm4-).
Parasitemia was analyzed on
days 6, 8, and 9 post infection
via flow cytometry (A). On
day 7, naïve control mice and
groups of 5 mice were
infected with each of the three
Pb mutant strains were
infected with 5x106 CFU of
ΔactA Lm. On day 9 post Pb
infection (day 2 post Lm),
mice were sacrificed, and
spleen and liver tissues were
collected for both Hz
quantification (B and C) and
bacterial burdens (D and E).
Data (mean ± S.D.) are
representative of a total of
three independent
experiments. Statistical
significance was determined
by one-way ANOVA
followed by Tukey’s multiple
comparisons.

Although we did not observe defective ROS production in innate immune cells
treated with Hz in vitro or improved Lm clearance in spleens of mice infected with Hzdeficient Plasmodium, our strong rationale to investigate the immunosuppressive activity
of Hz led us to investigate the effect Hz has on survival of bacteria within splenic
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phagocytes. Therefore, we used a gentamicin protection assay using sort-purified splenic
phagocytes to test the hypothesis that in presence of Hz, cells would have a defective
ability to or control the intracellular growth of Lm. PyHz extracted from spleens and
livers of mice that had cleared a Py infection was incubated with sort purified splenic
phagocytes from naïve mice for 1-2 hours before cells were infected with Lm in a
gentamycin protection assay, as described in Figure 13 in Chapter II. Following
incubation with PyHz, some CD11b+CD11c- cells had phagocytosed PyHz, while others
did not (Fig. 21A). Consistent with the hypothesis, PyHz impaired the ability of
CD11b+CD11c- to kill intracellular Lm compared to PBS treated cells (Fig. 21B and C).
These data demonstrate that a parasite-derived factor (PyHz) was capable of impairing
the anti-bacterial effector mechanisms of CD11b+CD11c- cells in an in vitro assay.
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Figure 21. P. yoelii -derived hemozoin
and bound bioactive molecules impair
anti-bacterial functions of splenic
phagocytes. 105 sort-purified
CD11bhiCD11c- splenic phagocytes
were enriched, as in Figure 13 (A-B),
from naïve mice and were incubated
with 30μg hemozoin purified from
spleen and livers of mice previously
infected with Py (PyHz) for 1-2 hours.
A) A giemsa-stained cell containing
internalized PyHz (brown pigment),
indicated by arrow, and PyHz negative
cells containing no visible uptaken
pigment. Intracellular ΔactA Lm burden
was determined after 2 hours and 5 hours
(B) in a gentamicin protection assay to
evaluate fold change at 5 hours post
infection (C). Fold change in intracellular
bacteria was determined by cfu/well at 5
hours post infection divided by cfu/well at
2 hours post infection. Data (meanS.D.)
are representative of 3 independent
experiments each symbol represents an
individual replicate of pooled cells from 3
mouse spleens per group. Statistical
analysis was determined with MannWhitney test.

In vivo analysis of Hz-induced suppression of innate immunity during bacterial infection
To test whether PyHz was able to impair the clearance of Lm in vivo, naïve mice
were given intravenous injections of PyHz followed by ΔactA Lm infection 7-days later.
PyHz was observed in some, but not all circulating leukocytes both 1- and 7-days post
injection as well as in spleen and liver cells 9-days after injection (Fig. 22A). PyHz could
also be quantified in both the spleen and liver 9-days post PyHz injection (Fig. 22B).
When Lm burden was quantified, PyHz treated mice had an elevated burden in the spleen
(Fig 22C). With this data, we have shown that a parasite factor alone, PyHz, is capable
of impairing innate immune response to a secondary bacterial infection.
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Figure 22. P. yoelii hemozoin with bound bioactive molecules is sufficient to impair clearance of
ΔactA Lm in vivo. C57BL/6N mice treated i.v. with 1mg PyHz isolated from livers and spleens of Py
infected mice (A-C). 7 days after Hz treatment mice were infected with 5x10 6 CFUs ΔactA Lm. A )
Giemsa stained peripheral blood smears and cells mounted from spleen and liver single cell suspensions on
the indicated days post Hz treatment. Arrows indicate the presence of intracellular Hz, visible as brown
pigment. PyHz and PfHz-negative leukocytes were present at indicated time points in peripheral blood,
spleen or liver with no visible intracellular Hz pigment (B and E) Quantification of Hz in spleens and
livers. Data (meanS.D.) are from a single experiment representing three independent experiments. Dotted
lines represent the limit of Hz detection. Bacterial burden in spleens of PyHz (C) PfHz (F) or untreated
control mice was determined 2 days post Lm infection. Data (meanS.E.) are cumulative results from 2-3
independent experiments. Each symbol represents an individual mouse (G-I) C57BL/6N mice were treated
i.v. with 1-1.5mg PyHz followed by i.n. infection with 10 6 CFU Sp 7 days later. Mice were sacrificed 2
days after Sp infection and lungs, blood, and spleens were collected for bacterial burden analysis. Data
(meanS.E.) are pooled results from 3 independent experiments. For all data, each symbol represents an
individual mouse. Statistical significance was determined with Mann-Whitney test.
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Py is a rodent-specific species of Plasmodium, and previous studies exploring
immune modulatory effects of Hz have typically isolated Hz from P. falciparum infected
RBC cultures, rather than from organs of infected animal. To address potential
differences in isolating Hz from organs of previously infected mice, and the ability of
clinically relevant P. falciparum Hz to suppress innate immunity during bacteremia, Hz
from P. falciparum infected red blood cell cultures (PfHz) was also tested. Consistent
with Hz from Py infected mice, PfHz could be detected within some leukocytes in
peripheral blood following injection, while others remained PfHz-negative (Fig. 23A),
was quantified in both the spleen and liver (Fig. 23B), and PfHz treated mice had
elevated bacterial burden two-days post Lm infection (Fig. 23C).
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Figure 23. Plasmodium falciparum hemozoin (PfHz) is sufficient to impair clearance of ΔactA Lm in
vivo. C57BL/6N mice treated i.v. with 1mg hemozoin isolated from P. falciparum (Pf) infected red blood
cell culture (PfHz). 7 days after PfHz treatment mice were infected with 5x106 CFUs ΔactA Lm. A)
Giemsa stained peripheral blood smears and cells mounted from spleen and liver single cell suspensions on
the indicated days post Hz treatment. Arrows indicate the presence of intracellular Hz, visible as brown
pigment. PfHz-negative leukocytes were present at indicated time points in peripheral blood, spleen or liver
with no visible intracellular Hz pigment (B) Quantification of Hz in spleens and livers. Data (meanS.D.)
are from a single experiment representing three independent experiments. Dotted lines represent the limit of
Hz detection. Bacterial burden in spleens of PfHz (C) or untreated control mice was determined 2 days post
Lm infection. Data (meanS.E.) are cumulative results from 2-3 independent experiments. Each symbol
represents an individual mouse.
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Research concerning the immunomodulatory effects of hemozoin has been
conducted in a large variety of preparations, relating to drastic differences in molecular
components associated with the biocrystals, which confer dissimilar results. Thus, we
performed a series of experiments which aimed to explore how different hemozoin
preparation procedures, and therefore, surface-associated bioactive molecules impact the
clearance of Lm. PfHz was treated with DNase to remove DNA whereas PyHz had not
been DNase treated. When PyHz was treated with DNase to remove DNA, mice injected
with DNA free PyHz still exhibited elevated bacterial burden (Fig. 24A-C). In contrast to
these results, mice treated with ‘clean’ PyHz, which was treated with detergents and
proteinase K, followed by infection with Lm, showed no defect in the control of Lm (Fig.
24D). Similarly, mice that were treated with pure synthetic Hz followed by Lm infection,
also showed no defect in control of Lm (Fig. 24E). These results support the conclusion
that the bioactive molecules associated with hemozoin (other than DNA) are involved in
the immunomodulatory properties that contribute to delayed Lm clearance in our model.
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Figure 24. Hemozoin preperation differentially impacts anti-bacterial innate immunity. A) Agarose
gel containing PyHz samples labeled with GelRed Nucleic Acid stain to detect presence of DNA. Lane 1 –
1,000-100 base pair ladder, lane 2 – 15μL sample of 2mg/mL PyHz treated with 10 U/mL DNase, lane 3 –
15μL sample of 2mg/mL PyHz treated with 100 U/mL DNase, lane 4 – 15 μL sample of untreated 0.3
mg/mL PyHz, lane 5 – 15 μL sample of 0.3 mg/mL PyHz treated with 100U/mL DNase, lane 6 – 15μL of
100ng/mL untreated DNA, lane 7 – 15μL of 100ng/mL DNA treated with 100U/mL DNase. B)
Quantification of DNase treated PyHz in spleens and livers. Data (meanS.D.) are representative of three
independent experiments. Dotted lines represent the limit of Hz detection. C-E) Lm burdens in spleens and
livers from mice treated with DNase treated Hz (C), ‘clean’ PyHz (D), and synthetic Hz (E) on the
indicated days post Hz treatment and Lm infection. Data were analyzed by Mann Whitney test.
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So far, we have characterized the contribution of Hz to both the delayed clearance
of Lm in our Py+Lm coinfection model and demonstrated that Hz impairs antibacterial
functions of splenic phagocytes. Our use of the model bacterium, Lm, in our coinfection
model provided critical insight into how Plasmodium infection weakens host immunity to
invasive bacterial infections, we next sought to test whether hemozoin has a similar
impact on the more clinically relevant pneumococcal coinfection model. Similar to
experiments in figures 18-20, naïve mice were given intravenous injections of PyHz
followed by intranasal infection with Sp 7 days later. Unlike what was observed in Lm
infections, PyHz did not show different bacterial burdens in the lungs, peripheral blood,
or spleen compared to control mice (Fig. 25A-C). While this in vivo data does not support
a role for Hz in Plasmodium-induced susceptibility to invasive Sp infection, it does not
rule out the possibility. More work is needed to test this hypothesis further. Collectively,
the results of this chapter identify Hz with bound bioactive molecules, excluding DNA,
as a parasite-derived factor that is able to impair anti-bacterial innate immunity to some
bacterial pathogens.
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Figure 25. P. yoelii hemozoin with bound bioactive molecules does impair immunity to Sp. C57BL/6N
mice were treated i.v. with 1-1.5mg PyHz followed by i.n. infection with 10 6 CFU Sp 7 days later. Mice
were sacrificed 2 days after Sp infection and lungs, blood, and spleens were collected for bacterial burden
analysis. Data (meanS.E.) are pooled results from 3 independent experiments. For all data, each symbol
represents an individual mouse. Statistical significance was determined with Mann-Whitney test.

Discussion
It has been postulated that Plasmodium-induced immune suppression and
susceptibility to invasive bacterial infections is not attributed to a parasite-specific factor.
Rather, it is due to Plasmodium-induced hemolysis, and subsequent activation of HO-1
and IL-10 that inhibit neutrophil functions lead to weakened immune responses to
invasive bacterial infections [60]. Yet, we demonstrate that Py-induced immune
suppression lasts up to 2-months post clearance of Py, when the effects of hemolysis are
likely no longer in play. Additionally, Cunnington and colleagues demonstrated that
neutrophils collected from patients previously infected with P. falciparum had defective
ROS burst following PMA stimulation that lasted up to 8 weeks-post treatment [61]. Of
note, Hz from P. berghei infection remains deposited in liver, bone marrow, and spleen
tissues as well as within isolated CD11b+ cells isolated from those tissues and peripheral
blood of mice for at least 196 days post infection [110]. Collectively, these data provide
104

evidence that a parasite factor, Hz, may contribute to this impaired innate immunity to
bacterial coinfections and leads to the hypothesis that this factor contributes to clinical
observations of reduced immunity to invasive bacterial infections in patients with history
of malaria.
Using a murine infection model of malaria and ex vivo intracellular bacterial
survival assays we have determined that Hz is able to impair innate immunity to bacterial
infections independent of the parasite infection. Of note, we made this observation using
two different preparations of Hz. First, Hz was prepared via a novel method by extracting
Hz from organs of mice previously infected with Py. Importantly, DNase treated PyHz, to
eliminate parasite and mouse DNA, was still capable of suppressing innate immunity to
Lm in vivo (Fig. 24 A-C). Second, we demonstrated natural PfHz prepared from infected
red blood cell cultures [84] was able to suppress innate immunity in vivo. These data
demonstrate that the immune modulatory effect of PyHz is unlikely due to parasite or
mouse DNA. Whereas parasite or mouse DNA were not implicated in the immune
suppressive nature of PyHz, PyHz prepared in the presence of detergents and proteases
(Fig. 24 D), as well as synthetic Hz (Fig. 24 E) did not impair in vivo innate immune
responses. This supports the idea demonstrated by Carney et al. that the immune
modulatory effect of Hz is perhaps not due to Hz itself or adherent DNA, but attributed to
interactions with RBC membrane lipids and other debris that subsequently generate
highly reactive secondary metabolic products capable of disrupting cell functions (e.g.
NADPH oxidase and iNOS) upon uptake [185]. Furthermore, lipids within parasitized
RBCs and hemozoin, such as the hydroxy fatty acids, hydroxy-arachidonic acid (HETE)
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and hydroxy-linoleic acid (HODE), have been shown to inhibit PMA-stimulated reactive
oxygen burst in human peripheral blood monocytes [186].
Our results suggest the possibility that parasite-derived Hz and bound molecules
are contributing to the impaired innate immune response to Lm, potentially through
inhibition of ROS production. While our data indicate that Hz impairs immunity to Lm,
our ‘native’ preparations of PyHz did not impair immunity to Sp in our model system.
There are two potential explanations for this observation. First, intravenous injection of
PyHz may not have resulted in sufficient levels of Hz to suppress innate immunity to Sp.
This possibility is supported by the observation that Py infection impairs innate immunity
to Sp long after the clearance of Py (Fig. 9D-F), suggesting a bona fide role for Hz in this
immune suppression. Second, differences in Hz-driven impaired innate immunity
between Lm and Sp may be explained by the intracellular and extracellular nature of
theses pathogens, respectively. Lm is considered an “intracellular pathogen” since it
grows within cells, whereas Sp is generally thought of as extracellular. Although this is
not exclusive as Sp can grow in CD169+ splenic macrophages [187].
A previous study found that digestive vacuoles isolated from P. falciparuminfected human red blood cell culture are rapidly phagocytosed by neutrophils in a
complement-mediated manner [161]. This same group also showed that uptake of Hz
loaded digestive vacuoles induced a ROS burst when opsonized with active serum, but
both uptake and ROS burst did not occur if digestive vacuole membrane was disrupted by
either ultrasonication or detergent treatment [162]. Another interesting finding was that
internalizing digestive vacuoles by PMNs reduced ROS production in response to
infection with Staphylococcus aureus and also diminished bacterial killing. In agreement
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with the work of Dasari et. al, our purified PyHz and PfHz, which is freed from digestive
vacuoles, did not impair ROS production of either splenic neutrophils in whole spleen
single cell suspension or purified bone marrow neutrophils in response to PMA, Lm, or
Sp (Figure 18 and 19). Contrary to these studies, however, we were able to visualize
uptake of PyHz by sort-purified splenic CD11b+/CD11c- phagocytes (Figure 21A) and
found that PyHz-treatment reduced the ability of these cells to control intracellular
growth of Lm (Figure 21B and C).
When conducting our in vitro analysis of ROS production of PyHz treated whole
spleen single cell suspensions and purified bone marrow neutrophils, we observed
massive quantities of intracellular ROS being produced in cells infected with live
opsonized Sp, nearly 100-fold higher than uninfected cells and close to 10-fold higher
than heat-killed opsonized Sp or Lm infected cells (Figures 18 and 19). Furthermore,
PyHz treated splenic PMNs and cells infected with live opsonized-Sp had significantly
higher levels of intracellular ROS than cells with no Hz treatment. As mentioned in
Chapter III, Sp is resistant to ROS produced by PMNs and produce H2O2 itself [170].
This result could be interpreted as an indirect detection of metabolically active
intracellular Sp, through the production of ROS, and indicate that there is a greater
amount of unkilled Sp in cells that were treated with PyHz. Further experiments are
needed to determine if there is a Hz-dependent defect in the ability of PMNs to kill both
extracellular and intracellular Sp. Since it has been discovered that Sp is able to grow
intracellularly within some subsets of splenic macrophages [187], it would also be
interesting to explore the possibility that following Hz phagocytosis, Sp is able to grow
within some leukocytes.
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Despite the results in experiments with P. berghei mutants that did not support the
hypothesis that Hz contributes to delayed clearance of Lm in vivo (Figure 20),
modifications to the coinfection model could be made to improve the system in order to
better assess this question. One possible reason for the lack of a Hz-dependent phenotype
in this model is the relatively low parasitemia and the kinetics of Pb NK65 infection in
mice. In Py infection, parasites begin to replicate at detectable levels in the blood around
5 days post infection and by day 9 parasitemia reaches 10 to 15%. Mice go on to develop
acute hyperparasitemia that plateaus between 15- and 20-days post infection around 60%
(Fig. 4A). The progression of Pb NK65 is quite different, with parasitemia increasing
from approximately 1% on day 5 to ~8% on day 9 followed by a continued increase
[188]. During the early acute Pb NK65 parasitemia, lung weights begin increasing due to
hemozoin-induced acute lung injury and mice eventually succumb to malaria-associated
acute respiratory distress syndrome (MA-ARDS) around day 12 post infection without
complications from cerebral malaria [81, 177]. These differences may contribute to the
lack of impaired antibacterial immunity observed in the Pb+Lm coinfections. Another
complication preventing a definitive conclusion that Hz does not impair clearance of Lm
is that there was not a significant difference between Hz quantities of liver and spleens of
Pb Δpm4 (Hz-deficient) infected mice and Pb Δdpap infected mice which serve as a
control for the attenuated parasitemia of Pb Δpm4 (Figure 20B and C). To improve this
model it will be necessary to compare levels of Hz in spleens from Py-infected mice to
the three Pb strains used here at day 7 and 9 post infection to determine if Pb infected
mice had lower levels of Hz that may have impacted Lm clearance.
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Our in vitro data demonstrates the impaired anti-bacterial ability of splenic
phagocytes either isolated from Py-infected mice or treated with PyHz. Interestingly, the
analysis of intracellular cfu burdens in our in vitro assay found that splenic phagocytes
from Py-infected mice, or phagocytes treated with PyHz, contained significantly less Lm
at 2 hours post infection (with 1 hour in gentamicin) compared to cells from naïve mice
or untreated cells (Fig. 16C and F). There are several explanations for this result,
including a defect in Lm uptake, differences in Lm adherence, and altered killing of
intracellular or extracellular Lm during the time prior to the 2-hour time point.
Additional work will be needed to further understand the impact of Py-infection and
hemozoin in these interactions. Furthermore, cfu counts at 5 hours post infection suggest
that PyHz treated or Py-infected mouse phagocytes exhibit a profound inability to restrict
intracellular bacterial growth. In contrast, there may be a different mechanism
responsible for Plasmodium-dependent susceptibility to extracellular bacteria. For
example, serum-dependent effects as we observed (Fig. 15C). Further studies are
required to elucidate the mechanisms underlying susceptibility to Sp and other
extracellular bacterial pathogens during coinfection with Plasmodium. Methods that can
recognize the presence or absence of internalized Hz at the single cell level would
substantially enhance our understanding of this interaction. Additional work is also
needed to uncover the immune cell types affected as well as the antimicrobial functions
that are impaired by Plasmodium in the context of Sp and other clinically important
coinfections during malaria.
Hz may directly impair antibacterial effector mechanisms of innate immune cells
via uptake or interaction with Hz. Alternatively, the uptake and recognition of Hz by
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phagocytic cells could have an indirect effect through altering the host microenvironment
via the induction of pathways that influence the production of cytokines and chemokines
in a manner that creates a more favorable environment for invasive/pathogenic bacteria.
Additionally, Hz has been shown to induce trained immunity [112], suggesting the
possibility that long-term suppression of innate immunity to systemic bacterial infections
may in part be attributed Hz-induced epigenetic modifications.
Clinical reports of invasive bacterial disease coinciding with malaria often report
both NTS and Sp as the two organisms most commonly isolated from blood.
Experimental studies to date have focused almost exclusively on NTS and it is unknown
whether the mechanisms of Plasmodium-induced immune suppression to NTS will be
important for Sp or other bacterial pathogens found in coinfections with malaria (e.g.,
Haemophilus influenzae, Mycobacterium tuberculosis, Staphylococcus aureus,
Streptococcus pyogenes, etc. [42-49, 54]). We report for the first time, to our knowledge,
a murine Plasmodium and pneumococcal coinfection. Mice were infected with P. yoelii
17XNL followed by a S. pneumoniae ATCC #6303, a type 3 capsule serotype strain, via
the natural intranasal route. Consistent with the risk of invasive Sp infections in humans
with malaria [42], we found decreased survival and increased bacterial burdens in coinfected mice compared to control Sp only infected mice. Murine models of malaria
associated-respiratory distress syndrome (MA-ARDS) using P. berghei NK65 strain have
found an association between pulmonary pathology and the levels of Hz deposition [81].
Pulmonary pathology matching MA-ARDS has been reported in Py 17X but not Py
17XNL infection [189]; however, the parasitemia obtained in mice infected with Py
17XNL in that study were much lower than what was observed in this report where Py
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17XNL parasitemia reached 40-60%. Consequently, Hz deposition in the lung, and
potentially in spleen and other organs, may contribute to differential invasiveness of Sp
during Plasmodium infection. Further studies are necessary to determine to what degree
Plasmodium, via Hz or other mechanisms, induces lung pathology and to what degree
this contributes to increased susceptibility to invasive Sp infection.
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CHAPTER V
FINAL DISCUSSION AND FUTURE DIRECTIONS

In this work, we have characterized the impact of Plasmodium infection on
immunity to 3 different bacterial pathogens using three murine models of malaria bacteria
coinfections, and a series of in vitro assays. Our use of Listeria monocytogenes as a
model bacterium to probe antimicrobial immune responses led us to the findings that P.
yoelii infection delays clearance of bacteria from the spleen in a model of non-lethal
systemic infection using and attenuated strain of Lm. Further investigations led us to
discover that the impaired innate immune response associated with Py infection lasts long
after clearance of patent (i.e. detectable), Py infection, and this Py-driven
immunosuppression occurs independent of IFNγ or the hemolysis-dependent mechanisms
that have been attributed to the well-characterized increased susceptibility to invasive
Salmonella disease (HO-1, and IL-10). Perhaps most importantly, this work
demonstrates for the first time, that hemozoin, a parasite factor, contributes to impaired
immunity to secondary bacterial infection. These findings are summarized in Figure 28.
Hemozoin had previously been shown to have many effects on in vitro cultured
cells, yet, inconsistency in source, purification, and preparation techniques have resulted
in different camps regarding whether hemozoin is immunomodulatory at all or which of
the surface-bound biomolecules are relevant. This work has contributed to the
conversation by showing that Hz alone (“clean” preparation with detergents and protease
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treatment) did not impair immunity to Lm, whereas Hz containing bound-bioactive
molecules is sufficient to impair clearance of bacteria from spleens of Lm infected mice.
We also show in vitro that treating splenic phagocytes with Hz containing bioactive
molecules decreased their ability to limit the intracellular growth of Lm.
While we did not provide direct evidence of an Hz-dependent defect in ROS
production in vitro or enhanced susceptibility to invasive Pneumococcal disease, we have
two pieces of data that support a role for Hz in the impaired immunity to Sp. First, our
observation that Py infected mice are more susceptible to invasive Sp infection not only
during acute parasitemia, but months after clearance of detectable parasites from the
blood stream, suggests that Hz is likely involved due to its long-term deposition in tissues
with known importance in immune responses and active clearance of invasive Sp
infection [81]. Second, we found an influx of intracellular ROS in PMNs from whole
spleen single cell suspensions or BMNs isolated from naïve mice when they were treated
with PyHz and subsequently infected with live opsonized-Sp compared to controls with
no Hz treatment. We interpreted this result as potential indirect evidence of greater
amounts of live, metabolically active Sp in Hz-treated cells. In fact, Sp can produce large
quantities of H2O2, and several studies have provided evidence that Sp is not susceptible
to killing via NADPH oxidase-dependent mechanisms, such as experiments using
NADPH oxidase inhibitors, and the fact that PMNs isolated from patients with chronic
granulomatous disease are not defective in killing Sp [190, 191]. Thus, high levels of
ROS in Hz-treated PMNs infected with live-opsonized Sp compared to cells with no Hz
treatment could be indirect evidence supporting the hypothesis that Hz treatment impairs
the ability to kill Sp intracellularly. It is known that Sp is resistant to oxidative stress,
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such as ROS produced by PMNs, and is killed by PMN serine proteases. Both cathepsin
G and elastase are capable of killing Sp, since the individual inhibition of either did not
decrease Sp killing in an opsonophagocytic assay, yet treatment with a protease inhibitor
eliminated killing [172]. Thus, there is apparent redundancy in the capacity of neutrophil
proteases to sufficiently kill Sp in the context of complement-dependent
opsonophagocytosis and serine proteases appear to be the main factors in Sp killing.
More work is required to investigate the hypotheses that the ROS we observed in Hz
treated PMNs was produced by viable, metabolically active Sp rather than from the
PMNs intracellular NADPH oxidase-dependent ROS production and that there is indeed
an Hz-dependent defect in killing of Sp. The experiments that aim to explore the role of
Hz in enhanced susceptibility to Sp are highlighted in the future directions section in this
chapter.
Considering whether neutrophils acquire their defective antibacterial functions in
the bone marrow or after entering a tissue will be important in pursuing the mechanisms
that lead to neutrophil disfunction in Plasmodium infections. By isolating neutrophils
from bone marrow of Py-infected and naïve mice and performing experiments testing
their antibacterial functions in vitro, it would be possible to compare with peripheral
blood and tissue-isolated neutrophils to determine the origin of the defect. While data
from Hz-treated PMNs isolated from bone marrow of naïve mice did not demonstrate a
role for Hz in Plasmodium-induced impaired ROS, other antibacterial functions could be
tested in this setting.
A key component of neutrophils arsenal against invading microbes is their ability
to exocytose granules that contain toxic products. Of the four granules, gelatinase,
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specific, and azurophilic types are antibacterial, while secretory vesicles are not [192].
Release of azurophilic, specific and gelatinase granules by naïve versus Py-infected
mouse BMNs can be tested in response stimuli by quantifying the surface markers
associated with each granule type using flow cytometry [193]. In these experiments,
granule exocytosis can be tested in response to fMLF, TNFα, or Sp with or without
opsonization from Py and naïve mouse serum. Given that serum opsonization of
bacterial pathogens can influence granule exocytosis [194], including different
preparations of serum in these experiments could help determine the contribution of a
defective serum component in Py-infected mice. Other neutrophil functions that would
be interesting to test, comparing BMNs from Py-infected and naïve mice to tissuederived or peripheral blood-isolated PMNs from Py-infected and naïve mice, include
phagocytic capacity, phagosome maturation and bacterial killing efficiency. Due to the
relatively low number of PMNs that can be isolated from peripheral blood of mice,
samples from several mice can be pooled together in obtain enough cells for the
conditions needed in the assays, as done in Schneider et al. [195].
In addition to antimicrobial functions, the ability of neutrophils to migrate to
infected tissues via chemotaxis could also be examined. Although greater numbers of
neutrophils were seen in spleens of Py-infected mice, compared with naïve mice at each
time point post Py that was examined (Figure 12C), the ability of neutrophils to migrate
to the spleen in response to an invasive bacterial infection following Py-infection is
unknown. A kinetic study of splenic myeloid cells similar to what was conducted in
Chapter III figures 11-13 could be performed to investigate this, where both naïve and
Py-infected mice would be infected with Lm or Sp and the quantities of neutrophils in
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spleens can be determined with the same method. An in vitro system could also
investigate the chemotactic ability of neutrophils following Py infection by placing Pyinfected and naïve mouse BMNs, peripheral blood neutrophils, or splenic neutrophils in a
transwell system and examine their movement across the membrane in response to fMLF,
IL-8, or IL-12, which is known to be protective in Sp infections by promoting recruitment
of neutrophils to lungs [196].
Since Hz is known to be deposited in bone marrow for up to 140 days post P.
chabaudi infection and is found in CD11b+ bone marrow cells over 280 days post P.
berghei [67], any Hz-dependent mechanism influencing the antibacterial functions of
neutrophils would detectable in an experiment with cells isolated from bone marrow of
Py-infected mice long after parasite clearance. Thus, the same neutrophil functional
responses mentioned above could be examined at timepoints during acute parasitemia at
15 days post-Py, after clearance of Py infection at day 30 post-Py, two months after Py
clearance on day 100 post-Py, and even longer to determine the full kinetics and
longevity of impaired neutrophil functions following Plasmodium infection.
Another important contribution this work adds to the study of bacterial
coinfections in malaria is the first murine model of malaria and Pneumococcus
coinfection. This model provides an essential tool to study the mechanisms contributing
to the enhanced susceptibility to invasive Pneumococcal disease that has been described
in patients with malaria in several clinical reports [42, 45, 47, 49, 52-54, 75, 76, 87]. In
characterizing this model, we found that Py infected mice had decreased survival and
higher bacterial burdens in peripheral blood and spleens compared to mice infected with
Sp alone 3 days after Sp infection. This impaired immunity to Sp in coinfected mice was
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apparent during acute malaria and 2 months after clearance of detectable parasites in the
bloodstream. Finally, our results indicated that the activity of Py-induced IL-10
contributes to the increased susceptibility to Sp in coinfected mice, similar to what has
been shown in NTS coinfections [59].
Together, our work reveals that Plasmodium infection induces long-term
immunosuppression that renders the host susceptible to invasive bacterial coinfections
that lasts beyond resolution of the parasite infection. Moreover, the data presented here,
in agreement with clinical observations connecting malaria with increased severity of
invasive bacterial disease, indicate the importance of obtaining information beyond a
blood smear in order to account for not only active cases of malaria, but any recent
history of Plasmodium infection. With the murine coinfection models, and in vitro assays
described here to test Plasmodium-induced immunosuppression, more discoveries can be
made to direct efforts to develop treatments and provide further evidence to argue for the
need of heightened clinical surveillance and perhaps intervention in patients with
invasive bacterial disease.

Additional directions for investigating Plasmodium-Pneumococcal coinfections

The Py-driven susceptibility/impaired innate immunity to Sp uncovered within
this work may be occurring by several potential mechanisms that were not examined
experimentally and there is rationale to further pursue these possibilities. Although Sp is
resistant to intra-phagolysosomal ROS [172, 197], the dramatic decrease in Sp-induced
intracellular ROS response in splenic PMNs from Py-infected mice (Figure 15) suggests
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other PMN antimicrobial responses may also be impaired in Py-infected mice.
Experimental tools are available to investigate PMN antimicrobial responses, including
inhibitors of specific PMN granules inhibitors of cell signaling pathways. These
experiments combined with an assay that tests intracellular and extracellular survival of
Sp in culture with splenic phagocytes from naïve and Py-infected mice, similar to the
gentamicin protection assay, would help elucidate specific mechanisms underlying
impaired immunity to Sp.
Previous work has found that inhibition of NADPH oxidase does not affect killing
of Sp by human PMNs in vitro, suggesting that Sp is not directly killed by PMN ROS
production [172]. This does not necessarily mean that this defective function does not
impair PMN antibacterial functions that contribute to Sp killing. The lack of PMN
production of ROS seen in cells from Py-infected mice could affect other antimicrobial
processes that are known to kill Sp, such as the activation of pre-formed neutrophil
proteases and myeloperoxidase catalysis, which require NADPH oxidase-dependent ROS
[172, 198, 199]. ROS production is also needed to acidify the phagolysosome to assist
this bactericidal process [152].
One serine protease produced in high amounts during release of azurophilic
granules by PMNs, elastase, is known to cleave TLR2, TLR4, and other important
surface proteins known to recognize Sp [166]. Additionally, the same study found that
this PMN elastase-dependent activity reduced cellular immune responses following heattreated Sp stimulation and reduced survival in an intratracheal model of murine Sp
infection [166]. Plasmodium infection elicits a release of extracellular serine proteases
that have been attributed to collateral inflammatory damage during malaria disease [200].
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Therefore, the serine proteases induced by Plasmodium infection may cleave important
receptors from innate immune cells, rendering them unable to perform their antibacterial
effector functions against a secondary Pneumococcal infection. This hypothesis could be
tested in our murine model of Py+Sp coinfection with either use of protease inhibitor
treatment, or conditional knockout mice that lack the ability to produce these enzymes.
Quantification of surface receptors impacted by protease cleavage could be performed
with flow cytometry to verify the extent of the Plasmodium-elicited damage, and then
correlate with a careful characterization of Sp burdens.

Further experiments to explore whether differences in splenocyte populations between
Py-infected and naïve mice impacts antibacterial immunity

To follow up the extensive characterization of splenic myeloid cells over the
course of Py infection (Figure 12), a similar approach can be used to identify differences
in cells that infiltrate infected tissues, such as the spleen and lungs, following secondary
bacterial infection. By using similar methods (same cell isolation method, antibody
staining and gating strategy), an experiment could determine whether or not there are
differences in myeloid cells that enter the spleen (for Lm, Sp, even NTS) or lung (Sp
only) at 3, 6, 12, 24 and 48 hours after the bacterial challenge between naïve and Pyinfected mice. A reduction in neutrophil migration to the liver 4 days after NTS infection
has already been described in Py-infected mice compared to mice challenges with NTS
alone [59]. Expanding on the characterization of cell types that have impaired or
differential mobilization to sites of infection at various times after bacterial challenge
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would give additional insight into how changes in myeloid cell functions during malaria
can impact innate immunity to bacterial coinfections. Since the spleen is impacted
heavily during Plasmodium infection, and is vital to controlling bacterial infections
during sepsis, a characterization of myeloid cells mobilization to the spleen following
bacterial challenge would improve our understanding of exactly which cells are
interacting with an invasive bacterial pathogen [47]. Dynamics of myeloid cell
infiltration into lung tissue would also be of interest, given the potential for Plasmodium
infections to induce lung pathology and the importance of neutrophils and monocytes
during upper respiratory Pneumococcal infection [81, 172, 200]. Additional experiments
using a fluorescent bacteria could determine which myeloid cell subsets are able to
uptake bacteria and a time-course study, where investigators could look at the presence
and abundance of bacteria within a variation cell types over the course of the bacterial
infection in naïve and Py-infected mice to understand which cell types are involved with
the uptake of bacteria, as well as the ability of those cells to control the infection. Further
in vitro and ex vivo functional experiments can then be performed on the cells to explore
potential Plasmodium-driven mechanisms of impaired anti-bacterial functions.
A different approach that would enhance the sensitivity, increase number of
surface proteins that can be analyzed, and eliminate the complications of
autofluorescence is with the cytometry by time-of-flight or CyTOF method [201, 202].
By utilizing this more advanced method, splenic myeloid cell populations could be
identified with higher clarity and it would be possible to identify more distinct trends than
I was able to obtain with the method described in this work.
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Identifying and characterizing the contribution of a defective serum component in
elevated susceptibility to bacterial coinfections in malaria

A serum factor that was identified in Figure 15, where we saw decreased ROS
production from PMNs infected with heat-treated Sp that had been opsonized with serum
collected from Py-infected mice (Py-ops Ht Sp). This effect occurred in PMNs from
spleens of both naïve and Py-infected
mice, but Py-ops Ht Sp exacerbated
the already
significant ROS production defect
compared to cells from naïve mice.
Interestingly, cells from Py-infected
mice infected with naïve serumopsonized Sp and naïve mouse cells
infected with Py-ops Ht Sp produced
comparable levels of ROS. These data
suggest that, in addition to an
underlying defect in ROS production,
a defective serum component in Pyinfected mice contributes to the PyFigure 26. Complement depletion during malaria. Adapted from Mooney et al. 2018 Journal of
Leukocyte Biology. “Malaria, anemia, and bacterial disease: A neutrophil problem?” Malaria is
accompanied by systemic complement activation and deposition on infected and uninfected RBCs.
This decreases concentrations of circulating C3 and C5, and generates anaphylatoxins (C3a and
C5a), potentially impacting important antibacterial PMN functions and contributing to increased
risk of bacteremia during malaria.
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dependent impaired ROS response. There is strong rationale to conduct further research
on the role of serum-opsonizing factors, namely complement factors, given that it is well
established that Plasmodium infection activates and eventually functionally depletes
complement components [120, 203, 204]. The connection between complement
deficiency was discussed recently[60], where the authors postulate that Plasmodiumdriven complement depletion relates to decreased opsonization of NTS, lower neutrophil
migration, ROS and TNFα production, and contribute to impairments in other PMN
antimicrobial functions in response to NTS (Figure 26). The first steps needed to
continue investigating the role of complement in Plasmodium-driven susceptibility would
to verify that the serum factor involved in the decreased ROS production (Fig. 15) is in
fact a complement component. A simple way to test this would be to heat-inactivate
serum from both naïve and Py-infected mice and repeat the DCF ROS experiments with
heat-treated Sp. If a decrease in ROS is found in cells infected with heat-inactivated
naïve mouse serum opsonized Ht-Sp, the contribution of opsonizing antibodies can be
ruled out, indicating the defective serum factor in Py-infected mice is a heat-labile
complement factor. Conversely, experiments could be performed where individual
complement components could be added to serum from Py-infected mice and incubated
with Sp preparations prior to infection in order to identify precisely which complement
protein is responsible for the Py-induced serum defect observed in this work. After a
complement factor is identified in vitro, it can be verified in an in vivo co-infection
experiment using a knockout mouse strain that lacks the gene coding for the protein of
interest.
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Quantitative analysis of the complement components in serum of naïve vs. Pyinfected mice would serve as a preliminary screen in an effort to identify a specific
protein that could be responsible for the defective ROS production function. This could
be done either with comparing protein quantities in serum between naïve and Py-infected
mouse serum via Western Blot, or via detection with a multiplex ELISA kit for
complement factors or a flow cytometric analysis. Another approach could be performed
in vivo with Py+Sp or Py+Lm coinfected mice compared with mice given bacteria alone
with broad depletion of complement factors via treatment with Cobra Venom Factor
(CVF) or depletion of specific complement components with some other method [127,
205]. An important interaction to consider in investigating interactions between
Pneumococcus and complement is the Sp capsule, which in some cases binds directly to
complement receptors or complement factors, and Sp capsule-mediated inhibition of
complement activity [126, 127, 206]. For these reasons, it would be diligent to include
capsulated, uncapsulated, and potentially a variety of capsular serotypes in any
experiments involving Sp-complement interactions. Finally, it would also be interesting
to investigate the contribution of the defective serum factor we found with defective
PMN ROS production during Ht-ops Sp infection in an assay where Sp intracellular and
extracellular viability is determined in coculture with PMNs isolated from naïve or Pyinfected mice, with the different manipulations of serum opsonins described above.
These experiments would provide mechanistic insight into the Plasmodium-dependent
susceptibility to invasive Pneumococcal disease that is currently lacking from the field
that could lead to novel therapies for coinfected individuals.
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Next steps in examining role of hemozoin

The next steps in characterizing the role of hemozoin in suppression to bacterial
coinfections will involve determining what specific innate immune cell populations have
impaired antimicrobial functions and which important mechanism are impacted. This
will require either visualization of hemozoin pigment within cells or an analysis method
similar to what has been described with flow cytometry, taking advantage of the
birefringent or ultraparamagnetic properties, as done in Frita et. al [207]. This will allow
analysis of the percentage of cells with intracellular Hz, and with the inclusion of
antibodies specific to certain innate immune cell subsets, information about the identities
of the cells and to some degree, the amount of Hz they uptake. In future experiments
seeking to identify mechanisms of Hz-dependent impaired antimicrobial function,
determining cell types with particular defects will be very helpful and obtaining this
information from in vitro assays will pave the way for experiments with in vivo models
where susceptibility to bacterial infection is analyzed in Hz treated mice and compared to
untreated controls. Imagestream® equipment made by Amnis® (Seattle, WA), for
example, would allow for analysis of fluorescence marker quantification that is paired to
bright field images at the single cell level and analysis of intracellular Hz has been done
with this equipment [184]. ROS detection and bacterial uptake, survival, and growth
would also be detectible with use of DCF, as done in this dissertation, and a fluorescence
expressing bacteria. Also, a fluorescent strain of Sp could be used in a DCF assay to
potentially determine whether Sp is the source of the large amount ROS we observed in
Figures 18 and 19.
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In addition to these experiments, more work is also needed to identify precisely
which Hz-bound bioactive molecules are responsible for the immunomodulatory activity
of Hz that we have observed. This can be achieved via careful molecular characterization
of the different preparations of hemozoin described here. There is reason to suspect that
the immunomodulatory effects we have observed in both the delayed clearance of Lm
from spleens of PyHz-treated mice and the inability of PyHz-treated splenic phagocytes
to control intracellular growth of Lm in vitro (Figures 22 and 21, respectively), is due to
hydroxy fatty acids described by Schwarzer et al. [186]. Performing the experiments
described in this work which involve Hz, as well as those mentioned in future directions,
with de-lipidation treatment used by Schwarzer and colleagues [186]on Hz will provide
meaningful insight to move the project forward into high-impact mechanistic studies.

RNA-seq analysis to characterize overall effect of hemozoin uptake on myeloid
cell with systematic function analysis
Currently, very little is known about how phagocyte antimicrobial functions
change following the uptake of Hz. One study has investigated changes in gene
expression in human peripheral blood monocytes treated with Hz or iRBCs and found
that Hz and iRBC-treated cells were hyperresponsive in response to a second stimulus 3
days after Hz or iRBC exposure [112]. A similar RNA-seq approach could be used to
examine gene expression of ultra-purified Hz-treated and untreated PMNs and
macrophage cultures with multiple stimuli to determine specific mechanisms by which
their effector functions are impaired. Such an analysis would compare mRNA levels of
these cells with or without Hz treatment followed by stimulation with chemicals known
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to induce antimicrobial responses, including PMA, LPS, heat-treated Sp or
Staphylococcus aureus. Assessing gene expression in cells with or without Hz treatment
following stimulation could uncover a pathway that is made defective by internalization
or interaction with Hz in vitro and subsequent testing with gene silencing, knowckout
mice, or inhibitory molecules specific to pathways of interest can be used to validate
findings from RNA-seq analysis. The same method could also be used in comparing
cells from Py-infected and naïve mice or P. falciparum infected individuals compared to
healthy controls. Altogether, the combination of gene expression analysis cells with or
without Hz treatment and cells from patients with or without malaria would provide
insight to which defects in phagocyte antimicrobial function are specific to uptake or
interaction with Hz, and which are independent of Hz and caused by some other factor
during Plasmodium infection.

Contribution to the Field
Our findings provide evidence that there are multiple factors involved in
Plasmodium-induced suppression of antibacterial innate immunity. Combinations of
these factors likely contribute to the enhanced susceptibility to the different bacterial
pathogens seen in conjunction with malaria in sub-Saharan Africa. Given the increased
mortality rate associated with malaria and invasive bacterial coinfections, these results
may provide insight into new approaches to treat those individuals. Finally, this report
provides the first description, to our knowledge, of a murine model system of
Plasmodium and S. pneumoniae coinfection. In this model, Plasmodium infections impair
host immunity to S. pneumoniae, which resulted in increased mortality. As S.
pneumoniae is one of the most common bacteria identified in individuals with invasive
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bacterial infections during malaria, this model has the potential to provide further
knowledge into the dynamics of this coinfection and identify approaches to treat this
coinfection. A summary of the mechanisms of Plasmodium-induced immunosuppression
that have been experimentally explored in models of NTS, Lm, and Sp coinfections can
be found in Figure 27.

Figure 27. Potential mechanisms of Plasmodium-driven immune suppression to bacterial
coinfections. List of mechanisms of Plasmodium-induced impaired immunity to bacterial co-infections for
non-Typhoid Salmonella (NTS), Listeria monocytogenes(Lm), and Streptococcus pneumoniae (Sp). Check
mark = mechanism is known be involved, “X” mark = no experimental evidence that suggests mechanism
is involved, question mark = mechanism has not been tested for indicated bacterial pathogen. Black marks
indicate previously known mechanisms while the red marks indicate the results from this dissertation. See
text for references and details.
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Figure 28. Mechanisms of Plasmodium infection-driven suppression of antibacterial innate immunity
to invasive coinfections. 1) Rupture of parasitized red blood cells during the blood stage of malaria results
in hemolysis and the activation of HO-1(2) and IL-10 (3), which initiates a positive feedback loop of
activation. Both HO-1 and IL-10 are known to blunt neutrophil responses such as ROS production and
impair innate immunity to NTS, while only IL-10 has been found to impair immunity to Sp. Also, via
mechanisms that are not yet well understood, Plasmodium infection impairs the ability of splenic
phagocytes to control the intracellular growth of bacteria (4). Activation of the complement system occurs
during blood stage of Plasmodium infection, leading to their functional depletion. This defect in
complement or parasite driven changes to opsonizing antibodies are likely responsible for our observations
that a defective serum factor impairs the ROS response of neutrophils (5). Hemozoin crystals are
byproducts of the parasitic digestion of hemoglobin and are released into circulation upon rupture of
parasitized red blood cells. These crystals are deposited in tissues (6) where they are internalized by
phagocytes (7) which impairs their ability to control growth of intracellular bacteria (8) and causes
systemic defects in the ability of the innate immune response to clear an invasive bacterial infection (9).

128

REFERENCES
1.
2.
3.
4.

5.
6.
7.
8.
9.
10.
11.
12.

13.
14.
15.

16.
17.
18.

Organization, W.H., World Malaria Report 2018. 2018, Geneva: World Health
Organization.
Organization, W.H., World malaria report 2019. Geneva: Wolrd Health
Organization, 2019.
Cox, F.E., History of the discovery of the malaria parasites and their vectors.
Parasit Vectors, 2010. 3(1): p. 5.
Poinar, G., Jr. and S.R. Telford, Jr., Paleohaemoproteus burmacis gen. n., sp. n.
(Haemospororida: Plasmodiidae) from an Early Cretaceous biting midge
(Diptera: Ceratopogonidae). Parasitology, 2005. 131(Pt 1): p. 79-84.
Baird, J.K., Malaria zoonoses. Travel Med Infect Dis, 2009. 7(5): p. 269-77.
White, N.J., Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect
Dis, 2008. 46(2): p. 172-3.
Arese, P., How genetics and biology helped humanity to survive falciparum
malaria. Parassitologia, 2006. 48(4): p. 553-9.
Perkins, S.L., Malaria's many mates: past, present, and future of the systematics
of the order Haemosporida. J Parasitol, 2014. 100(1): p. 11-25.
Michalakis, Y. and F. Renaud, Malaria: Evolution in vector control. Nature,
2009. 462(7271): p. 298-300.
Tavares, J., et al., Role of host cell traversal by the malaria sporozoite during
liver infection. J Exp Med, 2013. 210(5): p. 905-15.
Cowman, A.F., et al., Malaria: Biology and Disease. Cell, 2016. 167(3): p. 610624.
Mo, A.X. and G. McGugan, Understanding the Liver-Stage Biology of Malaria
Parasites: Insights to Enable and Accelerate the Development of a Highly
Efficacious Vaccine. Am J Trop Med Hyg, 2018. 99(4): p. 827-832.
Sturm, A., et al., Manipulation of host hepatocytes by the malaria parasite for
delivery into liver sinusoids. Science, 2006. 313(5791): p. 1287-90.
Mideo, N., et al., The Cinderella syndrome: why do malaria-infected cells burst at
midnight? Trends Parasitol, 2013. 29(1): p. 10-6.
Hawking, F., M.J. Worms, and K. Gammage, 24- and 48-hour cycles of malaria
parasites in the blood; their purpose, production and control. Trans R Soc Trop
Med Hyg, 1968. 62(6): p. 731-65.
Garnham, P.C. and K.G. Powers, Periodicity of infectivity of plasmodial
gametocytes: the "Hawking phenomenon". Int J Parasitol, 1974. 4(1): p. 103-6.
Silver, A.C., et al., The circadian clock controls toll-like receptor 9-mediated
innate and adaptive immunity. Immunity, 2012. 36(2): p. 251-61.
Keller, M., et al., A circadian clock in macrophages controls inflammatory
immune responses. Proc Natl Acad Sci U S A, 2009. 106(50): p. 21407-12.
129

19.
20.

21.
22.
23.
24.

25.
26.

27.

28.

29.
30.
31.
32.
33.

34.

35.
36.
37.

Dondorp, A.M., et al., The relationship between age and the manifestations of and
mortality associated with severe malaria. Clin Infect Dis, 2008. 47(2): p. 151-7.
Reyburn, H., et al., Association of transmission intensity and age with clinical
manifestations and case fatality of severe Plasmodium falciparum malaria.
JAMA, 2005. 293(12): p. 1461-70.
Bartoloni, A. and L. Zammarchi, Clinical aspects of uncomplicated and severe
malaria. Mediterr J Hematol Infect Dis, 2012. 4(1): p. e2012026.
Krajden, S., et al., Prolonged infection with Plasmodium falciparum in a semiimmune patient. Trans R Soc Trop Med Hyg, 1991. 85(6): p. 731-2.
Greenwood, T., et al., Febrile Plasmodium falciparum malaria 4 years after
exposure in a man with sickle cell disease. Clin Infect Dis, 2008. 47(4): p. e39-41.
Szmitko, P.E., M.L. Kohn, and A.E. Simor, Plasmodium falciparum malaria
occurring 8 years after leaving an endemic area. Diagn Microbiol Infect Dis,
2009. 63(1): p. 105-7.
Silal, S.P., et al., Towards malaria elimination in Mpumalanga, South Africa: a
population-level mathematical modelling approach. Malar J, 2014. 13: p. 297.
Larsen, D.A., et al., Population-wide malaria testing and treatment with rapid
diagnostic tests and artemether-lumefantrine in southern Zambia: a community
randomized step-wedge control trial design. Am J Trop Med Hyg, 2015. 92(5): p.
913-921.
Cook, J., et al., Mass screening and treatment on the basis of results of a
Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria
incidence in Zanzibar. J Infect Dis, 2015. 211(9): p. 1476-83.
Mishra, N., et al., Surveillance of artemisinin resistance in Plasmodium
falciparum in India using the kelch13 molecular marker. Antimicrob Agents
Chemother, 2015. 59(5): p. 2548-53.
Dhiman, S., Are malaria elimination efforts on right track? An analysis of gains
achieved and challenges ahead. Infect Dis Poverty, 2019. 8(1): p. 14.
World malaria situation in 1994. Part II. Wkly Epidemiol Rec, 1997. 72(37): p.
277-83.
Gallup, J.L. and J.D. Sachs, The economic burden of malaria. Am J Trop Med
Hyg, 2001. 64(1-2 Suppl): p. 85-96.
Sachs, J. and P. Malaney, The economic and social burden of malaria. Nature,
2002. 415(6872): p. 680-5.
Hertig, E., Distribution of Anopheles vectors and potential malaria transmission
stability in Europe and the Mediterranean area under future climate change.
Parasit Vectors, 2019. 12(1): p. 18.
Mota, M.M., J.C. Hafalla, and A. Rodriguez, Migration through host cells
activates Plasmodium sporozoites for infection. Nat Med, 2002. 8(11): p. 131822.
Gowda, D.C. and X. Wu, Parasite Recognition and Signaling Mechanisms in
Innate Immune Responses to Malaria. Front Immunol, 2018. 9: p. 3006.
Aitken, E.H., A. Alemu, and S.J. Rogerson, Neutrophils and Malaria. Front
Immunol, 2018. 9: p. 3005.
Brinkmann, V., et al., Role of macrophages in malaria: O2 metabolite production
and phagocytosis by splenic macrophages during lethal Plasmodium berghei and
130

38.
39.
40.
41.
42.

43.
44.

45.

46.
47.

48.

49.
50.

51.
52.
53.

54.

55.

self-limiting Plasmodium yoelii infection in mice. Infect Immun, 1984. 44(3): p.
743-6.
Buffet, P.A., et al., The pathogenesis of Plasmodium falciparum malaria in
humans: insights from splenic physiology. Blood, 2011. 117(2): p. 381-92.
Borges da Silva, H., et al., Splenic Macrophage Subsets and Their Function
during Blood-Borne Infections. Front Immunol, 2015. 6: p. 480.
Leitner, W.W., et al., Role of Opsonophagocytosis in Immune Protection against
Malaria. Vaccines (Basel), 2020. 8(2).
Long, C.A. and F. Zavala, Immune Responses in Malaria. Cold Spring Harb
Perspect Med, 2017. 7(8).
Scott, J.A., et al., Relation between falciparum malaria and bacteraemia in
Kenyan children: a population-based, case-control study and a longitudinal
study. Lancet, 2011. 378(9799): p. 1316-23.
Auma, M.A., et al., Malaria is an uncommon cause of adult sepsis in southwestern Uganda. Malar J, 2013. 12: p. 146.
Morton, B., et al., The Early Recognition and Management of Sepsis in SubSaharan African Adults: A Systematic Review and Meta-Analysis. Int J Environ
Res Public Health, 2018. 15(9).
Reddy, E.A., A.V. Shaw, and J.A. Crump, Community-acquired bloodstream
infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis,
2010. 10(6): p. 417-32.
Were, T., et al., Bacteremia in Kenyan children presenting with malaria. J Clin
Microbiol, 2011. 49(2): p. 671-6.
Gomez-Perez, G.P., et al., Plasmodium falciparum malaria and invasive bacterial
co-infection in young African children: the dysfunctional spleen hypothesis. Malar
J, 2014. 13: p. 335.
Colombatti, R., et al., Malaria prevention reduces in-hospital mortality among
severely ill tuberculosis patients: a three-step intervention in Bissau, GuineaBissau. BMC Infect Dis, 2011. 11: p. 57.
Berkley, J.A., et al., Bacteremia among children admitted to a rural hospital in
Kenya. N Engl J Med, 2005. 352(1): p. 39-47.
Lalremruata, A., et al., Molecular identification of falciparum malaria and human
tuberculosis co-infections in mummies from the Fayum depression (Lower Egypt).
PLoS One, 2013. 8(4): p. e60307.
Walsh, A.L., et al., Bacteremia in febrile Malawian children: clinical and
microbiologic features. Pediatr Infect Dis J, 2000. 19(4): p. 312-8.
Nielsen, M.V., et al., Clinical indicators for bacterial co-infection in Ghanaian
children with P. falciparum infection. PLoS One, 2015. 10(4): p. e0122139.
Church, J. and K. Maitland, Invasive bacterial co-infection in African children
with Plasmodium falciparum malaria: a systematic review. BMC Med, 2014. 12:
p. 31.
Mourembou, G., et al., Co-circulation of Plasmodium and Bacterial DNAs in
Blood of Febrile and Afebrile Children from Urban and Rural Areas in Gabon.
Am J Trop Med Hyg, 2016. 95(1): p. 123-32.
Decuypere, S., et al., Diagnosis of Bacterial Bloodstream Infections: A 16S
Metagenomics Approach. PLoS Negl Trop Dis, 2016. 10(2): p. e0004470.
131

56.

57.
58.
59.

60.

61.

62.

63.

64.

65.
66.

67.

68.

69.

70.
71.

Mabey, D.C., A. Brown, and B.M. Greenwood, Plasmodium falciparum malaria
and Salmonella infections in Gambian children. J Infect Dis, 1987. 155(6): p.
1319-21.
Crum-Cianflone, N.F., Salmonellosis and the gastrointestinal tract: more than
just peanut butter. Curr Gastroenterol Rep, 2008. 10(4): p. 424-31.
MacLennan, C.A. and M.M. Levine, Invasive nontyphoidal Salmonella disease in
Africa: current status. Expert Rev Anti Infect Ther, 2013. 11(5): p. 443-6.
Lokken, K.L., et al., Malaria parasite infection compromises control of
concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated
alteration of myeloid cell function. PLoS Pathog, 2014. 10(5): p. e1004049.
Mooney, J.P., L.J. Galloway, and E.M. Riley, Malaria, anemia, and invasive
bacterial disease: A neutrophil problem? J Leukoc Biol, 2019. 105(4): p. 645655.
Cunnington, A.J., et al., Prolonged neutrophil dysfunction after Plasmodium
falciparum malaria is related to hemolysis and heme oxygenase-1 induction. J
Immunol, 2012. 189(11): p. 5336-46.
Cunnington, A.J., et al., Malaria impairs resistance to Salmonella through hemeand heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med,
2011. 18(1): p. 120-7.
Nyirenda, T.S., et al., Immunological bases of increased susceptibility to invasive
nontyphoidal Salmonella infection in children with malaria and anaemia.
Microbes Infect, 2018. 20(9-10): p. 589-598.
Nyirenda, T.S., et al., Loss of Humoral and Cellular Immunity to Invasive
Nontyphoidal Salmonella during Current or Convalescent Plasmodium
falciparum Infection in Malawian Children. Clin Vaccine Immunol, 2017. 24(7).
Valadas, E., et al., Tuberculosis with malaria or HIV co-infection in a large
hospital in Luanda, Angola. J Infect Dev Ctries, 2013. 7(3): p. 269-72.
Range, N., et al., HIV and parasitic co-infections in tuberculosis patients: a crosssectional study in Mwanza, Tanzania. Ann Trop Med Parasitol, 2007. 101(4): p.
343-51.
Frita, R.M.R.C., Malaria and Tuberculosis co-infection: role for Hemozoin
immunosyppression?, in Unidade de Microbiologia Molecular e Infecção do
Instituto de Medicina Molecular. 2014, Universidade de Lisboa, Faculdade de
Medicina: Lisbon, Portugal. p. 165.
Pisell, T.L., et al., Immune activation and induction of HIV-1 replication within
CD14 macrophages during acute Plasmodium falciparum malaria coinfection.
AIDS, 2002. 16(11): p. 1503-9.
Kublin, J.G., et al., Effect of Plasmodium falciparum malaria on concentration of
HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.
Lancet, 2005. 365(9455): p. 233-40.
Renia, L. and S.M. Potter, Co-infection of malaria with HIV: an immunological
perspective. Parasite Immunol, 2006. 28(11): p. 589-95.
Cuadros, D.F., A.J. Branscum, and P.H. Crowley, HIV-malaria co-infection:
effects of malaria on the prevalence of HIV in East sub-Saharan Africa. Int J
Epidemiol, 2011. 40(4): p. 931-9.

132

72.

73.

74.

75.

76.
77.
78.

79.
80.
81.

82.

83.

84.

85.

86.
87.
88.
89.

Andreani, G., et al., An in vitro co-infection model to study Plasmodium
falciparum-HIV-1 interactions in human primary monocyte-derived immune cells.
J Vis Exp, 2012(66): p. e4166.
Diou, J., et al., Malaria hemozoin modulates susceptibility of immature monocytederived dendritic cells to HIV-1 infection by inducing a mature-like phenotype.
Cell Microbiol, 2010. 12(5): p. 615-25.
Diou, J., et al., Dendritic cells derived from hemozoin-loaded monocytes display a
partial maturation phenotype that promotes HIV-1 trans-infection of CD4+ T
cells and virus replication. J Immunol, 2010. 184(6): p. 2899-907.
Nadjm, B., et al., WHO guidelines for antimicrobial treatment in children
admitted to hospital in an area of intense Plasmodium falciparum transmission:
prospective study. BMJ, 2010. 340: p. c1350.
Njim, T., et al., Identifying risk factors for the development of sepsis during adult
severe malaria. Malar J, 2018. 17(1): p. 278.
Dong, E., H. Du, and L. Gardner, An interactive web-based dashboard to track
COVID-19 in real time. Lancet Infect Dis, 2020. 20(5): p. 533-534.
Laroque, A., et al., Genetic control of susceptibility to infection with Plasmodium
chabaudi chabaudi AS in inbred mouse strains. Genes Immun, 2012. 13(2): p.
155-63.
Stevenson, M.M., J.J. Lyanga, and E. Skamene, Murine malaria: genetic control
of resistance to Plasmodium chabaudi. Infect Immun, 1982. 38(1): p. 80-8.
Fortin, A., et al., Genetic control of blood parasitaemia in mouse malaria maps to
chromosome 8. Nat Genet, 1997. 17(4): p. 382-3.
Deroost, K., et al., Hemozoin induces lung inflammation and correlates with
malaria-associated acute respiratory distress syndrome. Am J Respir Cell Mol
Biol, 2013. 48(5): p. 589-600.
Coban, C., et al., Purified malaria pigment (hemozoin) enhances dendritic cell
maturation and modulates the isotype of antibodies induced by a DNA vaccine.
Infect Immun, 2002. 70(7): p. 3939-43.
Deroost, K., et al., Improved methods for haemozoin quantification in tissues yield
organ-and parasite-specific information in malaria-infected mice. Malar J, 2012.
11: p. 166.
Barrera, V., et al., Host fibrinogen stably bound to hemozoin rapidly activates
monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin
action. Blood, 2011. 117(21): p. 5674-82.
Schwarzer, E., F. Turrini, and P. Arese, A luminescence method for the
quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized
erythrocytes and of malarial pigment. Br J Haematol, 1994. 88(4): p. 740-5.
Lee, T.S. and L.Y. Chau, Heme oxygenase-1 mediates the anti-inflammatory
effect of interleukin-10 in mice. Nat Med, 2002. 8(3): p. 240-6.
Usuf, E., et al., Pneumococcal carriage in sub-Saharan Africa--a systematic
review. PLoS One, 2014. 9(1): p. e85001.
Henriques-Normark, B. and E.I. Tuomanen, The pneumococcus: epidemiology,
microbiology, and pathogenesis. Cold Spring Harb Perspect Med, 2013. 3(7).
Song, J.Y., B.W. Eun, and M.H. Nahm, Diagnosis of pneumococcal pneumonia:
current pitfalls and the way forward. Infect Chemother, 2013. 45(4): p. 351-66.
133

90.

91.

92.

93.

94.
95.

96.

97.

98.

99.

100.

101.

102.

103.

104.

105.

Nadjm, B., et al., Severe febrile illness in adult hospital admissions in Tanzania: a
prospective study in an area of high malaria transmission. Trans R Soc Trop Med
Hyg, 2012. 106(11): p. 688-95.
Bassat, Q., et al., Severe malaria and concomitant bacteraemia in children
admitted to a rural Mozambican hospital. Trop Med Int Health, 2009. 14(9): p.
1011-9.
Amani, V., et al., Involvement of IFN-gamma receptor-medicated signaling in
pathology and anti-malarial immunity induced by Plasmodium berghei infection.
Eur J Immunol, 2000. 30(6): p. 1646-55.
Day, N.P., et al., The prognostic and pathophysiologic role of pro- and
antiinflammatory cytokines in severe malaria. J Infect Dis, 1999. 180(4): p. 128897.
Grau, G.E., et al., Tumor necrosis factor and disease severity in children with
falciparum malaria. N Engl J Med, 1989. 320(24): p. 1586-91.
Anstey, N.M., et al., Nitric oxide in Tanzanian children with malaria: inverse
relationship between malaria severity and nitric oxide production/nitric oxide
synthase type 2 expression. J Exp Med, 1996. 184(2): p. 557-67.
Omer, F.M., J.A. Kurtzhals, and E.M. Riley, Maintaining the immunological
balance in parasitic infections: a role for TGF-beta? Parasitol Today, 2000.
16(1): p. 18-23.
Omer, F.M. and E.M. Riley, Transforming growth factor beta production is
inversely correlated with severity of murine malaria infection. J Exp Med, 1998.
188(1): p. 39-48.
Othoro, C., et al., A low interleukin-10 tumor necrosis factor-alpha ratio is
associated with malaria anemia in children residing in a holoendemic malaria
region in western Kenya. J Infect Dis, 1999. 179(1): p. 279-82.
Mooney, J.P., et al., The mucosal inflammatory response to non-typhoidal
Salmonella in the intestine is blunted by IL-10 during concurrent malaria parasite
infection. Mucosal Immunol, 2014. 7(6): p. 1302-11.
Tilney, L.G. and D.A. Portnoy, Actin filaments and the growth, movement, and
spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol,
1989. 109(4 Pt 1): p. 1597-608.
Fritsche, G., et al., Regulatory interactions between iron and nitric oxide
metabolism for immune defense against Plasmodium falciparum infection. J Infect
Dis, 2001. 183(9): p. 1388-94.
Kern, P., et al., Elevated tumor necrosis factor alpha and interleukin-6 serum
levels as markers for complicated Plasmodium falciparum malaria. Am J Med,
1989. 87(2): p. 139-43.
McCall, M.B. and R.W. Sauerwein, Interferon-gamma--central mediator of
protective immune responses against the pre-erythrocytic and blood stage of
malaria. J Leukoc Biol, 2010. 88(6): p. 1131-43.
Villegas-Mendez, A., et al., IFN-gamma-producing CD4+ T cells promote
experimental cerebral malaria by modulating CD8+ T cell accumulation within
the brain. J Immunol, 2012. 189(2): p. 968-79.
Huang, S., et al., Immune response in mice that lack the interferon-gamma
receptor. Science, 1993. 259(5102): p. 1742-5.
134

106.
107.
108.

109.

110.
111.
112.
113.

114.

115.
116.

117.
118.
119.
120.
121.

122.
123.
124.
125.

Kocks, C., et al., L. monocytogenes-induced actin assembly requires the actA
gene product, a surface protein. Cell, 1992. 68(3): p. 521-31.
Pitts, M.G. and S.E.F. D'Orazio, A Comparison of Oral and Intravenous Mouse
Models of Listeriosis. Pathogens, 2018. 7(1).
Lokken, K.L., et al., Malaria Parasite-Mediated Alteration of Macrophage
Function and Increased Iron Availability Predispose to Disseminated
Nontyphoidal Salmonella Infection. Infect Immun, 2018. 86(9).
Mooney, J.P., et al., Haemolysis and haem oxygenase-1 induction during
persistent "asymptomatic" malaria infection in Burkinabe children. Malar J,
2018. 17(1): p. 253.
Frita, R., et al., In Vivo Hemozoin Kinetics after Clearance of Plasmodium
berghei Infection in Mice. Malar Res Treat, 2012. 2012: p. 373086.
Netea, M.G., Training innate immunity: the changing concept of immunological
memory in innate host defence. Eur J Clin Invest, 2013. 43(8): p. 881-4.
Schrum, J.E., et al., Cutting Edge: Plasmodium falciparum Induces Trained
Innate Immunity. J Immunol, 2018. 200(4): p. 1243-1248.
Franklin, B.S., et al., Malaria primes the innate immune response due to
interferon-gamma induced enhancement of toll-like receptor expression and
function. Proc Natl Acad Sci U S A, 2009. 106(14): p. 5789-94.
Ataide, M.A., et al., Malaria-induced NLRP12/NLRP3-dependent caspase-1
activation mediates inflammation and hypersensitivity to bacterial superinfection.
PLoS Pathog, 2014. 10(1): p. e1003885.
Lujan, M., et al., Influence of pneumococcal serotype group on outcome in adults
with bacteraemic pneumonia. Eur Respir J, 2010. 36(5): p. 1073-9.
van der Sluijs, K.F., et al., IL-10 is an important mediator of the enhanced
susceptibility to pneumococcal pneumonia after influenza infection. J Immunol,
2004. 172(12): p. 7603-9.
Leoratti, F.M., et al., Neutrophil paralysis in Plasmodium vivax malaria. PLoS
Negl Trop Dis, 2012. 6(6): p. e1710.
Peyron, F., et al., High levels of circulating IL-10 in human malaria. Clin Exp
Immunol, 1994. 95(2): p. 300-3.
White, C.E., et al., Plasmodium suppresses expansion of T cell responses to
heterologous infections. J Immunol, 2015. 194(2): p. 697-708.
Nyakoe, N.K., et al., Complement consumption in children with Plasmodium
falciparum malaria. Malar J, 2009. 8: p. 7.
Dey, S., et al., Association of heme oxygenase 1 with the restoration of liver
function after damage in murine malaria by Plasmodium yoelii. Infect Immun,
2014. 82(8): p. 3113-26.
Mebius, R.E. and G. Kraal, Structure and function of the spleen. Nat Rev
Immunol, 2005. 5(8): p. 606-16.
den Haan, J.M. and G. Kraal, Innate immune functions of macrophage
subpopulations in the spleen. J Innate Immun, 2012. 4(5-6): p. 437-45.
Perez, O.A., et al., CD169(+) macrophages orchestrate innate immune responses
by regulating bacterial localization in the spleen. Sci Immunol, 2017. 2(16).
Lanoue, A., et al., SIGN-R1 contributes to protection against lethal pneumococcal
infection in mice. J Exp Med, 2004. 200(11): p. 1383-93.
135

126.

127.

128.
129.
130.

131.

132.

133.

134.

135.
136.
137.
138.

139.

140.
141.
142.

143.

Kang, Y.S., et al., The C-type lectin SIGN-R1 mediates uptake of the capsular
polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse
spleen. Proc Natl Acad Sci U S A, 2004. 101(1): p. 215-20.
Kang, Y.S., et al., A dominant complement fixation pathway for pneumococcal
polysaccharides initiated by SIGN-R1 interacting with C1q. Cell, 2006. 125(1): p.
47-58.
Gough, P.J. and S. Gordon, The role of scavenger receptors in the innate immune
system. Microbes Infect, 2000. 2(3): p. 305-11.
Chen, Y., et al., A regulatory role for macrophage class A scavenger receptors in
TLR4-mediated LPS responses. Eur J Immunol, 2010. 40(5): p. 1451-60.
Elomaa, O., et al., Cloning of a novel bacteria-binding receptor structurally
related to scavenger receptors and expressed in a subset of macrophages. Cell,
1995. 80(4): p. 603-9.
Aichele, P., et al., Macrophages of the splenic marginal zone are essential for
trapping of blood-borne particulate antigen but dispensable for induction of
specific T cell responses. J Immunol, 2003. 171(3): p. 1148-55.
Backer, R., et al., Effective collaboration between marginal metallophilic
macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells.
Proc Natl Acad Sci U S A, 2010. 107(1): p. 216-21.
Kirby, A.C., et al., SIGNR1-negative red pulp macrophages protect against acute
streptococcal sepsis after Leishmania donovani-induced loss of marginal zone
macrophages. Am J Pathol, 2009. 175(3): p. 1107-15.
Beattie, L., et al., CD8+ T lymphocyte-mediated loss of marginal metallophilic
macrophages following infection with Plasmodium chabaudi chabaudi AS. J
Immunol, 2006. 177(4): p. 2518-26.
Bidegain, F., et al., Acute Plasmodium falciparum malaria following splenectomy
for suspected lymphoma in 2 patients. Clin Infect Dis, 2005. 40(11): p. e97-100.
Leoni, S., et al., The hyper-reactive malarial splenomegaly: a systematic review
of the literature. Malar J, 2015. 14: p. 185.
Urban, B.C., et al., Fatal Plasmodium falciparum malaria causes specific patterns
of splenic architectural disorganization. Infect Immun, 2005. 73(4): p. 1986-94.
Stevenson, M.M. and G. Kraal, Histological changes in the spleen and liver of
C57BL/6 and A/J mice during Plasmodium chabaudi AS infection. Exp Mol
Pathol, 1989. 51(1): p. 80-95.
Nagaoka, K., et al., Association of SIGNR1 with TLR4-MD-2 enhances signal
transduction by recognition of LPS in gram-negative bacteria. Int Immunol,
2005. 17(7): p. 827-36.
Bronte, V. and M.J. Pittet, The spleen in local and systemic regulation of
immunity. Immunity, 2013. 39(5): p. 806-18.
Delano, M.J., et al., Sepsis induces early alterations in innate immunity that
impact mortality to secondary infection. J Immunol, 2011. 186(1): p. 195-202.
Deniset, J.F., et al., Splenic Ly6G(high) mature and Ly6G(int) immature
neutrophils contribute to eradication of S. pneumoniae. J Exp Med, 2017. 214(5):
p. 1333-1350.
Ozarslan, N., J.F. Robinson, and S.L. Gaw, Circulating Monocytes, Tissue
Macrophages, and Malaria. J Trop Med, 2019. 2019: p. 3720838.
136

144.

145.

146.
147.

148.

149.

150.

151.

152.
153.

154.

155.
156.
157.

158.

159.

Olliaro, P., et al., Hematologic parameters in pediatric uncomplicated
Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg,
2011. 85(4): p. 619-25.
Teirlinck, A.C., et al., Plasmodium falciparum Infection of Human Volunteers
Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of
CD16 and CD1c Expression. Infect Immun, 2015. 83(9): p. 3732-9.
Ioannidis, L.J., C.Q. Nie, and D.S. Hansen, The role of chemokines in severe
malaria: more than meets the eye. Parasitology, 2014. 141(5): p. 602-13.
Chan, J.A., et al., Patterns of protective associations differ for antibodies to P.
falciparum-infected erythrocytes and merozoites in immunity against malaria in
children. Eur J Immunol, 2017. 47(12): p. 2124-2136.
Zhou, J., et al., CD14(hi)CD16+ monocytes phagocytose antibody-opsonised
Plasmodium falciparum infected erythrocytes more efficiently than other
monocyte subsets, and require CD16 and complement to do so. BMC Med, 2015.
13: p. 154.
McGilvray, I.D., et al., Nonopsonic monocyte/macrophage phagocytosis of
Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial
clearance. Blood, 2000. 96(9): p. 3231-40.
Sponaas, A.M., et al., Migrating monocytes recruited to the spleen play an
important role in control of blood stage malaria. Blood, 2009. 114(27): p. 552231.
Mandala, W.L., et al., Monocyte activation and cytokine production in Malawian
children presenting with P. falciparum malaria. Parasite Immunol, 2016. 38(5): p.
317-25.
Nunes, P., N. Demaurex, and M.C. Dinauer, Regulation of the NADPH oxidase
and associated ion fluxes during phagocytosis. Traffic, 2013. 14(11): p. 1118-31.
Brown, J.S., et al., The classical pathway is the dominant complement pathway
required for innate immunity to Streptococcus pneumoniae infection in mice. Proc
Natl Acad Sci U S A, 2002. 99(26): p. 16969-74.
Pitts, M.G., T.A. Combs, and S.E.F. D'Orazio, Neutrophils from Both Susceptible
and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes. Infect
Immun, 2018. 86(4).
Silver, K.L., et al., Complement driven innate immune response to malaria:
fuelling severe malarial diseases. Cell Microbiol, 2010. 12(8): p. 1036-45.
Aoshi, T., et al., The cellular niche of Listeria monocytogenes infection changes
rapidly in the spleen. Eur J Immunol, 2009. 39(2): p. 417-25.
Franken, L., et al., Splenic red pulp macrophages are intrinsically
superparamagnetic and contaminate magnetic cell isolates. Sci Rep, 2015. 5: p.
12940.
Nagelkerke, S.Q., et al., Red pulp macrophages in the human spleen are a distinct
cell population with a unique expression of Fc-gamma receptors. Blood Adv,
2018. 2(8): p. 941-953.
Mitchell, A.J., et al., Technical advance: autofluorescence as a tool for myeloid
cell analysis. J Leukoc Biol, 2010. 88(3): p. 597-603.

137

160.

161.

162.

163.

164.

165.

166.

167.
168.

169.

170.
171.

172.
173.

174.

175.

Nielsen, H., A. Kharazmi, and T.G. Theander, Suppression of blood monocyte
and neutrophil chemotaxis in acute human malaria. Parasite Immunol, 1986.
8(6): p. 541-50.
Dasari, P., et al., Digestive vacuole of Plasmodium falciparum released during
erythrocyte rupture dually activates complement and coagulation. Blood, 2012.
119(18): p. 4301-10.
Dasari, P., et al., Digestive vacuoles of Plasmodium falciparum are selectively
phagocytosed by and impair killing function of polymorphonuclear leukocytes.
Blood, 2011. 118(18): p. 4946-56.
Schwarzer, E., et al., Phagocytosis of the malarial pigment, hemozoin, impairs
expression of major histocompatibility complex class II antigen, CD54, and
CD11c in human monocytes. Infect Immun, 1998. 66(4): p. 1601-6.
Schwarzer, E. and P. Arese, Phagocytosis of malarial pigment hemozoin inhibits
NADPH-oxidase activity in human monocyte-derived macrophages. Biochim
Biophys Acta, 1996. 1316(3): p. 169-75.
Kim, C.C., et al., Splenic red pulp macrophages produce type I interferons as
early sentinels of malaria infection but are dispensable for control. PLoS One,
2012. 7(10): p. e48126.
Domon, H., et al., Neutrophil Elastase Subverts the Immune Response by
Cleaving Toll-Like Receptors and Cytokines in Pneumococcal Pneumonia. Front
Immunol, 2018. 9: p. 732.
Champagne, B., et al., Proteolytic cleavage of ICAM-1 by human neutrophil
elastase. J Immunol, 1998. 161(11): p. 6398-405.
Takem, E.N., A. Roca, and A. Cunnington, The association between malaria and
non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a
literature review. Malar J, 2014. 13: p. 400.
Mtove, G., et al., Invasive salmonellosis among children admitted to a rural
Tanzanian hospital and a comparison with previous studies. PLoS One, 2010.
5(2): p. e9244.
Hoffmann, O., et al., Interplay of pneumococcal hydrogen peroxide and hostderived nitric oxide. Infect Immun, 2006. 74(9): p. 5058-66.
Canvin, J.R., et al., The role of pneumolysin and autolysin in the pathology of
pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect
Dis, 1995. 172(1): p. 119-23.
Standish, A.J. and J.N. Weiser, Human neutrophils kill Streptococcus pneumoniae
via serine proteases. J Immunol, 2009. 183(4): p. 2602-9.
Schwarzer, E., et al., Impairment of macrophage functions after ingestion of
Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp
Med, 1992. 176(4): p. 1033-41.
Schwarzer, E., et al., Phagocytosis of malarial pigment haemozoin by human
monocytes: a confocal microscopy study. Parasitology, 2001. 123(Pt 2): p. 12531.
Witter, A.R., B.M. Okunnu, and R.E. Berg, The Essential Role of Neutrophils
during Infection with the Intracellular Bacterial Pathogen Listeria
monocytogenes. J Immunol, 2016. 197(5): p. 1557-65.

138

176.
177.

178.

179.

180.

181.

182.
183.
184.

185.
186.

187.

188.

189.
190.

191.

192.

Egan, T.J., Haemozoin formation. Mol Biochem Parasitol, 2008. 157(2): p. 12736.
Van den Steen, P.E., et al., Immunopathology and dexamethasone therapy in a
new model for malaria-associated acute respiratory distress syndrome. Am J
Respir Crit Care Med, 2010. 181(9): p. 957-68.
Eugenin, E.A., J.A. Martiney, and J.W. Berman, The malaria toxin hemozoin
induces apoptosis in human neurons and astrocytes: Potential role in the
pathogenesis of cerebral malaria. Brain Res, 2019. 1720: p. 146317.
Parroche, P., et al., Malaria hemozoin is immunologically inert but radically
enhances innate responses by presenting malaria DNA to Toll-like receptor 9.
Proc Natl Acad Sci U S A, 2007. 104(6): p. 1919-24.
Schwarzer, E., et al., Phagocytosis of P. falciparum malarial pigment hemozoin
by human monocytes inactivates monocyte protein kinase C. Biochim Biophys
Acta, 1993. 1181(1): p. 51-4.
Sherry, B.A., et al., Malaria-specific metabolite hemozoin mediates the release of
several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in
vitro, and altered thermoregulation in vivo. J Inflamm, 1995. 45(2): p. 85-96.
Giribaldi, G., et al., Involvement of inflammatory chemokines in survival of human
monocytes fed with malarial pigment. Infect Immun, 2010. 78(11): p. 4912-21.
Jani, D., et al., HDP-a novel heme detoxification protein from the malaria
parasite. PLoS Pathog, 2008. 4(4): p. e1000053.
Lin, J.W., et al., Replication of Plasmodium in reticulocytes can occur without
hemozoin formation, resulting in chloroquine resistance. J Exp Med, 2015.
212(6): p. 893-903.
Carney, C.K., et al., The basis of the immunomodulatory activity of malaria
pigment (hemozoin). J Biol Inorg Chem, 2006. 11(7): p. 917-29.
Schwarzer, E., et al., Malaria-parasitized erythrocytes and hemozoin
nonenzymatically generate large amounts of hydroxy fatty acids that inhibit
monocyte functions. Blood, 2003. 101(2): p. 722-8.
Ercoli, G., et al., Intracellular replication of Streptococcus pneumoniae inside
splenic macrophages serves as a reservoir for septicaemia. Nat Microbiol, 2018.
3(5): p. 600-610.
Long, T.T., et al., Influence of antimalarial treatment on acquisition of immunity
in Plasmodium berghei NK65 malaria. Clin Diagn Lab Immunol, 2002. 9(4): p.
933-4.
Fu, Y., et al., Comparative histopathology of mice infected with the 17XL and
17XNL strains of Plasmodium yoelii. J Parasitol, 2012. 98(2): p. 310-5.
Kaplan, E.L., T. Laxdal, and P.G. Quie, Studies of polymorphonuclear leukocytes
from patients with chronic granulomatous disease of childhood: bactericidal
capacity for streptococci. Pediatrics, 1968. 41(3): p. 591-9.
Barbuti, G., et al., Streptococcus pneumoniae modulates the respiratory burst
response in human neutrophils. FEMS Immunol Med Microbiol, 2010. 60(1): p.
57-62.
Segal, A.W., How neutrophils kill microbes. Annu Rev Immunol, 2005. 23: p.
197-223.

139

193.
194.
195.
196.

197.

198.
199.
200.

201.

202.

203.

204.

205.
206.

207.

Uriarte, S.M., et al., Granule exocytosis contributes to priming and activation of
the human neutrophil respiratory burst. J Immunol, 2011. 187(1): p. 391-400.
Miralda, I., et al., Human Neutrophil Granule Exocytosis in Response to
Mycobacterium smegmatis. Pathogens, 2020. 9(2).
Schneider, C., et al., IVIG regulates the survival of human but not mouse
neutrophils. Sci Rep, 2017. 7(1): p. 1296.
Sun, K., et al., Interleukin-12 promotes gamma interferon-dependent neutrophil
recruitment in the lung and improves protection against respiratory
Streptococcus pneumoniae infection. Infect Immun, 2007. 75(3): p. 1196-202.
Marriott, H.M., et al., Contrasting roles for reactive oxygen species and nitric
oxide in the innate response to pulmonary infection with Streptococcus
pneumoniae. Vaccine, 2007. 25(13): p. 2485-90.
Vethanayagam, R.R., et al., Role of NADPH oxidase versus neutrophil proteases
in antimicrobial host defense. PLoS One, 2011. 6(12): p. e28149.
Reeves, E.P., et al., Killing activity of neutrophils is mediated through activation
of proteases by K+ flux. Nature, 2002. 416(6878): p. 291-7.
Sercundes, M.K., et al., Targeting Neutrophils to Prevent Malaria-Associated
Acute Lung Injury/Acute Respiratory Distress Syndrome in Mice. PLoS Pathog,
2016. 12(12): p. e1006054.
Bandura, D.R., et al., Mass cytometry: technique for real time single cell
multitarget immunoassay based on inductively coupled plasma time-of-flight mass
spectrometry. Anal Chem, 2009. 81(16): p. 6813-22.
Bjornson, Z.B., G.P. Nolan, and W.J. Fantl, Single-cell mass cytometry for
analysis of immune system functional states. Curr Opin Immunol, 2013. 25(4): p.
484-94.
Facer, C.A., Direct Coombs antiglobulin reactions in Gambian children with
Plasmodium falciparum malaria. II. Specificity of erythrocyte-bound IgG. Clin
Exp Immunol, 1980. 39(2): p. 279-88.
Facer, C.A., R.S. Bray, and J. Brown, Direct Coombs antiglobulin reactions in
Gambian children with Plasmodium falciparum malaria. I. Incidence and class
specificity. Clin Exp Immunol, 1979. 35(1): p. 119-27.
Warren, J., et al., Increased susceptibility of C1q-deficient mice to Salmonella
enterica serovar Typhimurium infection. Infect Immun, 2002. 70(2): p. 551-7.
Hyams, C., et al., The Streptococcus pneumoniae capsule inhibits complement
activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun,
2010. 78(2): p. 704-15.
Frita, R., et al., Simple flow cytometric detection of haemozoin containing
leukocytes and erythrocytes for research on diagnosis, immunology and drug
sensitivity testing. Malar J, 2011. 10: p. 74.

140

APPENDICES
Terms, abbreviations, and definitions
Sp – Streptococcus pneumoniae aka Pneumococcus
Lm – Listeria monocytogenes
NTS – Non Typhoid Salmonella
Py – Plasmodium yoelii – rodent malaria
Pf – Plasmodium falciparum – causes most cases of human malaria
Hz – hemozoin – Plasmodium parasite biocrystal byproduct
Sepsis – bacterial infection in the blood
Bacteremia – bacterial infection in the blood
Hemolysis – lysis (bursting open) of red blood cells, like when parasites burst out. Kills
the cell
Parasitemia - % of red blood cells that are infected with the parasite
hyperparasitemia – high levels of parasitized red blood cells (over 5% in humans, over
20% in mice)
Colony forming units (CFU) – the unit that we use to measure amount of bacteria (1
CFU= ~1 single bacterium)
Neutrophil/polymorphonuclear cells (PMN) – fast acting innate immune cells. they
enter an infected tissue and gobble up bacteria and kill them quickly
Macrophages - more long term/always ready innate immune cells. Also gobble up and
kill bacteria, but not as quickly.
Flow cytometry – method for counting and characterizing cells. Uses lasers to detect
different things and can tell you what type of immune cell are in a sample, or how the
cells are functioning
HO-1 – Heme oxygenase-1: an enzyme produced after hemolysis, weakens some
immune cell functions
Sn PP – a molecule that inhibits HO-1 activity
IL-10 – an anti-inflammatory signal made by cells when the immune system is trying to
regulate or decrease potentially harmful levels of inflammation.
Anti-IL-10 antibody – an antibody treatment that blocks the activity of IL-10
Reactive oxygen species (ROS) – chemicals like hydrogen peroxide, free oxygen (O2)
produced by innate immune cells to kill bacteria
Opsonization – Molecules within the blood (serum) that can attach to pathogens and
label them for destruction. Immune cells can find opsonized bacteria easier and have a
more robust response against them
Serum – everything in the blood other than red blood cells(or other cells) and
coagulation factors.
PMA – A chemical that induces ROS production from immune cells when put into
culture
DCF – A chemical that fluoresces in the presence of ROS inside of cells. Used to
measure the amount of ROS a cell is producing.
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LAY AUDIENCE SUMMARY

My project is focused on understanding how malaria weakens immunity to
bacterial infections. I identified a parasite by-product that is capable of causing this
immune suppression. I also created and characterized the first model system of a
Plasmodium and Pneumococcus coinfection, a common and clinically important
coinfection in sub-Saharan Africa, and demonstrated that the Plasmodium infection
enhances the severity and mortality of pneumococcus. Finally, I identified immune cell
functions that are defective following malaria, one of which is caused directly by a
parasite byproduct.
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